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Summary 
Summary 
Synthetic biology is a young research field which aims at the design of artificial 
networks as well as the redesign of existing networks to obtain insight into 
complex biological relations. Since lately, synthetic approaches are used to 
interfere with mammalian networks. 
In this work, perturbation of the virus-induced IFN-β induction pathway was 
forced. For this purpose, synthetic cassettes were used. The interference was 
realized by exploiting natural, viral counteracting proteins. The viral proteins 
that were used in this work are the influenza A virus NS1 protein and the 
hepatitis C virus NS3/4A protein complex. The viral genes were fused to a tag to 
allow fluorescent ligand labeling of the proteins and besides, visualization on the 
single cell level. The respective fusion was expressed from a tetracycline-
dependent promoter within IFN-β reporter cells. These cells showed controlled 
regulation in response to the tetracycline derivative doxycycline and displayed 
graded induction on the single cell level. Both proteins were able to strongly 
interfere with IFN-β induction, whereas NS3/4A showed more pronounced 
effects already at low amounts of the protein. On the single cell level, this 
system allowed to correlate the virus-induced IFN-β expression course with the 
ectopically induced expression of the viral perturbators. The latter was clearly 
associated with an arrest of IFN-β signal increase. The results suggest that even 
an ongoing IFN-β induction can be interrupted by expression of NS1 and 
NS3/4A. This was confirmed by monitoring intracellular localization of tagged 
IRF-7 which translocates to the nucleus upon activation of the IFN-β induction 
pathway. Indeed, perturbation experiments showed that the relocation of 
activated IRF-7 into the cytosol occurred in direct temporal correlation to NS1 
induction. Importantly, the herein chosen viral proteins were highly specific in 
their action and were proven to have no impact on IFN-induced JAK/STAT 
signaling. In addition, any effect on the type I IFN post-transcriptional level 
could be excluded. Together, the results underline the benefit of synthetic 
expression modules/circuits to specifically perturb individual steps within 
complex regulatory cascades in a highly controlled way – a prerequisite to 
establish mathematical models towards systems biology based understanding. 
This work further provides first results on the realization of a complex, synthetic 
network. Cassettes for the establishment of a synthetic oscillatory expression 
circuit were stably integrated into mammalian cells. While final proof remains to 
be shown, the results highlight the requirements and challenges to realize such 
complex circuits in mammalian cells. 
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1 Introduction 
1.1 Synthetic biology approaches in mammalian cells 
Synthetic biology is a young research field addressing scientific problems by 
engineering systems. The main topics are the design of synthetic components or 
networks that do not exist in nature on the one hand and the rebuilding of 
existing systems on the other hand. Certainly, these methods contribute to 
solving complex problems in biological systems that are not understood, yet. 
Initial work in this field was performed in prokaryotes or Saccharomyces 
cerevisiae due to their accessible genome and easier handling in the case of 
genetic manipulation and cultivation. However, the recent progress in 
mammalian genetics and manipulation strategies as well as the development of a 
great number of mammalian transgene control networks within the past years 
enabled the use of mammalian models (reviewed in Tigges & Fussenegger, 
2009). Also, synthetic biology approaches can probably be used for drug 
discovery and pharmaceutical applications (reviewed in Neumann & Neumann-
Staubitz, 2010). Especially in the last two years, impressive approaches for 
complex synthetic networks could be demonstrated, even though they still lack 
stable integration into mammalian cells (Tigges et al, 2010; Tigges et al, 2009). 
A main goal addressed by synthetic biology is to gain information about the 
dynamics and mechanisms of biological systems ranging throughout the cellular 
hierarchy. Up to now, much is known about specific individual components and 
mechanisms within cellular networks, but it lacks knowledge on spatiotemporal 
dynamics and the interplay of these networks. 
Systems biology, on the other hand, contributes to the understanding of complex 
biological systems by converting biological facts (e.g. experimental data) into 
mathematical models. With such models, the simulation and prediction of the 
behavior of a distinct factor or system is possible as very recently demonstrated 
(Maiwald et al, 2010). Also, the behavior of synthetic circuits can be predicted, 
facilitating the work in the field of synthetic biology. Vice versa, quantitative 
and qualitative data for the construction of mathematical models can be 
provided by synthetic biology approaches. However, the modeling results still 
have to be verified by experimental procedures. Approaches like this are time-
consuming and demand strong collaborations between the respective scientists. 
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1.2 Cellular networks 
Within biological signaling networks, information processing is performed at 
intra- and extracellular stages. They are composed of many components like  
(co-) activators, enzymes or substrates which have specific functions and are 
organized in certain levels (reviewed by Scott & Pawson, 2009). The response 
of the cell to a certain signal can be multifaceted. Often, secondary cascades are 
induced, but anyway, at the end of the cascade(s), activation of gene expression, 
modification in the cellular metabolism, cell death or other alterations within the 
cell occur. 
Formerly, signal transduction was regarded as separate transmission of linear 
information, but this view has changed drastically. There is a tremendous variety 
of examples for crosstalk between signaling pathways that often have huge 
impact on cellular fate. For example, different receptors are able to induce the 
same signal transduction pathway and also the components are shared by 
multiple networks. This creates the possibility of a limited number of 
components to induce a variety of biological processes. The spatiotemporal 
organization of signaling networks certainly is of central importance for its 
outcome. 
1.3 Interfering with cellular networks for determining protein functions 
and dynamics 
Today, there is deep knowledge about the single components of many networks, 
but their spatiotemporal and dynamical interplay is hardly understood. For 
obtaining information about the “where-and-when” of signal transduction as 
well as connections between the networks and the discovery of key functions, 
perturbation of cellular pathways can be a good tool. Targeted interference with 
a cellular network allows the examination of an altered cellular phenotype. Up 
to date, there exist several methods to perturb cellular functions which all have 
assets and drawbacks. 
- Irreversible perturbation: Genetic knock-out 
 
- Reversible perturbation:  RNA interference (RNAi) 
Chemical perturbation 
Perturbation via synthetic constructs 
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The use of chemical agents can be efficient but is frequently unspecific due to 
possible down-regulation of related proteins. Furthermore, cell permeability and 
low toxicity is required which strongly reduces the choice of small compounds. 
Another technique is the creation of a genetic knock-out, which is time-
consuming and irreversible. Furthermore, the permanent deletion of a gene can 
have detrimental or even lethal effects on the cell or organism. Conditional 
knock-out strategies can overcome some of these problems. RNA interference 
allows targeted transcript deletion while a complete block usually cannot be 
achieved. All of these techniques lack true reversibility and the possibility of 
temporal regulation. 
Since recent studies in synthetic biology demonstrated successful results in 
mammalian cells, an interesting and demanding approach would be the usage of 
these tools to establish modules specifically perturbing signaling networks with 
biological molecules in a regulable and reversible manner. However, only minor 
data of related approaches are published. Few attempts for synthetic perturbation 
were demonstrated as it is the conditional immortalization (May et al, 2004). 
For synthetic perturbation, mammalian cells have to be repeatedly modified. 
Constructs need to be stably introduced into the cells to verify robustness, 
reliability and reproducibility of the system. Such constructs would harbor a 
factor that specifically interferes with the desired signaling process. Unspecific 
effects should be excluded. 
A further advantage is the usage of an inducible expression system in order to 
externally control the perturbation in a time- and dose-dependent manner. With 
such cells, temporal dynamics of a system could be determined in more detail in 
a predictable, reproducible and reversible manner. 
1.4 The tetracycline (Tet) responsive system 
Inducible expression systems are useful tools to control the level of a gene 
product of interest (GOI) within a mammalian cell. The most prominent among 
them is the Tet system (Gossen & Bujard, 1992). This system was developed 
from the Tn10-specific tetracycline-resistance operon of Escherichia Coli (E. 
Coli). It relies on the homodimerization of the Tet repressor (TetR; Postle et al, 
1984) and the binding to cognate tetracycline operator sequences (tetOs). 
Gossen and Bujard fused the tetR binding domain to the transactivating domain 
of Herpes Simplex Virus VP16 (Triezenberg et al, 1988). This fusion, namely 
tetracycline transactivator (tTA), can transactivate the synthetic promoter 
consisting of tetO repeats and a downstream minimal eukaryotic promoter. The 
first synthetic tetracycline-responsive promoter (Gossen & Bujard, 1992) 
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consisted of seven tetO repeats and a minimal Cytomegalovirus (CMV) 
promoter (PhCMV) (Boshart et al, 1985) devoid of its enhancer which is further on 
designated as PTet. Upon administration of the inducer tetracycline, the tTA 
undergoes a conformational change and dissociates from the promoter, leading 
to the arrest of gene expression (Tet-Off system). 
The originally described Tet system worked reliable and gave predictable 
expression for bulk assays. However, some drawbacks concerning regulation 
and leakiness of the promoter were connected with its use. 
The reverse tetracycline transactivator (rtTA) 
In the Tet-Off system, the constant presence of tetracycline is needed to keep 
synthetic gene expression silent. This is disadvantageous in long-term 
experiments, transgenic animals and for gene therapeutic approaches. 
Consequently, Gossen et al. (1995) designed a tetR domain with four amino acid 
exchanges, which exhibited reversed tetracycline dependence. The mutagenized 
tetR was fused to the HSV VP16 transactivating domain creating the so-called 
reverse tetracycline transactivator (rtTA). The rtTA exhibited binding to the tetO 
sequences only in the presence of tetracycline (Tet-On system, see fig. 1). This 
reverse transactivator led to strongest activation of gene induction upon 
administration of the tetracycline derivative doxycycline (Dox), which is 
nowadays commonly used. However, inducibility of this initial rtTA was 
inefficient, which led to the construction of improved versions like rtTA2(S)-M2 
(consecutively called rtTA2). This transactivator is more stable in eukaryotic 
cells, works at 10-fold lower doxycycline concentrations and shows a significant 
reduction in background activation of the respective promoter in the absence of 
doxycycline (Urlinger et al, 2000). Further improvements are reviewed by 
Berens and Hillen (2003). 
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Figure 1: Functionality of the Tet-On system. 
In the presence of doxycycline (Dox), rtTA dimerizes and associates with tetO sequences 
leading to the onset of downstream gene expression. In the absence of Dox, rtTA cannot 
dimerize or bind to the tetO repeats. 
Tetracycline-induced repression: the KRAB repressor 
Margolin et al. (1994) described that Krüppel-associated boxes (KRAB) can act 
as transcriptional repressors when fused to the DNA-binding domain of yeast 
Gal4 promoter. Fusion of tetR to the KRAB domain of the human Kox1 zinc 
finger motif led to the design of a tetracycline-dependent transcriptional 
suppressor, the KRAB repressor, (consecutively for simplicity called KRAB) for 
the use in eukaryotes (Deuschle et al, 1995). KRAB recognizes the operator 
sequences within the PTet and induces transcriptional repression of RNA 
polymerases I-III within the range of a few kilobases in the absence of 
doxycycline by an epigenetic silencing mechanism causing the induction of 
heterochromatin. Administration of doxycycline, in turn, enables the 
dissociation of the repressor from the tetO sites. Consequently, the TetR-KRAB 
fusion could be exploited for the repression of basal leakiness of the PTet. 
Since KRAB exhibits opposite binding capacities as the rtTA, it could be 
combined with the activation via the rtTA in one system. KRAB and rtTA could 
be provided with different DNA recognition and/or protein dimerization 
capabilities to overcome heterodimerization of the two compounds or 
competition for the same DNA binding sites (Forster et al, 1999). The KRAB 
repressor was improved for further silencing basal expression and for different 
ways to avoid heterodimerization of KRAB and the transactivator (Freundlieb et 
al, 1999; Hayakawa et al, 2006). 
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The Tet-dependent promoter 
In the initial Tet system, Gossen and Bujard designed a tetracycline-responsive 
promoter consisting of seven tetOs that were placed upstream of a minimal 
promoter (fig. 1). The arrangement of the promoter arised the idea to construct a 
bidirectional, tetracycline-dependent promoter (PbidiTet) which allows 
simultaneous expression of two GOIs (Baron et al, 1995). In this construct, 
heptamerized tetO sequences are flanked by two minimal promoters. 
An IFN-α stimulated response element (ISRE)-like element was discovered 
between the tetO repeats of PTet (Rang & Will, 2000). Consequently, improved 
variants of PTet were developed. One of these promoters, PTight from Clontech 
(2003), is purchasable and already commonly used. Other improvements to 
reduce leakiness of the promoter were e.g. performed by (Agha-Mohammadi et 
al, 2004; Loew et al, 2010; Pluta et al, 2005). 
1.5 The coumermycin (Cou) responsive system 
The mammalian expression Tet system is a well characterized and improved 
tool. However, in order to express two genes in one organism independent from 
each other, different systems are necessary. Up to date, there exist many of these 
systems exploiting e.g. light, temperature or steroid hormones. Those and further 
genetic switches have been reviewed by several groups (Aubel & Fussenegger, 
2010; Botezatu et al, submitted; Weber & Fussenegger, 2010). Indeed, the 
controlled expression by a second inducer would be easy to manage and 
therefore favored. Besides the Tet system there exist several other systems 
responding to antibiotic as a transcription inducer as e.g. macrolide- or 
streptogramin-responsive systems (Fussenegger et al, 2000; Weber et al, 2002). 
Another antibiotic-responsive system, the coumermycin (Cou) system was 
developed (Zhao et al, 2003). This system was already shown not to interfere 
with the Tet system (Kästner, 2007). In principal, this system works similar to 
the Tet system being composed of a transactivator and a corresponding 
promoter. The coumermycin transactivator (CouTA) is a chimeric protein built 
of the bacterial phage λ repressor-binding domain fused to the bacterial gyrase B 
subunit (GyrB) and the p65 activation domain of nuclear factor (NF)-κB. The 
coumermycin-responsive promoter (PCou) consists of 12 λ operator sequences 
located upstream of the PhCMV* minimal promoter. The addition of coumermycin 
induces dimerization of the transactivator which causes the binding of the phage 
λ repressor to the cognate λ operator sequences, thereby transactivating 
expression of the downstream gene. Administration of the coumermycin 
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antagonist novobiocin abolishes dimerization of the transactivator what leads to 
its dissociation from PCou, thereby interrupting gene expression. Basal 
expression levels by this system were already reduced by site-directed 
mutagenesis of the λ repressor-binding domain. Inductions of four orders of 
magnitude can be reached by this system (Zhao et al, 2003). 
1.6 Synthetic modules for the use in eukaryotic cells 
Synthetic biology aims at designing modules with the goal to resemble natural 
expression patterns. Even though pioneering work was performed in prokaryotes 
and lower eukaryotes, many approaches could be successfully transferred for the 
use in mammalian cells. Genetic switches serve as a platform for these 
approaches in eukaryotic cells (compare with chapter 1.5). 
It was shown that two different antibiotic-responsive switches, Pip-On and E-On 
(Fussenegger et al, 2000; Weber et al, 2002), can be combined to design an 
epigenetically controlled circuit (Kramer et al, 2004). The KRAB transrepressor 
is fused to the erythromycin or pristinamycin response regulators in this circuit. 
Thereby, it is directed to the respective responsive promoter and the two systems 
are able to repress each other‟s expression. Upon a transient dosage of the 
respective antibiotic, the binding of one of the fusions to the respective promoter 
is impaired and sustained expression of the second module can occur even in the 
presence of the transrepressor. A toggle-switch like phenotype can be obtained 
by this circuit. With this tool, long-term antibiotic administration to obtain 
desired expression levels can be circumvented. Also, a bimodal expression 
pattern could be realized by this constellation. 
Bimodal expression is a natural pattern occurring e.g. in the response of mouse 
embryonic stem cells to leukemia inhibitory factor (LIF) (Davey et al, 2007). By 
the usage of a positive feedback system, this pattern can be artificially induced. 
In the case of the Tet system, a construct harboring the rtTA and a reporter gene 
under control of PTet are induced via a feedback mechanism after administration 
of doxycycline (Kramer & Fussenegger, 2005; May et al, 2008). For this 
purpose, a bidirectional tetracycline-dependent promoter controlling the 
expression of rtTA and the gene of interest can also be exploited. Increasing 
concentrations of doxycycline rather affect the probability that a gene will be 
expressed than its expression strength. If expression is turned on, it shows 
reduced variability. 
The Tet system can also be used to generate graded gene expression by 
constitutive expression of rtTA while the GOI is expressed from PTet. Increasing 
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concentrations in this case lead to a continuous increase in the expression 
intensity of the GOI. 
Another naturally appearing expression pattern is the oscillation. This pattern 
appears e.g. for circadian clock genes (reviewed by Jolma et al, 2010). The work 
mechanism for this pattern is similar for these genes: it is based on a negative 
feedback loop after a time delay caused by the self-inhibition of the own gene 
product (reviewed by Van Gelder et al, 2003). Indeed, the design of an adequate 
system to mimic this expression pattern underlies a more complex composition 
than for graded or bimodal expression. 
The basic knowledge of oscillatory behavior was exploited to design diverse 
oscillating constructs. First works on complex multiple gene oscillators were 
also performed in bacteria or lower eukaryotes (Elowitz & Leibler, 2000). 
However, for mammalian cells, no stable oscillator could be introduced up to 
now. Indeed, a transient approach succeeded to obtain oscillations in single cells 
(Tigges et al, 2009). A synthetic low-frequency oscillator, which shows 
oscillation with a period of 26 h, was also introduced by Tigges et al. (2010). 
The current state of synthetic oscillator performance was reviewed (Purcell et al, 
2010). 
1.7 Viruses and type I IFNs 
As part of the innate immunity, the IFN system is one of the first host cell 
responses to intruding pathogens like viruses and is able to quickly induce a 
multitude of antiviral genes. Type I IFNs are directly induced in response to 
virus infection (early type I IFN genes) and in a response to early type I IFNs 
(late type I IFNs). 14 α genes as well as each one β, δ, ε, κ and ω gene belongs 
to the type I IFNs in mice (reviewed by Seo & Hahm, 2010). They can be 
produced from all nucleated cells, whereas plasmacytoid dendritic cells are often 
the major producers (reviewed by Barchet et al, 2005a; Barchet et al, 2005b). 
Today, recombinant interferon is used as a therapeutic for diverse diseases like 
multiple sclerosis, hepatitis C and some kinds of cancer. On the other hand, 
altered IFN induction can cause systemic autoimmune disorders like lupus 
erythematosus, rheumatoid arthritis or Sjögren‟s syndrome. Consequently, IFNs 
are of major interest for several clinical purposes. 
Type I IFNs are produced in response to pathogens like viruses and their 
products which are described as pathogen-associated molecular patterns 
(PAMPs). These PAMPs, e.g. viral nucleic acids, bind to specialized pattern 
recognition receptors (PRRs) which reside within the cell membrane or in the 
cytoplasm. PRRs can be divided in two groups: the transmembrane sensors 
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namely Toll-like receptors (TLRs) and the cytosolic sensors. The latter group is 
divided in two further groups: The RIG-I-like receptors (RLR) retinoic acid-
inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA-5) 
and laboratory of genetics and physiology (LGP-2) as well as the NOD-like 
receptors (NLR) (reviewed by Thompson & Locarnini, 2007). 
Recently, further intracellular DNA sensors DAI, IFI16 and Ku70 were 
discovered (Takaoka et al, 2007; Unterholzner et al, 2010; Zhang & Brann TW, 
2011). 
1.7.1 Virus-induced signaling via RLRs 
Specific PAMPs can be recognized by the host cell using currently discovered 
cytoplasmic sensor proteins of the RLR family. These ubiquitously expressed 
proteins have a helicase domain in common, but differ in their N- and C-termini. 
The prototypical member of the RLR family is the RIG-I protein which was 
originally identified as a gene induced in retinoic acid-treated cells (Sun, 1997). 
At the N-terminus, RIG-I contains two caspase recruitment domains (CARD), 
whereas the C-terminus exhibits repressor functions to keep RIG-I inactivated in 
the absence of the ligand inducer (Saito et al, 2007). The use of knock-out 
mouse models revealed that RIG-I is the major recognition receptor for RNA 
virus infection. It is specifically activated by 5‟ triphosphated ssRNA which 
contains partial dsRNA motifs. Such a structure occurs e.g. during influenza A 
virus (IAV) infection, also exposing a genomic panhandle RNA. Also, it 
responds to short fragments (~300 bp) of the dsRNA analogon poly I:C 
Furthermore, T7 in vitro transcripts and poly (rU) tract of HCV RNA are 
responsible for activating RIG-I (reviewed by Onoguchi et al, 2011). 
After recognition of an adequate substrate, RIG-I undergoes a conformational 
change leading to its activation and the exposure of CARD to interact with the 
mitochondrially anchored adaptor protein IFN-β promoter stimulator (IPS-1). 
This protein also contains a CARD domain leading to CARD-CARD association 
with RIG-I. The tripartite motif 25 (Trim25) E3 ubiquitin ligase was 
demonstrated to be essential for the ubiquitination of the RIG-CARDs (Gack et 
al, 2007). The translocase of outer membrane 70 (Tom70) interacts with IPS-1 
and causes the recruitment of downstream effectors of IFN-β induction, TBK1 
and the IFN regulatory factor (IRF) 3, to the mitochondria (Liu et al, 2010). At 
the surface of the mitochondria, around IPS-1, a number of further effectors 
accumulate like the ubiquitin ligase tumor necrosis factor (TNF)-receptor 
associated factor 3 (TRAF3) which activates Tank-binding kinase 1 (TBK1) and 
IκB kinase (IKK)-related kinase IKKε. These two kinases phosphorylate the 
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transcription factors IRF-3 and IRF-7 at distinct serine residues causing their 
homo- or heterodimerization. Subsequently, IRF-3/7 translocate to the nucleus 
(reviewed by Kumar et al, 2011; Onoguchi et al, 2011; Takeuchi & Akira, 2009; 
compare with fig. 2). 
Furthermore, IPS-1 initiates a second signaling targeting in NF-κB activation via 
the IKK complex (consisting of the kinases IKKα and IKKβ; compare with fig. 
2). 
Newcastle Disease Virus (NDV) is a potent inducer of type I IFN expression. As 
other viruses, it also exerts an IFN antagonistic effect by its V protein. However, 
MDA-5, but not RIG-I-mediated signaling is affected by this mechanism (Childs 
et al, 2007). For this reason, NDV is used as a model virus in this work. 
 
Figure 2: Early IFN induction and IFN-mediated signaling. 
Cytoplasmic viral dsRNA causes the activation of NF-κB and IRF-3. These proteins, together 
with other transcription factors, bind to the promoter region of early type I IFNs (see here 
IFN-β) and initiate their expression. The resulting IFN proteins are secreted from the cell and 
bind to their cognate receptor IFNAR in an auto- or paracrine manner. IFN stimulated genes 
(ISGs) are expressed as a result of JAK/STAT signaling. One of these ISGs, IRF-7, amplifies 
the IFN response by inducing several type I IFNs. SOCS and PIAS negatively regulate 
JAK/STAT signaling. Mx, ISG20, OAS and PKR are ISGs having antiviral activity (figure 
according to Haller et al, 2006). 
1.7.2. Virus-induced signaling via TLRs 
Another family of PRRs is the transmembrane sensors (TLRs). Those 
glycoproteins are encoded by 10 genes in humans and 12 genes in mice. They 
consist of extracellular leucin rich repeats which are necessary for ligand 
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binding and a cytoplasmic Toll/interleukin-1 receptor (TIR) which is 
indispensable for downstream signaling. 
From the family of TLRs, the receptors 3, 7/8 and 9 are located in intracellular, 
endosomal compartments and capable to induce type I IFNs (reviewed by 
Chaturvedi & Pierce, 2009). TLR3 is specialized for sensing dsRNA 
(Alexopoulou et al, 2001). Signaling occurs through the adaptor protein TRIF 
which activates the noncanonical IKK kinases TBK-1 and IKK-ε. Those cause 
the phosphorylation of IRF-3 and thereby its translocation to the nucleus. The 
IKK-α, β and γ kinases are also stimulated by TRIF leading to the 
phosphorylation of NF-κB and its translocation to the nucleus. TLR-7 and 8 
recognize ssRNA (Heil et al, 2004), whereas TLR-9 senses unmethylated 
cytosine phosphatidyl guanine (CpG) motifs (Hemmi et al, 2000). 
TLRs use the myeloid differentiation primary-response gene 88 (MyD88) as a 
signaling adaptor causing the activation of IRF-7 (reviewed by Honda & 
Taniguchi, 2006; Takeuchi & Akira, 2009; Thompson & Locarnini, 2007). 
1.7.3 The interferon regulatory factors 3 and 7 
The family of interferon regulatory factors consists of nine members 
contributing to immune response, cytokine signaling, cell cycle and growth as 
well as apoptosis, tumor suppression and hematopoietic development. They 
share high homology especially in the N-terminal DNA binding domain. This 
domain mediates binding to the interferon-stimulated response element (ISRE) 
within the promoter region of IFN-stimulated genes (ISGs). 
Of all the IRFs, IRF-3 and IRF-7 share the greatest homology and are directly 
associated with RIG-I-mediated signaling. Both factors are activated through 
phosphorylation of their C-terminal serine/threonine residues by TBK-1 or/and 
IKK-ε (Fitzgerald et al, 2003; Sharma et al, 2003). Also, they share similarities 
concerning dimerization and translocation (Hiscott, 2007; Lin et al, 1999; Marié 
et al, 2000). Indeed, they also exhibit distinct behavior caused by the C-terminus 
which is less conserved transmitting uniqueness to every IRF (reviewed by 
Servant et al, 2002). 
Since IRF-3 is constitutively expressed in all cell types, it is able to directly 
respond to virus infection and leads to the induction of early type I IFN genes 
(IFN-α4 and IFN-β). Meanwhile, IRF-7 is mainly induced by these secreted type 
I IFNs in most cell types (Sato et al, 1998). In lymphoid cells and some DC 
subsets, IRF-7 is constitutively expressed which causes high antiviral potential 
of these cell types. 
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Indeed, cytoplasmic IRF-7 molecules can also be activated by IKK-ε and TBK1 
kinases and induce the expression of type I IFNs differentially (Marié et al, 
1998). Despite the time delay in IRF-3 and IRF-7 presence, they also show 
specificities concerning type I IFN activation (Yeow et al, 2000). 
The existence of three promoter proximal IRF elements (B, C and D) within 
respective promoter regions of IFN-α genes was displayed (Civas et al, 2006). 
They show distinct preferences for IRF-3 and IRF-7 binding which leads to the 
differential activation of IFN-α genes by the two IRFs (reviewed by Hiscott, 
2007). 
1.7.4 The induction of early type I interferons 
Signaling of the RLR pathway ends up in the induction of early type I IFNs 
mediated by the specific binding of transcription factors to IFN-α4 and IFN-β 
promoter regions. Individual activity of these factors is not sufficient to induce 
efficient expression from these promoters. In order to verify proper expression 
of the desired gene, all factors that are necessary for efficient initiation, 
reinitiation and pursuing of expression are assembled in one enhanceosome. 
Engaged into this stable protein complex are ATF-2/c-Jun and the high mobility 
group protein (HMGI(Y)), NF-κB, IRF-3 and, if present, IRF-7. The 
enhanceosome promotes the recruitment of these activators and further co-
activators (CREB-binding proteins (CBP/p300)) as well as the RNAPII complex 
to the active site of transcription (Kim et al, 1998; Wathelet et al, 1998). 
Efficient (re-) initiation of transcription is promoted by these co-activators (Yie 
et al, 1999). Acetylation of HMG I(Y) by the co-activators leads to the 
termination of transcription (reviewed by Ford & Thanos, 2010; Vo & 
Goodman, 2001). 
1.7.5 The induction of interferon stimulated genes 
After efficient transcription and translation of the early IFNs α4 and β, the 
proteins are secreted from the cell. In an auto- or paracrine manner, they bind to 
their cognate receptor IFN-α receptor (IFNAR) which consists of the subunits 
IFNAR1 and 2 (Cutrone & Langer, 2001). IFNAR associated Janus kinases 
(JAK) JAK1 and TYK2 activate the signal transducer and activator of 
transcription (STAT) 1 and 2 by phosphorylation. Their activated forms build 
heterodimers which associate with IRF-9 building the IFN-stimulated gene 
factor 3 (ISGF-3) complex (Horvath et al, 1996; Levy et al, 1989; Martinez-
Moczygemba et al, 1997). In the nucleus, ISGF-3 recognizes the interferon 
stimulated response element (ISRE) within the promoter regions of ISGs by the 
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DNA-binding domain of IRF-9. STAT2 leads to the activation of gene 
transcription via its C-terminal transcriptional activation domain. ISGs comprise 
a group of more than 300 antiviral effectors such as the myxovirus-resistance 
protein (Mx) GTPase, RNA-dependent protein kinase (PKR), ribonuclease L 
(RNase L), oligo-adenylate synthetase (OAS) and IRF-7. 
Rapid onset and termination of JAK/STAT signaling is considered to be 
characteristic for JAK/STAT signaling (Schindler & Plumlee, 2008). In 
agreement with this, STATs are known to interact with several regulators. In the 
last years, the suppressors of cytokine signaling (SOCS) have been discovered 
and well characterized. Inhibition of IFN signaling was assigned to SOCS1 and 
SOCS3, both of them containing a kinase inhibitory region (KIR) which 
interacts with Janus kinase (Sasaki et al, 1999). SOCS-1 was also shown to 
directly interact with the IFNAR1 subunit (Fenner et al, 2006). 
Expression of the ISG IRF-7 is strongly induced upon JAK/STAT signaling. 
Synthesized IRF-7 proteins can be activated upon stimulation via virus-activated 
IKK kinases. After homo- or hetero-dimerization with IRF-3, they translocate to 
the nucleus and contribute to the induction of the second wave of IFNs, the late 
type I IFNs. 
Another important ISG is the Mx guanosine 5´triphosphatase (GTPase) which 
exerts essential influences in host immune response against various viruses, 
especially influenza A virus (Koerner et al, 2007). Mx genes (two in mice and 
humans) are present in most vertebrates and share high molecular weight. The 
importance of these genes became obvious when mice harboring a mutated Mx1 
gene were more susceptible to orthomyxovirus infection than those with the 
native Mx1 gene. Mx consists of three domains that are highly conserved in all 
species; an N-terminal GTPase domain, a linker domain and a GTPase effector 
domain at the C-terminus. Viral ligands are recognized by a central interacting 
domain and a C-terminal leucine zipper. By recognizing and detracting viral 
nucleocapsid proteins, Mx interferes with virus entry into the nucleus and the 
assembly of virus particles after replication (reviewed in Boo & Yang, 2010; 
Sadler & Williams, 2008). 
1.7.6 Dynamics of interferon induction 
Early and fast induction of type I IFNs after viral infection is essential for the 
clearance of a pathogen. As one of the first antiviral mechanisms, it needs to be 
tightly regulated at various levels. Indeed, many components are found to 
contribute to IFN induction and new factors are regularly identified. However, 
the discrete time points of the respective steps within the cascade as well as their 
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relation to each other are not well understood. Also, key functions and 
intracellular localization at various time points post infection are not fully 
discovered, yet. Consequently, only marginal information exists about the 
spatiotemporal dynamics of IFN induction.  
Despite the general lack of data, few publications could give at least indications 
suiting to this topic. Zawatzky et al (1985) postulated that only a couple of 
infected cells transcribe IFN-β mRNA. The topic recently gained interest due to 
modern experimental procedures and mathematical modeling. The alleles of the 
gene are unequally transcribed, what is proposed to occur from the complexity 
of the IFN-β enhanceosome (Hu et al, 2007). Indeed, the stochasticity of 
monoallelic expression was demonstrated to occur from interchromosomal 
association. Using a YFP knock-in mouse, Scheu et al. (2008) also demonstrated 
that only a fraction of cells responds to stimulation independent of the origin. 
They further displayed differential onset of IFN-β in varying cell types. In A549 
cells harboring a lentiviral construct on which eGFP is driven by the IFN-β 
promoter, the induction of a fraction of cells post infection with a variety of 
negative sense RNA viruses at a high multiplicity of infection (MOI) was 
demonstrated (Chen et al, 2010). However, MuV infection turned out to give 
high rates of IFN-β positive cells upon infection which increase overtime. IFN-β 
positive cells were displayed by a distinct population indicating an on- or off-
mechanism of IFN-β induction. 
Contradictory results concerning this point were obtained from U. Rand (2010), 
who demonstrated a great variety in IFN-β intensity following NDV infection or 
poly I:C transfection. He also demonstrated that successfully infected cells do 
not necessarily induce IFN-β production. 
1.8 Perturbation of the interferon system by pathogens 
The IFN system plays a major role in early recognition and counteraction of 
virus infection (McInerney & Karlsson Hedestam, 2009; Randall & Goodbourn, 
2008). It is an unspecific mechanism to quickly induce an antiviral state of the 
infected cell and neighboring cells. However, viruses co-evolved with the 
immune system and are able to evade the host immune response by diverse 
mechanisms encoded by the viral genome. Some of these mechanisms were 
shown to act on multiple levels and signaling pathways. Up to now, more than 
170 viral IFN antagonists were identified from 93 different virus strains. Every 
virus has evolved distinct strategies to interfere with the host immune response 
to allow the verification of replication and persistence within host cells, but 
some overall strategies arise regularly. 
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 Minimizing PAMP production (e.g. poxviruses, picornaviruses) 
 Sequestration/inactivation of host proteins/viral PAMPs (e.g. IAV 
NS1, Poxvirus E3L) 
 Interference with cellular gene expression (e.g. Bunyamwera NSs 
protein, foot-and-mouth-disease virus L proteinase) 
 Direct (proteolytic) cleavage of host proteins (e.g. HCV NS3/4A; 
Poliovirus 3C protein) 
 Recruitment of the host cell ubiquitin proteasome system to induce 
degradation of host targets (e.g. Rotavirus NS1, N proteases of 
classical swine fever) 
(reviewed by Haller et al, 2006; Haller & Weber, 2009; McInerney & Karlsson 
Hedestam, 2009; Randall & Goodbourn, 2008; Versteeg & García-Sastre, 2010) 
In the following chapters, the main antagonistic functions of two major viruses 
are described in detail with respect to their main IFN antagonist. 
1.9 Influenza A virus and its general perturbation mechanisms against 
the IFN response 
The influenza A virus, a member of the Orthomyxoviridae, is responsible for 
seasonal outbreaks of influenza, a disease which infects epithelial cells of the 
upper and lower respiratory tract. In the last century, three severe influenza 
pandemics occurred of which the Spanish flu from 1918 resulted in up to 40 
million deaths. Every year, 500 million of infections are estimated to occur, with 
250-500 thousand of deaths, mostly caused by seasonal influenza. 
The viral genes contain 3‟ and 5‟ non-translated regions (NTR) that are 
necessary for replication and the formation of the capsid. Importantly, in 
contrast to cellular transcripts, 5‟ ends of viral RNAs carry uncapped 
triphosphate groups that are recognized as foreign by the cellular IFN system, 
namely the RIG-I protein. Nevertheless, IAV is able to successfully infect host 
cells. This is caused by its IFN antagonistic functions supported by regularly 
occurring genetic drift. Recently, the protein PB1-F2, derived from an 
alternative open reading frame of IAV, was demonstrated to cause alteration in 
the cytokine response, but a concrete link to innate immunity has not yet been 
demonstrated. Indeed, the non-structural protein 1 (NS1) which was initially 
described to have regulatory functions on the viral life cycle, was shown to have 
multiple effects on the immune response caused by IAV infection. In the next 
chapter, NS1 will be introduced with a focus on its ability to interfere with type I 
IFN induction (further reviewed by Arias et al, 2009; Ehrhardt et al, 2010). 
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1.9.1 The influenza A virus non-structural protein 1 – evasion from the 
host immune system 
The non-structural protein 1 (NS1) shows strong IFN antagonistic functions and 
mutations within NS1 are related to the multifaceted pathogenicity of different 
IAV subtypes. Within cells, NS1 is highly expressed post infection. The protein 
comprises a length of 230 to 237 aa with strain-specific C-terminal truncations 
(Suarez & Perdue, 1998). It is composed of two major domains, the N-terminal 
RNA binding domain and the variable, C-terminal effector domain (fig. 3). 
Dimerization of the protein occurs via its RNA-binding domain in the absence 
and presence of a respective substrate (Nemeroff et al, 1995). Further, NS1 
possesses two nuclear localization signals (NLS; Greenspan et al, 1988). These 
signals mediate the nuclear import of NS1 via importin-α (Melén et al, 2007). 
The second NLS, which is located at the C-terminus of the protein, also 
functions as a nucleolar localization signal (NoLS) probably having an influence 
on pathogenicity of the respective IAV strain. 
 
Figure 3: Constitution of the IAV NS1 protein. 
The NS1 protein of IAV is composed of an N-terminal RNA-binding domain and an effector 
domain. The C-terminal tail has varying length between IAV subtypes. Detected nuclear 
localization signals (NLS), nucleolar localization signals (NoLS) and nuclear export signals 
(NES) as well as protein binding sites are indicated (figure according to Hale et al, 2008). 
Its strong IFN antagonistic effect became obvious when an IAV mutant lacking 
NS1 was determined for its virulence (García-Sastre et al, 1998). This mutant, 
designated delNS1, was attenuated in replication within Madin-Darby canine 
kidney (MDCK) cells. However, in IFN-deficient cells, delNS1 replication 
could be rescued. While NS1 was firstly proposed to have regulatory functions 
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in the viral life cycle, it was shown to additionally effectively act as an IFN 
antagonist on multiple cellular levels. 
The first discovered mechanism for evading the innate immune response was the 
sequestration of dsRNA by NS1. Previous dimerization of NS1 is essential for 
binding dsRNA (Wang et al, 1999). By this mechanism, dsRNA is withdrawn 
from recognition by PRRs (Lu et al, 1995). Also, the activation of PKR, which 
is able to exert antiviral effects, is prevented. The dsRNA-dependent 2'-5' oligo 
(A) synthetase (OAS) cannot activate RNaseL, which could exert antiviral 
activity (Min & Krug, 2006). However, the strength of the effect related to this 
mechanism is controversially discussed, since only minor levels of dsRNA are 
produced during the replication of negative-strand RNA viruses (Weber et al, 
2006). In influenza B virus, mutational deletion of the NS1 dsRNA binding 
domain revealed that IFN induction is only marginally influenced by this 
domain (Dauber et al, 2006). 
Besides RNA-dependent effects of NS1 on IFN induction, it was shown to 
interact with cellular proteins depriving them from their further action. NS1 was 
demonstrated to build a stable complex with RIG-I (Pichlmair et al, 2006). NS1 
was further identified to bind TRIM25, thereby inhibiting multimerization of 
TRIM25 and consequently RIG-I ubiquitination (Gack et al, 2009). In addition, 
an effect of avian influenza NS1 on JAK/STAT signaling could be demonstrated 
(Jia et al, 2010). Further, NS1 of some IAV strains exhibits regulatory functions 
on the posttranscriptional level leading to an alteration of host cell protein 
production (Chen et al, 1999; Nemeroff et al, 1998; Satterly et al, 2007). Since 
viral mRNAs are not modified by the 3‟ end processing factors, their 
polyadenylation is not affected. These and other functions of NS1 and other IAV 
proteins on the host cell metabolism are reviewed in Hale et al (2008). 
1.10 The hepatitis C virus 
The hepatitis C virus (HCV) is a member of the Flaviviridae (genus 
Hepaciviridae) and causes chronic liver disease. HCV has a positive-sense, 
ssRNA genome with a length of 9.6 kb encoding a single open reading frame 
(fig. 4). HCV replication, as for all +ssRNA viruses, occurs at intracellular 
membranes (Ahlquist et al, 2005). 
The polyprotein is co- and post-translationally processed by both, cellular and 
viral proteases. The host cell proteases cleave the polyprotein at the N-terminal 
region, whereas viral proteases NS2 and NS3 cleave in the middle and C-
terminal region (reviewed by Tang & Grisé, 2009). 
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Figure 4: Composition of the HCV genome. 
The HCV genome is transcribed as a single polyprotein that is co- and post-translationally 
processed by viral and cellular proteases. Within the polyprotein reside three structural 
proteins, one ion channel protein (N-terminus) and six non-structural proteins (C-terminus). 
The cleavage sites are denoted as follows. Filled arrowhead: signal peptide peptidase site; 
open arrowhead: signal peptidase sites; filled diamond: cleavage site for the NS2/3 protease; 
open diamond: cleavage sites for the NS3/4A protease (figure according to McLauchlan, 
2009). 
1.10.1 Counteraction of the host immune response by HCV – the non-
structural protein 3/4A complex 
The NS3 protein obtains two specific domains. A serine protease at the N-
terminus is responsible for cleaving the C-terminal proteins of the polyprotein 
(Grakoui et al, 1993). The co-factor NS4A is also required for the proteolytic 
activity of NS3 (Failla et al, 1994). The NS3 C-terminus contains a 
helicase/NTPase function for unwinding RNA-RNA substrates and was 
demonstrated to be involved in HCV particle assembly (Ma et al, 2008). The 
two NS3 domains are connected by a linker peptide. Both functions are 
necessary for HCV replication (Lam & Frick, 2006; reviewed by Tang & Grisé, 
2009). 
The protease activity of NS3 and its co-factor NS4A (consecutively named 
NS3/4A) are also exploited by the virus to interrupt IFN induction. This strong 
interference causes persistence of the virus within the host. Abrogation of IFN 
induction occurs via specific cleavage of cellular factors. The RIG-I pathway is 
disturbed by the cleavage of the mitochondrial adaptor protein IPS-1, thereby 
disrupting downstream signaling which is targeted in early IFN induction (Foy 
et al, 2005; Loo et al, 2006). It was further demonstrated that NS3/4A leads to 
proteolysis of the TLR-3 adaptor protein TIR-domain-containing adapter-
inducing IFN-β TRIF in HeLa cells (Li et al, 2005). However, data concerning 
this item are controversial as it could also be demonstrated that NS3/4A was not 
able to cleave TRIF in human hepatocytes, regardless of the tested HCV strain 
(Dansako et al, 2009; Dansako et al, 2007). 
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Controversial results were shown for the effect of NS3/4A on JAK/STAT 
signaling. While Cheng and co-workers (2006) could not display any effect of 
NS3/4A on IFN-induced signaling, Helbig et al. (2008) realized an inhibitory 
effect on STAT1 phosphorylation. 
All these heterogenous effects could be explained by cell type- and species-
specificity, since isolate-dependent variations within the NS3/4A sequence exist. 
1.11 Reporter genes for the detection of cellular components 
The activity of a promoter or the intracellular localization of a certain 
component can only be detected indirectly. Most accurately, this information is 
obtained from living cells that can display natural changes and dynamics. This 
needs non-invasive techniques, e.g. by expressing a reporter gene driven by the 
promoter of interest or by fusing fluorescent reporters to the GOI. For these 
purposes, reporters are used that are not naturally present in the cell it is 
transferred to, meaning that it is “ectopically” expressed. This gene should not 
interfere with the cellular machinery. 
A very common reporter for bulk assays is luciferase being the first non-isotopic 
reporter assay (De Wet et al, 1987). The luciferase gene of Photinus pyralis is 
integrated as a reporter and bioluminescence is measured quickly after 
administration of the substrate luciferine as well as ATP to the cell lysate. 
Measurement occurs via a luminometer. With a half-life of approximately 3 h in 
mammals, this reporter is very suitable for the measurement of protein dynamics 
(Thompson et al, 1991) in bulk assays. This assay is fast and cheap, but since 
luminescent reporters need a constant presence of their substrate, the use for 
microscopic experiments, especially time-lapse experiments, is limited. 
Other non-isotopic assays were developed for chloramphenicol acetyltransferase 
(CAT) or β-galactosidase (β-gal, reviewed by Kain & Ganguly, 2001). 
Fluorescent reporter genes are preferred for microscopic analyses, especially of 
living cells. The first fluorescent gene discovered was the green fluorescent 
protein (GFP) from Aquorea victoria (Shimomura et al, 1962). Further 
fluorescent proteins were discovered in different organisms and adapted to the 
respective purpose by modulating e.g. expression intensity, half-life or 
maturation time (reviewed by Lukyanov et al, 2010). 
In addition to the described fluorescence genes, tagging proteins or sequences 
were developed which can, as the fluorescent reporters, be fused to the GOI. 
Measurement can be performed after administration of a fluorescence ligand or 
dye that specifically associates with the tag. A recent, versatile tool is the 
HaloTag Interchangeable Technology (Promega). The HaloTag V7 (HTV7) can 
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be used as a reporter or reporter fusion and can sequence-specifically and 
irreversibly be stained. For this tag, different fluorescent ligands are available 
(green, blue, and red). 
However, a pitfall of all reporter genes in fusion with the GOI is the change in 
length and secondary structure. Interference with functionality of the protein of 
interest cannot be excluded and must be checked carefully. 
With the tool of a reporter gene, light can be shed on many cellular processes as 
well as activity and localization of components after integration into a host cell. 
Indeed, diverse opinions come up concerning the reliability of data in transient 
or stable expression experiments. By transient expression experiments many 
data can be gained within a short time period. However, the reliability and 
reproducibility of these experiments is questionable. For these reasons, stable 
integration of the GOI into the host cell genome is often preferred. Even though 
it is more time-consuming to obtain the desired cells, a selected, stable cell clone 
allows reproducibility and long-term storage. 
1.12 Reporter systems for interferon induction and signaling 
The integration of a promoter of interest into a new environment can alter 
certain characteristics like its activity or expression pattern due to the impact of 
neighboring regulatory elements like enhancers or silencers. Consequently, 
reporter expression may differ from the native GOI and between single clones 
harboring the same construct(s). To overcome this so-called “position effect”, 
bacterial artificial chromosomes (BACs) can be used. These BACs are large 
DNA constructs based on the F plasmid of E. coli and can have a size of 300 kb 
or more. The sequences can easily be manipulated by homologous 
recombination. Since genome analysis is nowadays performed in BACs, a large 
variety of them exists and is commonly used. 
Research of promoter activities can be performed precisely by these tools, since 
the promoter of interest can be provided within its natural surroundings. In the 
following, murine NIH3T3 fibroblasts were used that stably express the 
respective BAC. NIH3T3 cells exert beneficial properties as low differentiation 
rate and the presence of numerous signal transduction pathways which can be 
investigated. Another important aspect is the ability of stable integration and 
expression of transgenes within these cells. 
For this work, it was necessary to perturb native IFN expression to obtain 
reliable data on the dynamics of the IFN system and to determine perturbator 
functions. U. Rand (2010) provided NIH3T3 cells stably harboring a BAC of 
originally ~ 280 kb of the natural murine locus of IFN-β. The IFN-β locus was 
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replaced by the fast maturing TurboGFP (Evrogen), which is a fluorescent 
protein based on CopGFP from the copepod Pontellina plumata. After induction 
of the IFN cascade, these cells, consecutively called IFN-β TurboGFP, display 
asynchronous onset of IFN-β and exert stochastic behavior concerning i) the 
decision whether IFN-β will be expressed, ii) the starting time of expression and 
iii) the strength and duration of expression. 
Two different kinds of reporter cells were used for the determination of the IFN 
response. These cells harbor a BAC derived from the murine genome that 
contains the ISG Mx2 locus. In this locus, the gene encoding Mx2 was replaced 
by either the reporter gene luciferase (Mx2Luc) or by the tandem dimer tomato 
(tdTomato, Mx2Tom). The cells exhibit high inducibility of the Mx2 promoter 
driven reporter upon induction by various stimuli (Pulverer, 2008; Pulverer et al, 
2010). 
1.13 Single cell analyses of fluorescently labeled cells 
For many years, bulk assays were performed to study promoter activities or 
protein function. However, today many methods for single-cell analyses are 
established. They give much more insight into the respective function since 
results are no longer mean values of a population of cells. Some of these 
analyses are reviewed by Lindström and Andersson-Svahn (2010). 
Using fluorescence reporter genes, an effective method to gain data of numerous 
single microscopic particles like cells is flow cytometry. Here, fluorescence, size 
and granularity of a high number of individual cells can be analyzed at a certain 
time point. Indeed, these cells cannot be followed over time. This can be 
performed using time-lapse microscopy. Here, repeated imaging of a previous 
selected area of cells can be done for various fluorescence colors. At the end of 
the measurement, single cells can be analyzed for the function of the 
fluorescently labeled factor. 
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2 Aims of this work 
So far, synthetic biology approaches have been mainly followed in bacterial 
systems or lower eukaryotes. While a number of different synthetic modules 
have been established also for mammalian cells, they were not yet employed to 
elucidate a cellular network in a time-resolved manner. 
The aim of this work was to employ synthetic expression modules for the 
controlled perturbation of a complex mammalian network. As a model network, 
the antiviral IFN cascade, i.e. RIG-I-mediated IFN-β induction, should be 
addressed. For this particular pathway, only marginal data concerning its 
spatiotemporal dynamics exist. Perturbation of this network should occur via 
exploitation of antagonistic viral mechanisms to evade this immune pathway. In 
particular, it was of interest to dissect the dynamics of individual 
perturbator/host interplay and inhibition kinetics. For monitoring the 
perturbation, the viral genes should be expressed in reporter cells that allow the 
visualization of IFN-β, thereby enabling monitoring on the single cell level. 
Onset and termination of perturbator expression should be mediated by 
transcriptional regulation which is externally adjustable by the administration or 
withdrawal of doxycycline (Tet system). Tight regulation of the expression level 
should be achieved by the dose- or time-dependent administration of the 
inducer. Furthermore, expression levels, and consequently perturbation levels, 
should be predictable and reproducible even on the single cell level. The data 
should further give information about the efficiency and properties of the 
perturbators. 
In addition, the results of this work should contribute to the establishment of a 
mathematical model of IFN-β induction. This model can be used to further 
characterize the network in a way that cannot or hardly be performed by 
laboratory work. 
Finally, this work also aimed at designing a synthetic network for stable 
oscillation in mammalian cells by means of synthetic regulatory modules. By 
directed interaction of these systems, oscillatory onset and termination of protein 
production should be monitored on the single cell level. 
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3 Results 
The aim of this work was to develop cells that allow the controlled perturbation 
of a cellular network by means of synthetic cassettes. The IFN network served 
as a model network. 
The strategy was to use synthetic cassettes that harbor a viral perturbator under 
the control of a tetracycline-dependent promoter. Viral genes (IAV NS1 and 
HCV NS3/4A) that are known to specifically interfere with the IFN network 
should represent different modes of action. It was intended to integrate these 
constructs into reporter cells that allow the visualization of IFN-β in the case of 
IFN induction or Mx2 as the outcome of JAK/STAT signaling. 
By means of controlled perturbator expression, the response of the respective 
pathway should be altered and give rise to the spatiotemporal dynamics of the 
network. 
3.1 Design of the perturbator constructs 
The first challenge was to design vector constructs which harbor the respective 
components necessary for controlled expression of the perturbator. The Tet 
system was exploited to obtain graded expression of the perturbator. High 
induction levels and low basal expression of NS1 and NS3/4A are necessary for 
a tightly regulable system. For this purpose, reporter cells need to be stably 
transfected with two constructs. The one harbors the constitutively expressed 
rtTA2 and the other one PTet driving the expression of the respective perturbator 
(fig. 5). In order to enable detection of NS1 and NS3/4A, they were c-terminally 
fused to HTV7 (see chapter 1.11 of introduction). These fusions are further on 
called NS1-H and NS3/4A-H. A specific ligand can persistently bind to HTV7, 
various fluorescent dyes coupled to the ligand are available (e.g. Oregon Green 
(green fluorescence) or Coumarin ligand (blue fluorescence)). Since IFN-β 
TurboGFP reporter cells (see chapter 1.12 of introduction) exhibit green 
fluorescence, a ligand emitting red fluorescent light (tetramethyl rhodamine = 
TMR) was used to discriminate NS1-H or NS3/4A-H expression in the 
following experiments. 
The functionality in expressing the fusion protein of the perturbator and HTV7 
was determined by flow cytometry analysis after transient transfection into 
NIH3T3 cells (data not shown). Sustained inducibility of the fusions was 
obtained for stable clones. 
Results 
24 
 
 
 
Figure 5: Vectors permitting regulated expression of viral IFN-counteractors. 
A: PTet drives the expression of the NS1-H fusion. B: PTet drives the expression of the 
NS3/4A-H fusion. C: The constitutively active Cytomegalo Virus (CMV) promoter drives the 
expression of rtTA2. The resistance gene is driven by an internal ribosomal entry site (IRES) 
or the constitutively active phosphoglycerate kinase (PGK) promoter. In all cases, an SV40 
polyadenylation signal (polyA) promotes efficient polyadenylation. For later experiments in 
this work, an improved tetracycline-dependent promoter (PTight, Clontech) was used to lower 
basal expression. Either constructs 1A and 1C or 1B and 1C were stably introduced into the 
reporter cells by co-transfection. If transfection occurred in two steps, constructs which each 
harbor selection markers were used. 
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3.2 Reporter cells for monitoring IFN-β and simultaneous IAV NS1-H or 
HCV NS3/4A-H expression 
The induction of NS1-H or NS3/4A-H within the IFN-β TurboGFP reporter 
cells should lead to an alteration in the outcome, namely IFN-β expression, of 
this signaling. To measure the alteration of the signaling in single cells, IFN-β 
expression is visualized by TurboGFP which was integrated into the IFN-β 
coding region of a BAC that was stably transferred to NIH3T3 cells. Authentic 
expression of IFN-β was previously confirmed, and a stochastic expression 
pattern could be observed (Rand, 2010; compare also with figure 6 and chapter 
1.12 of the introduction). 
3.2.1 The IFN-β TurboGFP reporter cells are suitable for the integration of 
doxycycline-controlled genes 
Since expression of NS1-H and NS3/4A-H should be visualized by exploiting 
red fluorescence in the following experiments, it was important to initially show 
that the expression of IFN-β TurboGFP does not lead to undesired fluorescence 
in the channel reserved for the perturbator. Also, an influence of the perturbator 
inducer doxycycline on IFN-β TurboGFP expression and intensity should be 
excluded. 
The cells were exposed to NDV for signaling induction to see whether an effect 
on red fluorescence occurs. Furthermore, IFN-β TurboGFP reporter cells were 
treated with doxycycline and compared to non-treated cells to see a potential 
effect of doxycycline on IFN-β TurboGFP expression or mean intensity. 
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Figure 6: Influence of doxycycline on IFN-β TurboGFP expression. 
IFN-β TurboGFP cells were either infected with 80 hemagglutinating units per milliliter 
(HAU/ml) NDV for 1 h or left uninfected. Cells were measured for the amount of TurboGFP 
positive cells after 24 h by flow cytometry. A: Density dot plots (red > blue) show fractions of 
IFN-β TurboGFP expressing cells (lower right gate) and cells with unaltered fluorescence 
(lower left gate). Strongly IFN-β TurboGFP expressing cells could not be compensated and 
therefore a low amount appears in the upper right gate. B: Mean intensity of IFN-β TurboGFP 
positive cells. The data shown represent average values +/- standard deviation of 3 
experiments. 
0
10
20
30
40
50
60
70
80
- Dox + Dox
m
ea
n
 i
n
te
n
si
ty
 o
f 
T
u
rb
o
G
F
P
p
o
si
ti
v
e 
ce
ll
s 
[a
.u
.]
- NDV
+ NDV
Results 
27 
 
In the absence of doxycycline, no fluorescence could be detected in uninfected 
cells. For the infected cells, proper expression of 39 % of IFN-β TurboGFP 
positive cells could be visualized in the lower right gate after compensation (fig. 
6A). For technical reasons, very high GFP expressing cells could not be fully 
compensated anymore and appear in the upper right quadrant (0.37%). This has 
to be taken into account also for later flow cytometry results. Importantly, no 
signal occurs in the channel displaying red fluorescence, which could thus be 
used for the visualization of the perturbators NS1-H and NS3/4A-H in the 
following experiments. 
The expression intensity of IFN-β TurboGFP is low in the absence and presence 
of doxycycline and without NDV infection (fig. 6B). After infection, intensities 
increased up to 70 a.u.. 
These results indicate proper and comparable expression of IFN-β TurboGFP in 
the absence and in the presence of doxycycline and demonstrate that no red 
fluorescence occurs under these conditions. 
3.2.2 Selection and characterization of IFN-β TurboGFP reporter cells 
harboring the perturbator constructs 
The IFN-β TurboGFP cells were shown not to exhibit undesired alteration in 
response to doxycycline or in the red fluorescence channel. The following 
chapters show the establishment of cells concomitantly harboring the IFN-β 
TurboGFP BAC and the vectors for controlled expression of the perturbators. 
3.2.2.1 Regulated expression of NS1-H in IFN-β TurboGFP cells 
After introduction of the respective constructs into IFN-β TurboGFP cells, 
regulation of NS1-H in stable clones was determined. Populations of the 
selected clones were cultivated either in the presence or in the absence of 
doxycycline and measured for NS1-H basal expression and inducibility. The 
three best regulated out of 15 measured clones are given in figure 7. 
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Figure 7: Regulated expression of NS1-H in IFN-β TurboGFP cells. 
Cell clones generated upon stable transduction of doxycycline-controlled NS1-H cassettes 
into IFN-β TurboGFP cells were either treated with 2 µg/ml doxycycline for 3 days (d) or left 
untreated and stained with TMR ligand. NS1-H expression (TMR) was detected by flow 
cytometry. Results are shown as density dot plots (red > blue) which show NS1-H expressing 
cells (lower right quadrant) and cells with unaltered fluorescence (lower left quadrant). 
The 3 clones show inducibility upon doxycycline treatment, but they differ in 
basal and maximal expression. These alterations in the expression pattern can be 
explained by random integration of NS1-H and the rtTA2 construct which may 
underlie position effects (chapter 1.12 of introduction). 
Clone 13 shows lowest basal expression of the 3 displayed clones. Concerning 
the induced state, clone 7 exhibits a broad pattern of NS1-H positive cells, 
whereas clones 13 and 14 show more distinct populations. Maximal NS1-H 
expression is comparable for clones 7 and 14, but slightly higher in the case of 
clone 13. Since clone 13 exhibits lowest basal expression, highest maximal 
expression and therefore best regulation, it was used for further experiments. 
These cells are consecutively termed IFN-β NS1-H. 
3.2.2.2 NS1-H is independently regulable from IFN-β TurboGFP 
Since cross-reaction of IFN-β TurboGFP and the doxycycline-dependent NS1-H 
module could result in misleading results, the cells were characterized 
concerning this property. In 3.2.1, it was clearly demonstrated that doxycycline 
has no influence on IFN-β TurboGFP, but clarification is needed for the effect of 
TMR-stained NS1-H on green fluorescence, where IFN-β TurboGFP occurs if 
induced. As can be seen in figure 8, the uninduced IFN-β NS1-H population 
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(lower left quadrant) is comparable to the IFN-β TurboGFP population, 
indicating no or low leaky expression of NS1-H in the uninduced state. Full 
induction of NS1-H can be demonstrated upon doxycycline treatment. It does 
not exert any alteration in IFN-β expression. 
 
 
Figure 8: Influence of NS1-H induction on IFN-β TurboGFP expression. 
IFN-β NS1-H cells were treated with 2 µg/ml doxycycline for 3 d or left untreated and were 
stained with TMR ligand. Cells were measured for the amount of NS1-H (TMR) positive cells 
by flow cytometry. Density dot plots (red > blue) show NS1-H expressing cells (upper left 
gate) and cells with unaltered fluorescence (lower left gate). 
 
3.2.2.3 IFN-β NS1-H cells show phenotypic alteration to untransfected 
cells 
The previous analyses showed no cross-reaction between the modules. As NS1 
is an IFN-β antagonist, basal NS1-H levels in the absence of the inducer 
doxycycline could cause alteration in IFN-β TurboGFP expression compared to 
untransfected cells, indeed. To investigate whether undetectable basal activation 
of NS1-H in the uninduced state would affect the amount or the intensity of 
IFN-β TurboGFP, the values of untransfected cells were directly compared to 
the values of IFN-β NS1-H cells. 
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Figure 9: Virus-induced IFN-β TurboGFP expression in uninduced IFN-β NS1-H cells. 
IFN-β TurboGFP cells, with or without stably integrated NS1-H, were seeded at equal 
densities and either infected with 80 HAU/ml NDV for 1 h or left uninfected. Cells were 
measured for the amount of TurboGFP positive cells after 24 h by flow cytometry. A: Density 
dot plots (red > blue) show fractions of IFN-β TurboGFP expressing cells (lower right gate) 
and cells with unaltered fluorescence (lower left gate). Some cells that highly express IFN-β 
TurboGFP could not be fully compensated and appear in the upper right gate. B: Mean 
intensity of IFN-β TurboGFP positive cells. The data shown represent average values +/- 
standard deviation of 3 experiments. 
As shown in figure 9, the total number of IFN-β TurboGFP expressing cells 
differs in the two cell populations. While in the case of untransfected cells, 32 % 
are positive for TurboGFP after NDV infection, only 17 % show green 
fluorescence in the cells harboring also NS1-H (fig. 9A). A similar picture could 
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be demonstrated for the mean intensity of TurboGFP fluorescence which drops 
to ~50% compared to untransfected cells (fig. 9B). A possible reason is basal 
expression of NS1-H in the absence of the inducer which could exert an 
inhibitory effect on IFN-β TurboGFP expression levels. However, this NS1-H 
expression is below the detection threshold of the flow cytometric device 
(compare with figs. 7 and 8). Taken together, IFN-β NS1-H cells show alteration 
in the amount as well as in the intensity of IFN-β TurboGFP positive cells. 
While this impairs a direct comparison between these cells, IFN-β NS1-H cells 
still provide substantial inducible expression of IFN-β TurboGFP and thus can 
be used for the perturbation of IFN-β induction. 
3.2.2.4 Ectopically controlled NS1-H expression reflects NS1 levels 
during early influenza A virus infection 
Ectopic expression of a gene is usually performed to gain information about a 
genes‟ function. In this work, the NS1 gene from influenza A/PR/8/34 strain 
(PR8) is ectopically expressed in a regulable manner with the primary aim to 
specifically perturb the IFN system. In addition, the results can give new 
insights into the work mechanism of NS1-H. The fact that NS1-H can be 
controlled by simply administering doxycycline to the medium makes it easy to 
adjust the level of intracellular NS1-H levels. Thus, perturbation of IFN-β 
TurboGFP can be controlled. However, it is unclear in how far the ectopically 
controlled NS1-H expression levels reflect those of NS1 obtained during natural 
IAV infection. IFN-β NS1-H cells were treated with increasing concentrations 
of doxycycline for a constant time period or with saturating doxycycline 
concentrations for differing periods of time. In parallel, untransfected IFN-β 
TurboGFP cells were infected with the IAV PR8 strain at different multiplicities 
of infection (MOI). Immunoblotting was performed to compare NS1 values of 
ectopic versus natural expression. 
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Figure 10: Ectopically induced versus native NS1 levels. 
IFN-β NS1-H cells were treated with doxycycline at the indicated concentrations for 3 d or 
with 2 µg/ml for the indicated time periods and subsequently harvested. IFN-β TurboGFP 
cells were infected with IAV PR8 for 1 h at an MOI of 1 or 5 and harvested at the indicated 
time points. Whole cell extracts were prepared and equal amounts of protein were loaded on a 
gel for SDS-PAGE and subsequently transferred to a membrane. The membrane was treated 
with an anti-NS1 antibody. After stripping of the membrane, it was treated with an actin-
specific antibody. A prestained molecular weight marker is loaded on the left and on the right. 
The amino acid sequences of ectopically inducible NS1-H and NS1 from viral infection differ 
in one amino acid (L->E) at position 55. The molecular weight of NS1 is about 26 to 32 kDa 
pursuant to Santa Cruz Biotechnology. The calculated molecular weight of NS1-H is 61.8 
kDa (Vector NTI). A: Western Blot; B: Quantification of the NS1 values (performed with 
Quantity One program). 
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Western Blotting shows distinct bands of NS1-H for the whole cell extracts from 
ectopically NS1-H expressing cells and for the extracts of cells infected with 
IAV PR8 (fig. 10A). The fusion of ectopically induced NS1 and HTV7 results in 
higher molecular weight than NS1 from IAV infection. 
The quantification of the Western Blot (fig. 10B) shows that ectopically 
controlled NS1-H levels increase with doxycycline concentrations and over 
time, as expected. The amount of native IAV NS1 increases until 12 h pi (MOI 
5) or 24 h pi (MOI 1). The level of NS1 does not strongly differ between cells 
infected with an MOI of 1 and an MOI of 5. It is not clear, whether the amount 
of infectious particles per cell has an impact on viral replication. 
The Western Blot and the quantification show that physiological levels of early 
influenza infection (3 - 6 h pi) can be mimicked by controlled ectopic expression 
of NS1-H. This underlines the validity of the synthetic NS1-based perturbation 
model. 
3.2.3 Reporter cells for monitoring IFN-β perturbation by hepatitis C virus 
NS3 protease/NS4A cofactor complex 
The IAV NS1 protein is said to inhibit IFN-β induction as well as IFN-induced 
antiviral effectors by diverse pre- and post-transcriptional mechanisms as well as 
sequestration of dsRNA. Also, interference with viral ssRNAs possessing 5‟ 
triphosphate groups was demonstrated (reviewed by Ehrhardt et al, 2010). 
However, some antagonistic functions of NS1 are virus strain specific (Hayman 
et al, 2006; Kochs et al, 2007). Another IFN antagonist, the non-structural 
protein 3 and its cofactor 4A from hepatitis C virus, follows a different and more 
specific way of perturbation. The virus-own protease NS3, whose activity is 
enhanced by binding its cofactor NS4A, leads to the specific cleavage of IPS-1 
in vitro and in vivo (Loo et al, 2006). This proteolytic reaction makes the IFN 
cascade lack a factor indispensable for the signaling. 
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3.2.3.1 Stable expression of NS3/4A-H renders cells unable to induce 
IFN-β following viral infection 
The mechanism of NS3/4A perturbation is different from NS1 and specifically 
relies on the cleavage of IPS-1. Thus, it was also chosen for perturbation 
experiments, as it will give additional information on the IFN system‟s 
dynamics. For this purpose, HCV NS3/4A genes from JFH-1 strain were set 
under the control of a tetracycline-inducible promoter and integrated into IFN-β 
TurboGFP reporter cells. After co-transfection of the cells with this construct 
and the constitutively expressed rtTA2, isolated clones did not show stable 
induction, but lost perturbator inducibility over longer cultivation periods (data 
not shown). One of these clones was subjected to single cell sorting. Resulting 
clones were expanded and basal expression as well as inducibility was 
determined. 
Figure 11: Basal expression and inducibility 
of stably integrated NS3/4A-H in IFN-β 
TurboGFP cells. 
IFN-β NS3/4A-H cells were treated with 2 
µg/ml doxycycline for 3 d or left untreated and 
stained with TMR ligand. Cells were measured 
for the amount of NS3/4A-H (TMR) positive 
cells by flow cytometry. The histogram shows 
basal expression and inducibility of IFN-β 
NS3/4A-H cells compared to untransfected 
cells. 
 
All resulting clones showed comparably high basal expression of NS3/4A-H and 
were inducible upon doxycycline treatment. The clone displaying lowest basal 
expression (fig. 11) was chosen for further analyses. These cells were termed 
IFN-β NS3/4A-H. In order to determine the level of IFN-β TurboGFP 
inducibility of these cells, it was compared to untransfected cells after viral 
infection. 
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Figure 12: Inducibility of IFN-β in absence of NS3/4A-H induction. 
IFN-β TurboGFP cells with or without NS3/4A-H were infected with 80 HAU/ml NDV for 1 
h. Cells were measured for the amount of TurboGFP positive cells after 24 h by flow 
cytometry. Results are displayed as density dot plots (red > blue). IFN-β TurboGFP 
expressing cells are gated in the lower right quadrant and cells with unaltered fluorescence are 
gated in the lower left quadrant. 
Figure 12 shows that untransfected IFN-β TurboGFP cells that were infected 
with NDV show proper induction of IFN-β TurboGFP, whereas IFN-β NS3/4A-
H cells resemble the uninfected control. This could have several reasons. On the 
one hand, it could be possible that – for unknown reasons – introduction of 
NS3/4A-H leads to an alteration of cellular mechanisms that renders the cell no 
longer responsive to NDV and unable to induce IFN-β TurboGFP. On the other 
hand, NS3/4A-H could be such a potent IFN antagonist that already basal 
expression is sufficient to totally block IFN-β induction. To verify this, a 
plasmid with the constitutively active IRF-3 5D (Lin et al, 1998) was transiently 
transfected to the IFN-β NS3/4A-H cells. IRF-3 5D is a mutant that carries 
phosphomimetic aspartic acid substitutions in its C-terminal domain rendering it 
independent of activational phosphorylation. Thus, it can translocate into the 
nucleus independent of the IFN-β induction cascade, thereby efficiently 
inducing IFN-β expression. Figure 13 displays that upon transient transfection 
with the vector harboring IRF-3 5D, IFN-β NS3/4A-H cells were competent to 
express IFN-β TurboGFP. Thus, the block of the IFN-β induction cascade is 
caused by high basal expression of NS3/4A-H. This reveals that NS3/4A in fact 
seems to be a potent inhibitor of IFN-β induction. 
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Figure 13: Response of IFN-β NS3/4A-H 
cells to constitutively active IRF-3 5D. 
IFN-β NS3/4A-H cells were transiently 
transfected with a plasmid harboring IRF-3 
5D or were left untreated. Cells were 
measured for the amount of TurboGFP 
positive cells after ~ 48 h by flow 
cytometry. Results are displayed as density 
dot plots (red > blue) showing IFN-β 
TurboGFP expressing cells (lower right 
quadrant) and cells with unaltered 
fluorescence (lower left quadrant). 
 
3.2.3.2 IFN-β TurboGFP inducibility is rescued by down-regulation of 
basal NS3/4A-H levels 
The just introduced IFN-β NS3/4A-H cells display high basal expression of 
NS3/4A-H that anticipates IFN-β TurboGFP induction. Consequently, 
diminution of basal expression needs to be performed by minimizing leaky 
expression through PTet. This can be performed by introduction of a 
transrepressor, the KRAB repressor, which exhibits opposite binding capacities 
to rtTA2. This activation-repression system should be exploited to reduce basal 
expression in IFN-β NS3/4A-H cells. For this reason, a plasmid constitutively 
expressing the KRAB repressor was introduced into the cells and single clones 
were expanded after selection. 
 
Figure 14: Determination of basal NS3/4A-
H levels in a stable IFN-β NS3/4A-H KRAB 
clone. 
IFN-β NS3/4A-H KRAB cells were treated 
with doxycycline for 3 d or left untreated. The 
cells were stained with TMR and measured for 
the amount of NS3/4A-H (TMR) expressing 
cells by flow cytometry. The histogram shows 
basal expression and inducibility of IFN-β 
NS3/4A-H compared to the levels in 
untransfected cells. 
 
 
 
 
Results 
37 
 
After introduction of KRAB, the obtained clones were measured for basal 
expression by comparing uninduced with untransfected cells after staining with 
TMR by a flow cytometric assay. The uninduced, displayed clone does not show 
significant alteration compared to untransfected cells (fig. 14). After 
doxycycline treatment, the population shifts to the right indicating that NS3/4A-
H can be properly induced. 
The important aspect of drastically reducing basal expression in this system is 
that NS3/4A-H levels are low enough to allow IFN-β TurboGFP induction. This 
capacity was determined for all obtained IFN-β NS3/4A-H KRAB clones. The 
most promising clone (also displayed in fig. 14) was directly compared to 
untransfected cells concerning IFN-β inducibility and mean intensity. 
A 
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Figure 15: Alterations in the IFN-β TurboGFP expression phenotype of IFN-β NS3/4A-
H KRAB cells. 
IFN-β TurboGFP cells with or without NS3/4A-H and KRAB were seeded at equal densities 
and either infected with 80 HAU/ml NDV for 1 h or left uninfected. Cells were measured for 
the amount of TurboGFP expressing cells after 24 h by flow cytometry. A: Density dot plots 
(red > blue) show IFN-β TurboGFP expressing cells (lower right gate) and cells with 
unaltered fluorescence (lower left gate). Cells that highly express IFN-β TurboGFP could not 
be fully compensated and appear in the upper right gate. B: Mean intensity of IFN-β 
TurboGFP positive cells. The data shown represent average values +/- standard deviation of 3 
experiments. 
As already shown for IFN-β NS1-H cells (compare with fig. 9A), also IFN-β 
expression in the IFN-β NS3/4A-H KRAB cells is not affecting red fluorescence 
(fig. 15A). Furthermore, IFN-β TurboGFP levels are only slightly diminished 
compared to untransfected cells. Indeed, IFN-β NS3/4A-H KRAB cells show 
appropriate IFN-β TurboGFP expression and can be used for further 
experiments. Figure 15B displays the mean intensity of untransfected IFN-β 
TurboGFP cells and the cells harboring NS3/4A-H. Comparable to IFN-β NS1-
H cells (compare with fig. 9B), uninduced cells with integrated NS3/4A-H show 
attenuation in IFN-β TurboGFP mean intensity levels. This could give an 
indication for residual basal expression of NS3/4A-H that causes a constant 
decrease in IFN-β TurboGFP expression intensity. Certainly, this basal 
expression would undergo the detection limit of the flow cytometric device. 
Additionally to these results, NS3/4A-H expression was demonstrated not to 
exert any effect on IFN-β induction when cells are not infected with NDV (data 
not shown). 
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3.3 Doxycycline-induced perturbator expression 
Tight regulation of transgene expression is important for the experimental 
success. In the present case, a strictly controlled, predictable and reliable 
expression of NS1-H or NS3/4A-H is necessary to later on correlate the 
expression value of the respective perturbator to IFN-β TurboGFP expression 
and to know when expression starts and when maximal levels are reached. The 
following experiments will show how perturbator expression can be controlled 
and what kind of induction and expression pattern can be obtained. This will be 
generally evaluated for cells harboring a doxycycline-inducible NS1-H 
construct, which is similar regulated as the above described cells. These cells, 
which are also based on IFN-β TurboGFP, are named Tet-NS1-H. 
3.3.1 Dynamics of doxycycline-induced perturbator expression 
Induction of transgene expression occurs via administration of doxycycline. This 
inducer can be added to the medium at different concentrations or for differing 
periods of time to obtain the desired expression of the transgene. To demonstrate 
in which range of concentration and time an adjustment is possible and to 
determine at which concentrations or time points post doxycycline 
administration perturbator induction occurs or maximal levels are reached, Tet-
NS1-H cells were analyzed as an example for inducibility in the present 
systems. Determination was performed for increasing concentrations of 
doxycycline for a constant time period (fig. 16 A) or for differing time periods 
in the constant presence of saturating doxycycline concentrations (fig. 16B). 
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Figure 16: Dynamics of doxycycline-induced NS1-H expression. 
Tet-NS1-H cells were treated with (A) increasing concentrations of doxycycline for 3 d or (B) 
with 2 µg/ml of doxycycline for indicated time spans and were stained with TMR. Cells were 
measured for the mean fluorescence of NS1-H (TMR) by flow cytometry. The data shown 
represent average values +/- standard deviation of 3 experiments. 
Without doxycycline, no NS1-H is detectable and for 10 ng/ml only minor NS1-
H (TMR) intensity can be detected (fig. 16A). However, at concentrations 
ranging from 25 to 100 ng/ml of doxycycline, NS1-H intensity constantly 
increases. At 250 ng/ml, cells pass over to plateau phase and no gradual increase 
can be observed anymore. Maximal intensity, plateau phase, is reached at ~ 500 
ng/ml, indicating that this concentration is sufficient to maximally induce NS1-
H. At higher concentration, no further increase can be observed. 
Figure 16B demonstrates that within the first 7 h of doxycycline administration 
(2 µg/ml, saturating conditions), no increase of NS1-H (TMR) intensity can be 
observed. In the range of 15 - 30 h, intensity continuously increases. Plateau 
phase is reached after constant exposition of the cells to doxycycline for 3 d or 
longer. 
Altogether, perturbator expression shows tight regulation in a dose- and time-
dependent manner. Low standard deviation gives rise to predictability and 
reproducibility of the results. 
It was of further interest to determine whether the cell populations‟ expression 
increases gradually and homogenously, as it is postulated for this system, in 
response to increasing concentrations of doxycycline (Schucht et al, 2010). 
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Figure 17: Expression pattern of 
doxycycline-dependent NS1-H expression. 
Tet-NS1-H cells were treated with increasing 
concentrations of doxycycline for 3 d or left 
untreated and were stained with TMR. Cells 
were measured for the amount of NS1-H 
(TMR) positive cells by flow cytometry. In 
the histogram, the distribution of NS1-H 
positive cells for increasing concentrations (0 
(red), 25 (blue), 2000 (orange) ng/ml) of 
doxycycline is shown.  
 
 
 
As can be seen in figure 17, a gradual shift of the whole cell population does not 
occur. Instead, the distribution of NS1-H positive cells is quite broad at 
intermediate doxycycline concentrations (25 ng/ml). A homogeneous population 
can finally be monitored for saturating concentrations of doxycycline. 
The heterogeneous illustration of NS1-H positive cells at intermediate 
concentrations of doxycycline displays that the cells do not respond uniformly to 
doxycycline. This can be validated for living single cells by time-lapse 
microscopy. 
3.3.2 Dynamics of NS1-H induction in single cells 
In order to shed light on the induction pattern of the perturbators, single cell 
analyses are necessary. Those were performed using a time-lapse microscope. In 
a pre-test, the optimal TMR concentration for these experiments was titrated, 
because too low concentration of the fluorescent ligand could fail to visualize 
NS1-H. The other way round, high concentrations of TMR would make even the 
medium emit the light, letting the resulting pictures appear outshined. The value 
of 20 nM TMR gave the best results (data not shown). IFN-β TurboGFP cells 
harboring NS1-H were determined for NS1-H induction in single cells by time-
lapse microscopy. 
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Figure 18: Single cell NS1-H induction in response to doxycycline. 
IFN-β TurboGFP cells stably transfected with NS1-H and the KRAB repressor (compare with 
chapter 3.4.3) were seeded on a collagen-treated chambered microscopy slide at a density of 
10^5 cells/ml. Cells were treated with 0.5 µg/ml of doxycycline and stained with TMR. 
Subsequently, cells were monitored by time-lapse microscopy. Pictures were taken every 30 
minutes (min). A: Fluorescence pictures of the indicated time points. B: Fluorescence profiles 
of representative single cells showing onset and course of NS1-H (TMR). 
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The fluorescence pictures in figure 18A show the onset of NS1-H overtime in a 
batch of cells. At early time points of induction (8 - 16 h pi), obviously not all 
cells behave equally, because only few cells have turned on NS1-H expression. 
Indeed, the strength of the cells expressing NS1-H strongly differs. A direct 
comparison of the induction curves of single cells illustrates that NS1-H 
induction between the cells differs at three levels (fig. 18B). i) The time point of 
NS1-H induction. ii) Maximal expression levels. iii) The course of NS1-H onset. 
In fact, the onset in some cells happens slowly, while others are quickly induced. 
These data indicate that doxycycline-dependent expression shows heterogeneity 
at multiple levels, while the overall pattern of gradual induction within single 
cells is maintained. For later experiments, these results indicate that single cells 
need to be monitored under distinct conditions, as NS1-H and IFN-β TurboGFP 
are both stochastically induced. 
The time point of NS1-H induction was shown to strongly vary between single 
cells and it was of interest to see whether the concentration of doxycycline can 
affect it. For this reason, doxycycline-induced expression onset time points were 
counted for intermediate and high concentrations of doxycycline. As 
demonstrated in figure 19, under intermediate concentrations of doxycycline 
(0.1 µg/ml) most cells turn on NS1-H expression between 3 and 12 h with a 
maximum at 6 – 9 h (40% of all measured cells). Under saturating conditions 
(0.5 µg/ml), cells respond more pronounced to the inducer and show almost 
60% of the cells inducing NS1-H between 3 and 6 h post doxycycline 
administration.  
Together, these data show that different doxycycline concentrations affect the 
time point of NS1-H onset. The induction time point at lower concentrations 
varies in a greater range as for higher concentrations, where earlier and more 
homogeneous induction occurs. Also, the mean time point for the lower 
doxycycline concentration is higher (mean value: 8.4 h; SD: 3.6 h) than for 
saturating conditions (mean value: 6.9; SD: 5.3 h). This underlines the 
hypothesis of earlier induction for higher doxycycline concentrations. 
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Figure 19: NS1-H induction in response to different concentrations of doxycycline. 
NIH3T3 based cells stably transfected with NS1-H (compare with chapter 3.5.3) were seeded 
on a collagen-treated chambered microscopy slide at a density of 10^5 cells/ml. Cells were 
treated with 0.1 (left diagram) or 0.5 (right diagram) µg/ml of doxycycline and stained with 
20 nM TMR. These cells were monitored by time-lapse microscopy taking pictures every 30 
min. The bars demonstrate the distribution of NS1-H inducing cells at different time points 
post induction. n=56 for 0.1 µg/ml doxycycline (mean value: 8.4 h; SD: 3.6 h); n=86 for 0.5 
µg/ml doxycycline (mean value: 6.9; SD: 5.3 h). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
45 
 
3.4 Timing of NS1-H or NS3/4A-H induction has an impact on efficiency 
of IFN-β TurboGFP perturbation 
Regarding pathway progression on the single cell level is a very modern tool to 
get insight into the spatiotemporal dynamics of cellular networks. So far, IFN 
induction as well as its repression by NS1-H or NS3/4A-H has been mostly 
investigated on the mRNA or protein level by bulk assays like Western/Northern 
Blot or by RT-PCR. Thereby, the influence on single cells can give detailed 
information about the temporal course of perturbation as well as the dynamics 
and efficiency of the perturbator itself. Via flow cytometry, a high number of 
single cells can be quantitatively analyzed for a certain time point. By means of 
such measurements, the impact of NS1-H or NS3/4A-H levels and induction 
time point relative to infection on IFN-β TurboGFP levels and intensity were 
determined. 
3.4.1 NS3/4A-H and NS1-H counteract IFN-β induction with different 
efficiencies 
The determination of the effect of perturbator induction at different time points 
can give rise to the moment when the action of a perturbator is most sufficient. 
This, in turn, indicates which moment or step of the IFN network is crucial for 
ongoing signaling. To find this out, the overall distribution of NS1-H or 
NS3/4A-H positive cells after induction at certain time points relative to NDV 
infection was observed with regard to IFN-β TurboGFP expression. 
Representative density dot plots of some of the determined time points are given 
in figure 20A and B. 
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Figure 20: Influence of the perturbation time point on IFN-β TurboGFP expression. 
Equal densities of IFN-β NS1-H or IFN-β NS3/4A-H KRAB cells were treated with 2 µg/ml 
doxycycline at different time points relative to NDV infection (80 HAU/ml; 1 h). Cells were 
stained with TMR and measured 24 h pi. IFN-β NS1-H (A) or IFN-β NS3/4A-H KRAB (B) 
cells were measured for the amount of IFN-β TurboGFP and NS1-H or NS3/4A-H (TMR) 
positive cells by flow cytometry. The results are displayed as density dot plots (red > blue) 
showing IFN-β expressing cells in the lower right gate and NS1-H or NS3/4A-H positive cells 
in the upper left gate. Cells positive for IFN-β TurboGFP and NS1-H or NS3/4A-H are gated 
in the upper right and cells with unaltered fluorescence in the lower left. Representative 
examples of the tested time points of perturbator induction relative to NDV infection are 
shown. 
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The dot plots in figures 20A and B display the distribution of NS1-H or 
NS3/4A-H and IFN-β TurboGFP in a cell population after doxycycline 
treatment at different time points relative to infection. 
Without doxycycline, cells are just positive for IFN-β TurboGFP. It is obvious 
that NS1-H or NS3/4A-H expression increases the earlier the cells were treated 
with doxycycline. In parallel, IFN-β TurboGFP levels decrease. This clearly 
demonstrates that NS1-H as well as NS3/4A-H exerts an IFN-β TurboGFP 
antagonizing effect. According to this, the fusions of the viral perturbators to 
HaloTag have retained their perturbing function. 
Especially in the case of NS1-H, cells positive for both markers could be 
visualized. This is a minor but significant amount of cells. For NS3/4A-H, those 
cells only exerted low intensities of IFN-β TurboGFP. The existence of these 
cells indicates that a state of the cells exists in which they are able to express 
both, the perturbator and IFN-β TurboGFP. Indeed, further experiments on these 
cells are given in chapter 3.5. 
It is further obvious that differences between the perturbation via NS1-H and 
NS3/4A-H exist. While cells harboring NS1-H still show a significant amount of 
cells positive for IFN-β TurboGFP or both markers even though treated with 
doxycycline for 24 h before infection, IFN-β TurboGFP expression is already 
fully interrupted when the NS3/4A-H cells were kept under doxycycline from 12 
h ai on. In fact, the levels of NS1-H and NS3/4A-H cannot be directly compared 
with each other, but since NS3/4A-H intensities in the induced state are also 
lower than those of NS1-H, this indicates a faster perturbation behavior by 
NS3/4A-H. 
3.4.1.1 NS1-H or NS3/4A-H induction shortly after infection causes a 
drastic decrease in IFN-β TurboGFP levels 
The dot plots could already give information about the distribution of NS1-H or 
NS3/4A-H and IFN-β TurboGFP, also with regard to the co-expression of both 
markers. However, by means of a correlation of NS1-H or NS3/4A-H versus 
IFN-β TurboGFP expression for all measured time points, their antithetic 
expression can be highlighted. For this reason, the amount of positive cells for 
the mean values of 3 experiments for both parameters were applied the one 
against the other for all measured time points. Cells positive for both markers 
are not shown. They will be further analyzed in chapter 3.4.1.2. 
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Figure 21: Correlation of NS1-H or NS3/4A-H expression with IFN-β TurboGFP 
expression. 
IFN-β NS1-H (A) or IFN-β NS3/4A-H KRAB (B) cells were treated with 2 µg/ml of 
doxycycline at different time points relative to infection. Cells were infected with 80 HAU/ml 
NDV for 1 h at time point “0” and stained with TMR. Cells were measured for the amount of 
IFN-β TurboGFP and NS1-H or NS3/4A-H (TMR) positive cells 24 h pi by flow cytometry. 
The data shown represent average values +/- standard deviation of 3 experiments. In figure B, 
the values for the time point 12 h pi were determined from duplicates. Standard deviation is 
not given in this case. Cells positive for both IFN-β TurboGFP and NS1-H or NS3/4A-H were 
skipped in these figures. If the measurements were arranged at different time points, the 
amount of positive cells was equalized by using NDV-infected IFN-β TurboGFP cells or the 
cells harboring NS1-H. 
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In figures 21A and B, the correlations of NS1-H or NS3/4A-H onset versus the 
decrease/arrest in IFN-β TurboGFP are given. In addition to the results 
visualized by the dot plots, it is eye-catching that the amount of IFN-β 
TurboGFP positive cells only drops to 5 % in the case of NS1-H, but a complete 
block of IFN-β expression does not occur. This block could be demonstrated for 
NS3/4A-H expressing cells at similar time points. Indeed, a stronger 
perturbation via NS1-H could be detected when the cells were kept under 
doxycycline for a longer time period (e.g. 7 days, data not shown), although no 
complete block was possible. This could be due to the fact that NS1-H usually is 
higher expressed in IAV-infected cells than in maximally induced cells of this 
work (compare with fig. 10). 
It is eye-catching that the levels of IFN-β TurboGFP continuously decrease 
overtime in the case of NS1-H with a slightly higher effect shortly after 
infection. However, this effect is much more drastic for the cells expressing 
NS3/4A-H, which show a strong effect of NS3/4A-H on IFN-β TurboGFP levels 
in a small time window between 3 and 6 h pi. This effect can be related to the 
fact that in natural infection, the virus needs some time to let the cellular 
machinery express its genome. Consequently, NS1 or NS3/4A is just present 
after infection and probably is most efficient at this time point. 
The differences in the perturbation patterns of NS1-H and NS3/4A-H can be 
explained by their different types of interference with the IFN network. The 
proteolytic cleavage which occurs via NS3/4A-H is very efficient, since one 
NS3/4A-H complex is able to cleave several IPS-1 molecules. In contrast, 
certain NS1-H dimers are necessary to bind the same amount of RIG-I or 
TRIM25. Accordingly, the stoichiometry for the factors would be very different 
and significantly more NS1-H molecules would be needed for the counteraction 
of IFN-β TurboGFP. 
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3.4.1.2 Cells positive for both IFN-β TurboGFP and NS1-H or NS3/4A-
H turn up after IFN-β and perturbator induction 
In the previous analyses, cells positive for the perturbator and IFN-β TurboGFP 
could be visualized. These cells are of exceptional interest, because they indicate 
that the perturbation is not an all-or nothing event, but intermediate steps occur. 
This is probably caused by a belated induction of the perturbator occurring after 
IFN-β TurboGFP induction. Another reason could be that perturbator levels are 
too low to suffice for perturbation. 
The number of cells expressing both markers is constant overtime and ranges 
from 2 – 4 % in the case of NS1-H and from 1 – 4 % for NS3/4A-H (data not 
shown). This could indicate a continuous onset and termination of IFN-β 
TurboGFP expressing cells which has to be clarified by single cell microscopic 
analyses (see chapter 3.5). 
Perturbator induction at various time points could affect IFN-β TurboGFP mean 
intensity since already constant basal levels of the perturbators give rise to this 
behavior (compare fig. 9B and 15B). Such an effect would indicate that i) the 
distribution of IFN-β TurboGFP positive cells is altered due to perturbator 
expression or ii) ongoing IFN-β TurboGFP expression can be blocked or 
inverted. Determination of the mean intensities of cells positive for the 
respective perturbator and IFN-β TurboGFP could give insight into the 
mechanism. However, flow cytometry analyses on the mean intensity of these 
cells were limited due to highly expressing IFN-β TurboGFP that could not be 
compensated. For this reason, the course of perturbator increase compared to a 
possible IFN-β TurboGFP arrest in single cells is addressed later in this work 
(chapter 3.5). 
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3.4.2. Influence of increasing NS1-H or NS3/4A-H levels on IFN-β 
TurboGFP induction 
After the analysis of the influence of the perturbators‟ induction time point on 
IFN-β expression, it was of interest to analyze which effect a dose-dependent 
increase of the perturbators (displayed in chapter 3.3.1) would have on IFN-β 
TurboGFP expression. For this examination, IFN-β NS1-H and IFN-β NS3/4A-
H KRAB cells were kept under a certain concentration of doxycycline for a 
constant period of time. The dot plots in figure 22 monitor the influence of the 
respective amount of NS1-H or NS3/4A-H which can be equated with a certain 
concentration of doxycycline that was administered to the cells. Representative 
dot plots of several concentrations are shown. 
A NS1-H 
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Figure 22: Influence of increasing perturbator levels on IFN-β TurboGFP expression. 
IFN-β NS1-H (A) or IFN-β NS3/4A-H KRAB (B) cells were pre-treated with increasing 
amounts of doxycycline for 3 d. Then, cells were infected with 80 HAU/ml NDV for 1 h and 
stained with TMR. Cells were measured for the amount of IFN-β TurboGFP and for NS1-H 
e.g. NS3/4A-H (TMR) positive cells 24 h pi by flow cytometry. The results are displayed as 
density dot plots (red > blue) showing IFN-β expressing cells in the lower right gate and NS1-
H or NS3/4A-H (TMR) positive cells in the upper left gate. Cells positive for IFN-β 
TurboGFP and NS1-H e.g. NS3/4A-H are gated in the upper right and cells with unaltered 
fluorescence in the lower left. Examples of the tested concentrations are shown here. 
As expected and as shown before, the uninfected and uninduced IFN-β NS1-H 
and IFN-β NS3/4A-H KRAB cells do not show expression in the channels for 
NS1-H or NS3/4A-H (TMR) and IFN-β TurboGFP. 
The infected, uninduced IFN-β NS1-H cells exhibit strict IFN-β TurboGFP 
expression (17.5 %). At low doxycycline concentrations (25 ng/ml), 15 % of 
NS1-H positive cells shift to the upper left gate, whereas the amount of IFN-β 
TurboGFP positive cells (lower right channel) is decreasing to 11.5 % (fig. 
22A). Only very few cells (0.37 %) express both reporters. With increasing 
concentrations of the inducer, NS1-H positive cells increase and the amount of 
IFN-β TurboGFP positive cells decreases. At the same time, the amount of cells 
expressing both reporters is constantly low. 
The NDV-infected, uninduced cells stably harboring NS3/4A-H show 36 % of 
IFN-β TurboGFP positive cells (fig. 22B). However, when 10 µg/ml 
doxycycline were administered to the cells for 3 d, the corresponding NS3/4A-H 
levels suffice to almost block IFN-β TurboGFP expression (only 1.42 % left 
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behind). Also, it is remarkable that at this concentration, only 1.9 % of the cells 
actually shifted to the upper left channel where the NS3/4A-H positive cells 
should be monitored. As already mentioned before, low amounts of protein 
tagged to HTV-7 cannot be visualized by the flow cytometric device. This 
underlines the theory that very low levels of NS3/4A-H are sufficient to 
efficiently perturb IFN-β TurboGFP expression. At higher concentrations of 
doxycycline, NS3/4A-H expressing cells can be visualized, but concomitantly, 
almost no IFN-β positive cells can be determined. 
These data clearly demonstrate that the perturbator cassettes can be used to 
interfere with IFN induction in a dose-dependent manner. However, IFN-β 
TurboGFP is much more sensitive to NS3/4A-H perturbation and regulation can 
be obtained only at very low doxycycline concentrations. 
For a better overview of the results for all tested concentrations of doxycycline, 
a correlation of the dot plots from figure 22 was realized in figure 23. 
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Figure 23: Correlation of NS1-H and NS3/4A-H with IFN-β TurboGFP expression. 
IFN-β NS1-H (A) or IFN-β NS3/4A-H KRAB (B) cells were pre-treated with increasing 
amounts of doxycycline for 3 d. Then, cells were infected with 80 HAU/ml NDV for 1 h and 
stained with TMR. Cells were measured for the amount of IFN-β TurboGFP and for NS1-H 
or NS3/4A-H (TMR) positive cells 24 h pi by flow cytometry. The data shown represent 
average values +/- standard deviation of 3 experiments. 
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IFN-β NS1-H cells that were treated with increasing concentrations of 
doxycycline show a constant increase of NS1-H positive cells until maximal 
levels are reached at a concentration of 500 ng/ml (fig. 23A). As a consequence, 
IFN-β TurboGFP gradually decreases and nearly reaches the base line. 
For the IFN-β NS3/4A-H KRAB cells, a completely different perturbation 
pattern was obtained (fig. 23B). NS3/4A-H also constantly increases the higher 
the doxycycline concentration is, but administration of only 10 ng/ml 
doxycycline leads to a drastic decrease of IFN-β TurboGFP expression. After 
addition of 50 ng/ml of the inducer, the base line is reached and for higher 
concentrations only minor effects can be visualized. 
These data clearly demonstrate the differences, and thereby probably the 
advantages, of the perturbation mode for the respective virus. The abrupt 
perturbation at low levels of NS3/4A-H might contribute to the persistence of 
HCV within a host. In contrast, NS1-H interference occurs creeping whereby at 
least low levels of IFN-β can be produced to induce an antiviral state of the cells 
in the end. 
3.4.2.1 Co-expression of IFN-β TurboGFP and the perturbator 
Cells positive for both reporters could be visualized especially for time-
dependent doxycycline administration, but also in the dose-dependent 
experiments they turned up. The number of these cells (compare with the upper 
right gate of fig. 22A and B) was determined for IFN-β NS1-H as well as for 
IFN-β NS3/4A-H cells (data not shown). For NS1-H, the amount slightly 
increases with rising concentrations of doxycycline until 75 ng/ml. Afterwards, a 
constant level of 1 – 1.5 % appears. For NS3/4A-H, a constant level of 0.5 % of 
these cells could be visualized. These low levels indicate the presence of a state, 
where almost no IFN-β TurboGFP can be induced as a result of pre-treatment of 
the cells with the perturbators. 
Analyses on the course of IFN-β TurboGFP mean intensity of these cell 
populations are not given here for the reasons described in chapter 3.4.1.2. Also, 
the levels of cells expressing both reporters are, especially in the case of 
NS3/4A-H, too low to display significant alterations. The question of a possible 
interruption of IFN-β TurboGFP expression by the perturbators will be 
addressed in chapter 3.5. 
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3.4.3 IFN-β NS1-H reporter cells show improved inducibility after 
integration of KRAB 
IFN-β NS1-H cells did not show significant basal levels of NS1-H, but proper 
inducibility upon doxycycline administration. However, the amount and 
intensity of IFN-β TurboGFP compared to untransfected cells was altered. To 
obtain IFN-β NS1-H cells displaying comparable values in IFN-β TurboGFP 
expression and intensity, an improvement of the cells was performed. Such cells 
which do not show significant differences to untransfected cells can be taken for 
single cell analyses without respect to untransfected cells. For NS3/4A-H, this 
improvement has previously been done (chapter 3.2.3.2). 
For IFN-β NS1-H cells, a corresponding improvement was performed by stably 
integrating the KRAB repressor. After selection, several clones were evaluated. 
The characteristics of the most promising one are given in figure 24 (IFN-β 
NS1-H KRAB). In the uninduced state, this clone displays red fluorescence 
comparable to the one of untransfected cells. Further on, it is properly induced 
upon doxycycline treatment. 
 
 
 
 
 
 
 
 
Figure 24: Expression characteristics of an IFN-β TurboGFP clone expressing NS1-H 
and KRAB. 
IFN-β NS1-H KRAB cells were either treated with doxycycline for 3 d or left untreated and 
stained with TMR. Cells were measured for the amount of NS1-H (TMR) positive cells by 
flow cytometry. In the histogram, the fluorescence of untransfected IFN-β TurboGFP cells is 
compared to the fluorescence of uninduced and induced IFN-β NS1-H KRAB cells. 
Basal levels of IFN-β NS1-H KRAB cells can hardly be distinguished from 
untransfected cells. However, this was expected since IFN-β NS1-H cells also 
resembled the untransfected cells for this criterion. To exclude whether 
undetectable basal levels influence IFN-β TurboGFP inducibility and intensity 
these and untransfected IFN-β TurboGFP cells were determined for these 
parameters. 
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Figure 25: Comparison of IFN-β TurboGFP cells harboring NS1-H and KRAB with 
untransfected cells. 
Untransfected cells or IFN-β NS1-H KRAB cells were seeded at equal densities and were 
either infected with 80 HAU/ml NDV for 1 h or left uninfected. Cells were measured for the 
amount of TurboGFP positive cells after 24 h by flow cytometry. A: Density dot plots (red > 
blue) show IFN-β TurboGFP expressing cells (lower right gate) and cells with unaltered 
fluorescence (lower left gate). B: Mean intensity of IFN-β TurboGFP positive cells. The data 
shown represent average values +/- standard deviation of 3 experiments. 
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Before introduction of KRAB, the amount of IFN-β TurboGFP expressing cells 
was strikingly diminished in IFN-β NS1-H cells compared to untransfected cells 
(compare with fig. 9A). In figure 25A, inducibility of IFN-β NS1-H KRAB cells 
compared with untransfected cells is given. Both exhibit around 50 % of the 
cells expressing IFN-β TurboGFP under the present conditions. The values for 
the IFN-β NS1-H KRAB cells, indeed, are directly comparable with the ones of 
untransfected IFN-β TurboGFP cells. 
Before the introduction of the KRAB repressor, also the intensity of IFN-β 
TurboGFP was reduced in the cells harboring the NS1-H construct (compare 
with fig. 9B). The mean intensity of IFN-β TurboGFP positive cells was also 
determined for the IFN-β NS1-H KRAB cells compared to untransfected cells 
and is given in figure 25B. In the uninfected state, IFN-β NS1-H KRAB and 
untransfected cells exhibit mean intensities of ~ 25a.u.. After infection, levels 
increased 10-fold in both cases. For the uninfected as well as the infected state, 
cells show comparable values, indicating that the obtained IFN-β NS1-H KRAB 
clone does not show alteration concerning the important parameters for this 
work. For this reason, the IFN-β NS1-H KRAB clone was used for time-lapse 
experiments of this work. 
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3.5 Single cell analysis of IFN-β perturbation by NS1-H and NS3/4A-H 
Perturbation experiments of cellular networks are usually performed for cell 
populations. However, important aspects like the temporal course and the 
localization of both, signaling target and perturbator cannot be followed in detail 
by those methods. Also the alteration of the outcome after perturbation can only 
be given quantitatively, but not qualitatively. Those results can only give mean 
values of a batch of cells, but this is hardly transferable to a single cell. Since 
cells usually do not behave equally, single cell analyses via live-cell imaging is 
an emerging tool. 
For this work, it was of particular importance to perform this analysis, since all 
determined factors, IFN-β TurboGFP and NS1-H or NS3/4A-H, display 
stochastic behavior on several levels. However, high-throughput computational 
analysis programs were not available and hampered an automatic analysis of 
large numbers of individual cells. For this reason, in this study, a representative 
amount of cells was evaluated by mechanical tracking. 
3.5.1 Perturbation of IFN-β induction by NS1-H in single living cells 
Flow cytometry analyses already gave a lot of indications for the behavior of the 
cells during IFN-β perturbation. They demonstrated that cells that were pre-
treated with doxycycline (compare with fig. 22) exhibited strong counteraction 
against IFN induction, indicating that pre-treatment leads to an “anti-IFN state” 
of the cells. Also, the amount of cells positive for both, IFN-β TurboGFP and 
the respective perturbator are low in this experimental setup. For NS1-H or 
NS3/4A-H induction at the time point of infection or later, an increase in cells 
positive for both reporters could be demonstrated until a decrease occurred at 
late times of induction (compare with fig. 20). However, single cells cannot be 
measured over time in this approach. 
The appearance of cells positive for both, IFN-β TurboGFP and NS1-H or 
NS3/4A-H, indicates that the perturbation of IFN-β induction is a dynamic 
process causing intermediate states of perturbator and IFN-β TurboGFP 
expression. To verify what the matter is with single living cells emitting green 
and red fluorescence, time-lapse experiments were performed. Treatment of the 
cells for all following time-lapse experiments was performed according to a 
standard protocol: After adherence on a micro-slide, the cells were infected with 
80 HAU/ml for 1h and subsequently treated with 0.5 µg/ml doxycycline and 20 
nM TMR. Pictures were taken every 15 or 30 min. Since NS1 is known to 
shuttle between the cytoplasm and the nucleus, measurement of the cells was 
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standardized on cytosolic tracking (Han et al, 2010). Differences and intricacies 
are depicted in the figure legends. 
 
A 
 
B 
Figure 26: Concomitant IFN-β 
TurboGFP and NS1-H induction. 
IFN-β NS1-H KRAB cells were infected 
with 80 HAU/ml NDV for 1 h. 4 h post 
infection, new medium was added 
including 0.5 µg/ml doxycycline and 20 nM 
TMR. Subsequently, cells were monitored 
by time-lapse microscopy taking images 
every 15 min. A: Fluorescence pictures of 
the indicated time points pi are shown. B: 
Cut of fig 27A 21 h pi showing cells double 
positive for both, IFN-β TurboGFP and 
NS1-H (TMR). 
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In figure 26A, the onset of IFN-β TurboGFP and NS1-H within a population of 
cells is given for the indicated time points. In this experiment, first NS1-H 
expressing cells appear at approximately 7 - 9 h pi, meaning 3 – 5 h post 
induction via doxycycline, since it was administered to the cells 4 h pi. In the 
flow cytometry experiments these cells appear a little belated (compare with fig. 
16B) indicating that time-lapse microscopy is more sensitive. Indeed, these 
results fit to the induction of NS1-H in single cells of a different origin (compare 
with figure 19B). 
First cells positive for IFN-β TurboGFP can be visualized in this particular 
cutting at 9 – 11 h pi, what is in agreement with the results for untransfected 
cells (Rand, 2010). From this time on, cells positive for both, green and red 
fluorescence, can also be visualized (see magnification of time point 21 h pi in 
fig. 26B). At late time points pi, many cells positive for either IFN-β TurboGFP 
or NS1-H and only a minor number of cells positive for both reporters can be 
visualized. These cells co-expressed both reporters for around 10 h before the 
observation was stopped. Three hypotheses can be suggested from ongoing GFP 
expression in the presence of NS1-H: 
i) NS1-H expression does not show an effect on cells that do already 
express IFN-β TurboGFP. 
ii) NS1-H slowly down-regulates IFN-β TurboGFP expression. 
iii) NS1-H stops the increase of IFN-β TurboGFP causing a premature 
plateau phase. 
In untransfected IFN-β TurboGFP cells, GFP expression gradually increases 
after NDV infection, suddenly reaching a maximum of expression and staying at 
this level (plateau phase). However, maximal expression of IFN-β TurboGFP 
strongly varies between single cells (Rand, 2010). It would be interesting to 
determine whether a premature plateau is reached or whether IFN-β TurboGFP 
expression can even be inverted after perturbation of IFN-β induction. A 
disruption of ongoing RIG-I-mediated signaling causing arrest or inversion of 
IFN-β induction has not been demonstrated, yet. However, it cannot be 
distinguished between a “natural” and a “perturbed” plateau. For this reason, the 
relation between the time point of perturbator induction and the time point when 
IFN-β TurboGFP expression stops increasing need to be analyzed. This can be 
performed by correlating these two parameters with each other after following 
single cells over time. Indeed, IFN-β TurboGFP and perturbator induction vary 
strongly in the intensity of their courses, which consequently can lead to a 
certain variation in the correlation. 
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In fact, not all cells that are positive for both markers can be used for this 
measurement. Perturbator onset should occur a certain time before IFN-β 
TurboGFP arrest or inversion in order to increase the probability that a 
“perturbed” plateau or even inversion is analyzed. The time period, in which 
IFN-β TurboGFP and NS1-H have to come up, is small and consequently, only a 
low frequency of cells shows this pattern. Single cells corresponding to these 
demands were measured for green and red fluorescence overtime (see the 
fluorescence profile of a single cell in fig. 27A) and a correlation was performed 
in the described manner (fig. 27B). 
A 
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Figure 27: Correlation of NS1-H onset with the termination of IFN-β TurboGFP 
induction. 
IFN-β NS1-H KRAB cells were infected with 80 HAU/ml NDV for 1 h. 4 h pi, a medium 
exchange was performed for medium containing 0.5 µg/ml doxycycline and 20 nM TMR. 
Subsequently, cells were monitored by time-lapse microscopy taking images every 30 min. A: 
Fluorescence profile of a single cell showing onset and course of IFN-β TurboGFP (green 
line) and NS1-H (TMR, red line). Cells were tracked within the cytoplasm. B: Onset of NS1-
H (TMR) induction plotted against the time point of IFN-β TurboGFP induction arrest. 15 
single cells were found in this experimental run, measured and related to a linear trend line. 
In figure 27A, the course of IFN-β TurboGFP and NS1-H expression of a single 
cell is given. NS1-H relative intensity starts to come up at ~ 7 h pi and quickly 
increases until a maximum (plateau phase) is reached at ~ 17 h pi. Meanwhile, 
IFN-β TurboGFP expression is set on at ~ 20 h pi increasing in intensity until 25 
h pi. From 38 h pi on, IFN-β TurboGFP intensity drops continuously. 
15 cells which fulfill the above described demands for the correlation were 
found in this experimental run. 39 % of them showed an inverted phenotype and 
61 % of the determined cells went to plateau phase. To demonstrate whether the 
establishment of an IFN-β TurboGFP plateau or its inversion can be related to 
NS1-H expression, the arrest of IFN-β TurboGFP increase was plotted against 
NS1-H induction (fig. 27B). A linear trend line was drawn to compare the 
events with each other. It is obvious that the determined events reflecting single 
cells do not strongly deflect from the trend line (R
2
 = 0.69), indicating that the 
time between NS1-H increase and IFN-β TurboGFP arrest is constant. Indeed, 
the time span between NS1-H increase and IFN-β TurboGFP arrest or inversion 
is 12 h with a standard deviation of 5.4 h. For most cells, NS1-H increases in the 
range of 7 to 12 h pi with few strong outliers (mean value 13.6 h, SD 8 h) 
whereas the maximum of IFN-β TurboGFP is reached between 15 and 29 h pi 
(mean value 26 h, SD 9.8 h). The difference in the time point of NS1-H increase 
to previous results can be explained by the fact that in this experiment here, cells 
were chosen which fulfill specific demands. Probably, early NS1-H expressing 
cells would not be able to additionally induce IFN-β TurboGFP, because the 
NS1-H value in these cells does not allow it. 
These results indicate that the arrest of IFN-β TurboGFP increase and the 
induction of NS1-H are related to each other and that belated interruption of 
IFN-β induction is possible via perturbation by NS1-H. 
In this experimental setup, cells could also be observed in which NS1-H 
expression decreases and IFN-β TurboGFP was subsequently induced even 
though doxycycline was present, what was not expected (data not shown). Also, 
it could be observed that IFN-β TurboGFP expression is not affected if only low 
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levels of NS1-H are expressed, giving rise to a certain threshold that needs to be 
reached by NS1-H to affect IFN-β TurboGFP expression. 
3.5.2 Interference of NS3/4A-H and IFN-β TurboGFP expression in living 
single cells 
The perturbation mechanism of NS3/4A differs significantly from the 
perturbation via NS1. Some discrepancies in the corresponding perturbation 
patterns could already be shown by flow cytometry analyses. Single cell 
analyses can shed light on further differences between the two perturbators as 
well as on the dynamics of IFN induction. Single cell analyses were already 
shown for NS1-H. In the following, live cell imaging of IFN-β perturbation via 
NS3/4A-H will be performed. 
Concerning the onset of IFN-β TurboGFP and NS3/4A-H in a population of 
cells, a similar picture could be observed after time-lapse performance as for 
NS1-H (compare with fig. 26A); hence this is not shown again. Indeed, single 
cells expressing both, IFN-β TurboGFP and NS3/4A-H were measured for the 
ability of NS3/4A-H to arrest or invert IFN-β TurboGFP expression. For this 
reason, time-lapse microscopy was performed for IFN-β NS3/4A-H KRAB cells 
infected with NDV. Since flow cytometry analyses displayed highest amounts of 
cells positive for IFN-β TurboGFP as well as for NS3/4A-H at 6 to 12 h pi, 
doxycycline was administered 10 h pi. In this run, 14 cells fulfilled the demands 
which were already described for the correlation of NS1-H induction with the 
arrest of IFN-β TurboGFP increase. 
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Figure 28: Correlation of NS3/4A-H onset with arrest or inversion of IFN-β TurboGFP 
induction. 
IFN-β TurboGFP cells harboring NS3/4A-H and KRAB were infected with 80 HAU/ml NDV 
for 1 h. A medium exchange was performed for medium containing 0.5 µg/ml doxycycline 
and 20 nM TMR 10 h pi. Subsequently, cells were monitored by time-lapse microscopy 
taking images every 30 min. The subsequent measurement of fluorescence intensities was 
done in the cytoplasm of the cells. A: Fluorescence profile of a single cell showing onset and 
course of IFN-β TurboGFP (green line) and NS3/4A-H (TMR, red line). B: Onset of NS3/4A-
H (TMR) induction plotted against time point of IFN-β TurboGFP arrest or inversion. 14 
single cells could be measured from this run and were related to a linear trend line. 
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For this experiment, 33 % of the cells showed an inverted phenotype, whereas 
67 % terminated IFN-β TurboGFP increase and went over to plateau phase. The 
fluorescent profile of one cell of the first group is demonstrated in figure 28A. 
For this cell, IFN-β TurboGFP is induced around 16 h pi and maximally 
expressed at ~ 46 h. Afterwards, IFN-β TurboGFP intensity decreases again. 
NS3/4A-H is induced at ~ 37.5 h and continuously increases until the end of the 
measurement. The graphs attract attention concerning the transition point of 
IFN-β TurboGFP expression, because slightly before (~8.5 h pi) NS3/4A-H 
starts to intensify. This gives an indication that these mechanisms are coupled 
with each other. To verify this, a correlation of the induction arrest of IFN-β 
TurboGFP versus the onset of NS3/4A-H was performed. The result is given in 
figure 28B. A linear trend line was drawn for better comparability of the 
individual events with each other. This figure shows that all events hardly 
deflect from the linear trend line, indicating a strong relation between NS3/4A-H 
induction and the arrest of IFN-β TurboGFP increase (R2 = 0.958). This is also 
underlined by a constant mean value of the time span between NS3/4A-H onset 
and IFN-β TurboGFP arrest/inversion (4.8 h; SD 1.9 h). NS3/4A-H increase 
appeared lately, at a mean time point of 21.9 h (SD 7.7) and IFN-β TurboGFP 
arrest occurs short time later (mean: 26.7; SD 8.6). 
These data indicate a strict, time-dependent perturbation of IFN-β TurboGFP 
expression in the case of NS3/4A-H. The time period between NS3/4A-H onset 
is shorter and has a lower SD as in the case of NS1-H. This might result from a 
faster action of NS3/4A-H or could be caused by the perturbation mechanism or 
the point of action within the IFN-β induction cascade which are multiple for 
NS1-H. Another reason could be stochasticity within pathway progression. 
3.5.3 Inversion of IRF-7 nuclear translocation by NS1-H expression 
It was demonstrated that IRF-3, which is necessary for the induction of early 
type I IFNs, is activated by TBK-1 and IKKε. Also, it was shown that IRF-7, the 
transcription factor inducing the second, stronger wave of the IFN response, is 
activated by the same batch of kinases (Sharma et al, 2003). Since IRF-7 shares 
great homology with IRF-3 it could work as an IRF-3 surrogate in this work. 
In the previous experiments it was shown that ongoing IFN-β TurboGFP 
expression can be interrupted by the viral perturbators. The use of reporter cells 
stably expressing fluorescently labeled IRF-7 and the doxycycline-dependent 
NS1-H cassette would allow answering the question whether translocation of 
activated IRF-7, which is an event upstream of IFN-β induction, can also be 
inverted by perturbation of the cascade. The temporal dynamics between NS1-H 
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onset and the relocation of IRF-7 will be of interest and can be compared to 
previous results for IFN-β TurboGFP perturbation. 
For the further perturbation experiments, NIH3T3-based reporter cells stably 
expressing IRF-7 fused to the cyan fluorescence protein (CFP) were used (Rand, 
2010). These reporter cells are further called IRF-7-C. By means of these cells, 
U. Rand could show that virus-induced IRF-7 translocation is a stochastic 
process ranging from 6 to 22 h pi. He could also demonstrate that a very 
consistent delay of 2 - 6 h occurs between IRF-7 translocation to the nucleus and 
IFN-β TurboGFP onset. This indicates a relation between the two events. 
3.5.3.1 Characterization of IRF-7-C reporter cells expressing NS1-H 
IRF-7-C reporter cells were stably transfected with the rtTA2 construct and, in a 
second transfection step, with the construct harboring NS1-H under control of 
PTight, an improved variant of PTet which demonstrates lower basal leakiness and 
higher inducibility due to reduction of potential transcription factor binding sites 
in the spacer region between the tetOs (Clontech, 2003). With this promoter, the 
additional integration of KRAB could be lapsed. 
24 single clones were measured for leaky expression and for inducibility of 
NS1-H. Most of them displayed low basal expression (data not shown), but one 
clone displayed exceptional low levels. Indeed, this clone (fig. 29) shows proper 
regulation of NS1-H upon doxycycline administration. For these reasons, it was 
used for further experiments and termed IRF-7 NS1-H. 
 
Figure 29: Regulation of NS1-H in IRF-7-C 
cells. 
IRF-7 NS1-H cells were either treated with 
doxycycline for 3 d or left untreated and stained 
with TMR. Cells were measured for the amount of 
NS1-H (TMR) positive cells by flow cytometry. 
The histogram shows an overlay of untransfected 
IRF-7-C reporter cells with uninduced and 
induced IRF-7 NS1-H cells. 
 
 
Since NS1-H is known to at least partially block the IFN induction pathway 
upstream of the kinases TBK-1 and IKKε, it is unclear whether marginal NS1-H 
basal expression could block translocation of the IRF-7 CFP fusion. 
Results 
68 
 
Consequently, the IRF-7-C reporter cells harboring NS1-H were measured for 
the ability of IRF-7-C to translocate in the presence of potential basal NS1-H 
expression. The cells were infected with NDV and time-lapse recording was 
performed (figs. 30A and B). 
A 
 
B 
 
Figure 30: Nuclear accumulation of IRF-7 CFP in IRF-7 NS1-H cells. 
IRF-7 NS1-H cells were seeded on a collagen-treated chambered microscopy slide at a 
density of 2.5 * 10^4 cells/well. Adherent cells were infected with 80 HAU/ml NDV for 1 h 
and subsequently monitored by time-lapse microscopy. A: Cells before nuclear accumulation 
of IRF-7 CFP (12:35 h pi). B: Cells showing nuclear accumulation of IRF-7 CFP (20:05 h pi). 
Uninduced IRF-7 NS1-H cells do not show nuclear accumulation of IRF-7-C at 
early time points after infection (12:35 h pi), which is expected (fig. 30A). 
However, translocation can clearly be monitored at later time points pi (20:05 h 
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pi; fig. 30B). This indicates that even though minor levels of NS1-H could 
constantly be present in the cells, the translocation of IRF-7 CFP is still possible. 
Certainly, these pictures do not show whether the translocation efficiency is 
somehow altered. For this reason, the number of IRF-7 CFP translocation events 
in equally treated untransfected IRF-7-C cells and IRF-7 NS1-H cells was 
measured. As a proof for the perturbing effect of NS1-H on the level of RIG-I-
mediated signaling, a third batch of IRF-7 NS1-H cells, which were pre-treated 
with doxycycline from 24 h pi on, was also counted for translocation events. 
As expected, in the case of doxycycline treatment, only a minor part of cells 
shows translocation (~13 %). For the uninduced IRF-7 NS1-H cells, 30 % of the 
cells translocate. 47 % of the untransfected cells are displaying translocation 
events (fig. 31). 
These results demonstrate that potential basal levels of NS1-H cause decreased 
translocation events in the described cells, even though basal expression could 
hardly be measured by flow cytometry. This is probably due to the limited 
sensitivity of this assay, as mentioned before. Indeed, this effect was shown to 
be caused by NS1-H, since induction of NS1-H leads to a further decrease. 
 
 
Figure 31: Comparison of translocation events in IRF-7-C and IRF-7 NS1-H cells. 
IRF-7-C and IRF-7 NS1-H cells were seeded on a collagen-treated chambered microscopy 
slide at a density of 2.5 * 10^4 cells/well. Adherent cells were infected with 80 HAU/ml NDV 
for 1 h and subsequently monitored by time-lapse microscopy. The percentage of 
translocating cells within the analyzed sections is given. The first bar demonstrates IRF-7 
NS1-H cells that were pre-treated with doxycycline from 24h ai on (n = 153). The second bar 
shows uninduced IRF-7 NS1-H cells (n = 227). The third bar displays untransfected cells (n = 
119). 
Even though IRF-7 NS1-H cells display attenuation compared to untransfected 
cells, these cells were used for further perturbation experiments, since a 
respective amount of cells still responds to NDV infection. 
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3.5.4 Inversion of IRF-7 CFP translocation after perturbation with NS1-H 
In this work, it was shown that the appearance of IFN-β TurboGFP protein is 
strongly altered in response to the presence of NS1-H and that ongoing 
expression can be blocked or even inverted. It was of interest to find out whether 
the relocation of IRF-7 CFP into the cytoplasm can be initiated by NS1-H. 
Indeed, nucleus to cytoplasm relocation is a naturally occurring event, which has 
to be further elucidated. For this reason, a correlation between the time point of 
NS1-H induction and IRF-7 CFP relocation was chosen to display a possible 
relation between the two events. 
For the determination, cells were monitored using time-lapse microscopy. Single 
cells were tracked for NS1-H relative intensity in the cytoplasm and tracks for 
IRF-7 CFP were taken for the relative intensity in the cytoplasm and in the 
nucleus. The nucleus/cytoplasm ratio of IRF-7 CFP was determined and values 
higher than “1” indicate nuclear translocation. 
 
A 
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Figure 32: Correlation of NS1-H induction with IRF-7 CFP nuclear-cytoplasmic 
relocation. 
IRF-7 NS1-H cells were infected with 80 HAU/ml NDV for 1 h. 8 h pi, a medium exchange 
was performed for medium containing 0.5 µg/ml doxycycline and 20 nM TMR. 
Subsequently, cells were monitored by time-lapse microscopy taking images every 30 min. A: 
Fluorescence profile of a single cell showing onset and course of NS1-H (TMR, red line) and 
IRF-7 CFP ratio of nucleus/cytoplasm (blue line). Values higher than “1” indicate nuclear 
translocation. B: NS1-H (TMR) induction plotted against time point of IRF-7 CFP nuclear-
cytoplasmic relocation of 14 single cells (related to a linear trend line). 
The NS1-H induction graph versus nucleus/cytoplasm ratio of IRF-7 CFP is 
shown in figure 32A. NS1-H expression is induced around 12 h pi in this single 
cell. Translocation appears 10 h pi and persists for 4.5 h with a maximum at the 
same time point of NS1-H induction. Inversion of translocation shortly after 
NS1-H induction could indicate an influence of the perturbator on this behavior. 
Since relocation also occurs in untransfected cells, it was of interest to determine 
the relation between NS1-H induction and IRF-7 CFP relocation by means of a 
correlation (fig. 32B). For this correlation, cells were chosen which show 
relocation of IRF-7 CFP after NS1-H onset. 14 cells in this experiment fitted to 
the demands. One of these cells showed a slightly higher aberration than the 
others and caused a drop of the correlation coefficient from 0.7 to 0.45, what 
needs to be mentioned since the other 13 cells show much higher consistency. 
Anyway, this correlation clearly demonstrates that NS1-H induction is related to 
IRF-7 CFP relocation showing that NS1-H can indeed cause shuttling of IRF-7 
CFP from the nucleus to the cytoplasm what is probably coupled with the earlier 
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demonstrated interruption of IFN-β TurboGFP induction. Indeed, the mean 
period between pathway induction (NDV infection) and IRF-7 CFP relocation is 
15.3 h (SD 2.3 h). The time span between NS1-H onset and IRF-7 CFP 
relocation was determined to be low for all tested cells (mean: 2.7 h; SD: 2 h) 
which is expected since IRF-7 relocation occurs upstream of IFN-β TurboGFP 
arrest. The short time frame also demonstrates the influence of NS1-H on a 
factor closely related to IRF-7. Interruption in this case is assumed to appear 
fast. 
As demonstrated for the cell in figure 32A, IRF-7-C cells expressing NS1-H 
show a relatively short retention time of IRF-7 CFP within the nucleus. It was 
previously demonstrated that IRF-7 CFP has a retention time of 12.6 h (SD: 7.2 
h) within the nucleus of IRF-7-C cells (Rand, 2010). However, for cells 
expressing NS1-H after doxycycline treatment, this time span is significantly 
decreased to 5 h (SD: 2.4; fig. 33). Untreated IRF-7 NS1-H cells do not show 
significantly different nuclear accumulation of IRF-7 CFP (4 h; SD: 3.7). This 
might indicate a lack in significance due to small sample numbers (n=12 for 
untreated and n=8 for doxycycline-treated IRF-7 NS1-H cells). Procentual 
standard deviation shows highest variation in case of untreated IRF-7 NS1-H 
cells (94 %). For the doxycycline-treated cells, this value is about 47 % and 57% 
for untransfected cells, indicating more pronounced effects for the cells 
expressing NS1-H. 
These data also give a hint that a premature relocation occurs through NS1-H, 
because retention time within the nucleus is drastically decreased for cells that 
undergo relocation of IRF-7 CFP. 
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Figure 33: IRF-7 CFP retention in the nucleus of untransfected and IRF-7 NS1-H cells. 
IRF-7-C and IRF-7 NS1-H cells were seeded onto a collagen-treated chambered microscopy 
slide at a density of 2.5 * 10^4 cells/well. Adherent cells were infected with 80 HAU/ml NDV 
for 1 h and treated with 0.5 µg/ml doxycycline 4 – 8 h pi, if necessary. Subsequently, cells 
were monitored by time-lapse microscopy taking pictures every 30 min. The retention time of 
IRF-7 CFP is given in the figure. The first bar demonstrates IRF-7 CFP retention in IRF-7-C 
cells. These data were kindly provided by U. Rand (2010; n = 55). The second bar 
demonstrates the retention time of IRF-7 CFP in IRF-7 NS1-H cells (n = 12) and the third bar 
shows these cells exposed to doxycycline (n = 8). The p-value between the untransfected cells 
and IRF-7 NS1-H cells without doxycycline is 1.17 * 10
-6
. Untransfected cells compared to 
doxycycline-treated IRF-7 NS1-H cells have a p-value of 2.3 * 10
-6
. P-values were calculated 
by student‟s t test. 
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3.6 Specificity of NS1-H and NS3/4A-H for the perturbation of early IFN 
induction 
In the previous experiments it was shown that as well NS1-H as NS3/4A-H are 
potently interfering with IFN-β TurboGFP induction. Furthermore, it was clearly 
demonstrated that NS3/4A-H is a much stronger IFN antagonist, of which 
already low levels are sufficient to interrupt IFN-β induction. In the introduction 
it was said that both factors are specifically interacting with this cascade, 
whereas NS1-H acts at multiple steps and NS3/4A-H cleaves one important 
factor of the pathway (chapters 1.9 – 1.10). However, publications for both, NS1 
and NS3/4A affirm a potential influence of the factors on IFN-induced signaling 
(Helbig et al, 2008; Jia et al, 2010). At least for NS1 could be shown that the 
anti-IFN mechanisms are strain-and cell type-specific (Han et al, 2010; Hayman 
et al, 2006; Melén et al, 2007). To clarify these assumptions about an effect of 
NS1 or NS3/4A on JAK/STAT signaling and therefore the induction of ISGs, an 
experiment was performed using two further reporter cells. They are based on 
NIH3T3 and harbor a BAC with the locus for an ISG, the murine Mx2 gene. In 
one of them luciferase and in the other tdTomato is driven by the Mx2 promoter 
(Pulverer, 2008; Pulverer et al, 2010). These cells show high induction of the 
reporters upon induction of the IFN signaling cascade and exhibit basal levels of 
luciferase or tdTomato in the uninduced state. 
3.6.1 Mx2 reporter cells harboring NS1-H 
The constructs coding for doxycycline-dependent NS1-H and the construct 
harboring the constitutively expressed rtTA2 were stably introduced into the 
cells displaying Mx2 induction by luciferase expression (Mx2Luc). The best 
clone was stably transduced with a lentivirus harboring the constitutively 
expressed KRAB repressor to lower basal NS1-H expression. After selection, 5 
regulated clones were characterized for low basal expression and high 
inducibility of NS1-H. The most promising clone (Mx2Luc NS1-H) was used 
for further experiments (fig. 34). Proper luciferase inducibility was also assumed 
(data not shown). 
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Figure 34: Expression characteristics of the 
Mx2Luc NS1-H clone. 
Mx2Luc NS1-H cells were either treated with 
doxycycline for 3 d or left untreated and stained with 
TMR. Cells were measured for the amount of NS1-
H (TMR) positive cells by flow cytometry. In the 
histogram, the fluorescence of untransfected 
NIH3T3 cells is compared with the fluorescence of 
uninduced and induced Mx2Luc NS1-H cells. As a 
control for these cells serve NIH3T3 wt cells. 
 
For untransfected Mx2Luc cells, it was shown that maximal luciferase amounts 
after stimulation with 500 Units (U) of IFN-β can be obtained 24 h post 
induction (Pulverer, 2008). For this purpose, this time point was elected for 
further determinations. Since measurements will also be performed after NDV 
infection, it was necessary to analyze the time point of maximal luciferase 
induction after NDV infection in order to obtain comparable results. For this 
purpose, equal amounts of Mx2Luc NS1-H cells were seeded and infected with 
80 HAU/ml NDV. Cells were harvested at the indicated time points pi (fig. 35) 
and measured for luciferase activity. 
Mx2Luc expression already shows an increase 24 h pi. The climax of the 
reporter cells was measured 48 h pi and for later time points, a decrease in Mx2 
promoter activity was realized. Luciferase levels that come close to basal 
expression were obtained 5 d pi. 
 
Figure 35: Mx2 induction in response to NDV infection. 
Mx2Luc NS1-H cells were infected with 80 HAU/ml NDV for 1 h. At the indicated time 
points pi, cells were harvested and whole cell extracts were prepared. Luciferase activity was 
measured (as described in Materials and Methods). The data shown represent average values 
+/- SD of 3 experiments. For the 72 h value, no SD is given, since only one experiment was 
performed. 
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3.6.2 NS1-H does not affect interferon stimulated gene expression 
As previously described in this work, early IFN induction in response to viral 
infection could be efficiently perturbed. However, a second, even stronger wave 
of IFN induction follows when secreted IFN-α/β molecules bind to the IFNAR 
receptor which induces JAK/STAT signaling (see introduction chapter 1.7.5 and 
fig. 2) and targets in the induction of ISGs. 
H5N1 NS1 interferes with JAK/STAT signaling in HeLa cells by inhibiting 
STAT phosphorylation due to restriction of IFNAR and induction of SOCS 
protein expression (Jia et al, 2010). Furthermore, it is known that NS1 acts at the 
post-transcriptional level by blocking host cell mRNA processing and nuclear 
export (Hale et al, 2008). It was investigated whether the influenza strain PR8 
encoded NS1 protein (as used in this study) influences IFN signaling and 
therefore might also affect the induction of ISGs like IRF-7 or Mx2. This will 
show whether PR8 NS1 perturbation is specific for IFN induction and whether 
NS1-H also acts on the post-transcriptional level. 
In the present case, JAK/STAT signaling was either directly induced by 
administration of 500 U/ml IFN-β into the medium of cells or by NDV infection. 
The latter method leads to the secretion of early IFNs which subsequently bind 
to the IFNAR receptor causing JAK/STAT signaling. By these methods the 
direct and indirect effect of the perturbator on this pathway can be shown. 
NS1-H expression was induced at varying time points relative to IFN-β 
induction or NDV infection. After harvesting, cells were measured for luciferase 
activity. 
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Figure 36: Influence of NS1-H on JAK/STAT signaling. 
Mx2Luc NS1-H cells were treated with 2 µg/ml doxycycline at certain time points relative to 
IFN-β induction/NDV infection. A: Cells were exposed to 500 U of IFN-β. B: Cells were 
infected with 80 HAU/ml NDV for 1 h. 48 h pi or rather 24 h post induction via IFN-β, cells 
were harvested for analysis of luciferase activity (as described in Materials and Methods). The 
data shown represent average values +/- SD of 3 experiments. 
In figure 36A, it is clearly visualized that the NS1 variant used in this work does 
not directly influence IFN-β-mediated signaling, since no alteration of luciferase 
could be detected for any time point of NS1-H induction. Levels are constant at 
approximately 6 million RLU/µg protein. 
Indeed, when cells were infected with NDV, a time-dependent decrease of 
luciferase can be observed. Since JAK/STAT signaling is not influenced by 
NS1-H expression, this effect fully reflects the influence of NS1-H on IFN 
induction. Also doxycycline administration pi still leads to a decrease in the 
Mx2 response. Similar results could be seen for flow cytometry analyses (fig. 
21A). Consequently, the results for Mx2 support the results gained for IFN-β 
NS1-H cells. 
The fact that NS1-H does not influence IFN-β-induced luciferase expression 
also shows that neither post-transcriptional nor –translational mechanisms of 
NS1-H occur. 
 
3.6.3 Reporter cells for monitoring the influence of NS3/4A-H on Mx2 
induction 
For the NS1 variant used in this work, no direct influence on JAK/STAT 
signaling could be measured. It was of further interest to see whether NS3/4A-H 
of JFH-1 strain directly affects this pathway. 
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So far, contradictory results were obtained by independent groups. For instance, 
Cheng et al. (2006) declared that NS3/4A leaves IFN signaling intact, whereas 
two other groups claimed a perturbing effect (Helbig et al, 2008; Lin et al, 
2005). 
In order to be able to clarify this, an NS3/4A-H expressing clone of Mx2Tom 
reporter cells was established. Regulation of NS3/4A-H upon doxycycline 
administration is displayed in figure 37. Low basal expression of NS3/4A-H 
could also be detected. Mx2Tom NS3/4A-H cells as depicted in figure 37 were 
used for further analyses. 
 
Figure 37: Expression characteristics of 
NS3/4A-H in Mx2Tom cells. 
Mx2Tom NS3/4A-H cells were either treated 
with doxycycline for 3 d or left untreated and 
stained with Oregon Green (OG). Cells were 
measured for the amount of NS3/4A-H (OG) 
positive cells by flow cytometry. In the 
histogram, the fluorescence of untransfected 
NIH3T3 cells is compared to the fluorescence 
of uninduced and induced Mx2Tom NS3/4A-H 
cells. 
 
The direct influence of NS3/4A-H on JAK/STAT signaling was to be 
determined in Mx2Tom NS3/4A-H cells. For this purpose, it was necessary to 
induce this pathway via IFN-β administration to the medium. In this case, pre-
treatment with doxycycline does not alter Mx2Tom expression (fig. 38A) 
indicating that NS3/4A-H does not affect JAK/STAT signaling. Since the 
question arises, whether Mx2Tom alteration via NS3/4A-H can be visualized in 
these cells, Mx2Tom induction was also measured 48 h after NDV infection. In 
untransfected Mx2Tom cells, proper induction after NDV infection was 
measured by this method (data not shown). Cells were also pre-treated with or 
without doxycycline, but Mx2Tom induction could neither be shown in the 
presence nor in the absence of doxycycline (fig. 38B). This indicates that 
NS3/4A-H basal expression totally blocks IFN induction and does not allow 
IFN-β secretion and binding to IFNAR. Together with the previous findings, 
these results demonstrate that NS3/4A-H effectively acts on IFN induction, but 
not on JAK/STAT signaling. 
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Figure 38: Influence of NS3/4A-H on JAK/STAT signaling. 
Mx2Tom NS3/4A-H cells were treated with 2 µg/ml doxycycline. A: Cells were exposed to 
500 U of IFN-β. B: Cells were infected with 80 HAU/ml NDV for 1 h. 24 h pi or rather 48 h 
post IFN-β induction, cells were measured for the amount of Mx2Tom positive cells by flow 
cytometry. In the histogram, the fluorescence of uninfected Mx2Tom NS3/4A-H cells is 
compared to the fluorescence of uninduced and induced Mx2Tom NS3/4A-H cells 48 h post 
NDV infection. 
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3.7 A synthetic mammalian oscillator 
In the previous experiments, a successful, synthetic biology approach for the 
perturbation of a cellular network was shown. However, synthetic biology also 
aims at rebuilding biological circuits and designing components and networks 
that do not yet exist in nature. These factors or networks should give predictable 
function and be inert to the cellular machinery. 
A very recent synthetic biology approach is the establishment of oscillatory 
circuits in mammalian cells. First synthetic oscillators were demonstrated to 
work in prokaryotes and lower eukaryotes. In 2009, the first oscillator was 
shown in mammalian cells (Tigges et al, 2009). However, this approach was 
only successful in transient experiments (see chapter 1.6 of introduction). 
3.7.1 Towards a stable, synthetic mammalian oscillator 
The aim of this part of the work was to establish a stable oscillator in 
mammalian cells. The oscillator should consist of one positive and one time-
delayed negative feedback loop that are reciprocally regulated. Important is that 
the negative feedback loop does not totally block the expression of the positive 
part, because otherwise, expression of both would be interrupted in a delayed 
manner. To visualize oscillation, at least these loops were coupled to the 
expression of a fluorescence reporter. The onset as well as the amplitude of 
oscillation should be regulated by an external inducer. 
Our approach is based on two mammalian expression systems, the Tet-(Off) and 
the Cou system (see chapter 1.4 - 1.5 of introduction), that are independently 
regulable from each other (Kästner, 2007). The coumermycin-dependent 
promoter (PCou) drives the expression of the KRAB repressor and a destabilized 
variant of the marker protein TurboRFP (tRFP, Evrogen). The CouTA, tTA and 
a destabilized TurboGFP (tGFP, Evrogen) are expressed from PTet. TurboRFP 
and TurboGFP are fused to the destabilizing sequence PEST (Li et al, 1998; 
Rogers et al, 1986). For simplicity, the markers which indicate the state of the 
respective proteins driven by the same promoter are not mentioned further. The 
mechanism of oscillation is described in figure 39. 
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Figure 39: Design of the synthetic oscillator. 
In the absence of doxycycline, the tTA and the CouTA are continuously expressed (A). When 
coumermycin is present, the CouTA dimerizes and binds to PCou where it induces KRAB 
expression (B). The KRAB repressor binds to PTet and represses expression from this 
promoter (C). tTA and CouTA are not built until the CouTA in the cell is depleted. Then, 
expression of KRAB terminates and because of the autoregulated tTA expression, tTA and 
CouTA come up again and the circuit starts anew (D). An approximate state of tGFP and 
tRFP expression is indicated by light and dark coloring of the components. Fine-tuning of the 
network occurs via control of transactivator expression by the administration of doxycycline. 
The components that are necessary for this oscillator are assembled on two 
vectors which harbor each a different selection marker. The composition of 
these vectors is demonstrated in figure 40. 
 
 
 
 
 
 
Figure 40: Composition of the oscillator vectors. 
Two vectors with different selection markers harboring all necessary components for the 
oscillator were constructed. The so-called Tet-Unit is composed of a bidirectional 
tetracycline-dependent promoter (PbidiTet) driving the expression of the Tet-Off tTA on the one 
hand and the CouTA on the other hand. A second, unidirectional PTet controls the expression 
of tGFP. The second construct, the Cou-Unit, is composed of a bidirectional coumermycin-
dependent promoter (PbidiCou) driving the expression of the KRAB repressor and tRFP to 
monitor the intracellular levels of the KRAB repressor. 
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3.7.2 Doxycycline-dependent expression upon stable implementation of the 
Tet-Unit 
After verification of the function of all Tet-Unit components in transient (data 
not shown), it was stably integrated into human embryonic kidney cells stably 
harboring the SV40 large T-antigen (HEK-293T). 19 stable clones were checked 
for tGFP expression. Since the Tet-Off system is used for the oscillator, tGFP is 
expected to be induced in the absence of doxycycline, whereas reduced levels 
are expected in the presence of doxycycline. 
Unfortunately, none of the clones showed strong expression and especially none 
showed reliable regulation (fig. 41A). However, the co-transfection of the Tet-
Unit and another vector expressing eGFP under the control of PTet showed by far 
more expression of GFP (fig. 41B). While almost 100 % of the cells shift to the 
lower right quadrant in the absence of doxycycline, only 39 % do this in the 
presence of doxycycline. 
Taken together, this means that low levels of tGFP in the induced state are 
caused by the GFP variant, perhaps by the short half-life. Since the Cou-Unit 
also contains a marker to describe the state of the components and therefore 
indicates oscillations, the visualization via tGFP is not mandatory for 
verification of the oscillator. 
A 
 
 
 
 
Results 
83 
 
B 
 
Figure 41: tGFP expression in a stable Tet-Unit expressing clone. 
HEK-293T cells stably transfected with the Tet-Unit (A) or stably transfected with the Tet-
Unit and transiently transfected with a construct driving eGFP from PTet (B) were treated with 
2 µg/ml doxycycline or left untreated. Flow cytometry measurement was done for the amount 
of tGFP positive cells ~ 48 h post transfection. Results are displayed as density dot plots (red 
> blue) showing GFP expressing cells in the lower right quadrant and cells with unchanged 
fluorescence in the lower left quadrant. 
3.7.3 Functionality of the Cou-Unit in stably transfected cells 
The Cou-system, a mammalian expression system which is induced upon 
coumermycin administration, consists of the coumermycin-dependent promoter 
and the respective transactivator (Zhao et al, 2003). However, the concomitant 
expression of two genes was not possible due to a lack in a bidirectional 
promoter. Especially for the herein described oscillator, such a promoter was 
established. Functionality of the promoter was verified by expressing tRFP from 
the one and tGFP from the other side (data not shown). With this tool, 
concomitant expression of tRFP and KRAB from the same promoter is feasible. 
The functionality of tRFP in the Cou-Unit was first determined by a transient 
co-expression with the constitutively expressed CouTA, demonstrating 
functionality, but high basal levels of the Cou-Unit (data not shown). 
Afterwards, HEK-293T cells were stably transfected with the Cou-Unit. 
Functionality was measured for 23 clones after transient transfection with the 
constitutively expressed CouTA with or without coumermycin. The best clone 
shows only slight levels of tRFP positive cells in the absence of coumermycin. 
However, only low induction was demonstrated to occur in the presence of 
coumermycin (data not shown). 
It was demonstrated that the Cou-Unit is stably integrated into the cells, but it 
exhibits low tRFP expression. This might be due to the short half-life of this 
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protein which affects stability during the preparation of the cells for the 
measurement. However, during live-cell imaging this should not exhibit a 
problem. 
3.7.4 Combination of both units in one cell 
After verification of their stable function in HEK-293T cells, the constructs were 
both stably integrated into the same cells and clonal populations were expanded. 
Time-lapse microscopy was performed with the resulting clones. 
As in the flow cytometry data, visualization of the reporters was not possible. 
Consequently, oscillations could not be measured. Indeed, this does not mean 
that no oscillations of the respective factors in the circuit occur, but it lacks in 
the visualization of the destabilized reporters. A reason for this could be a too 
short half-life of the reporters. This needs to be further examined. 
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4 Discussion 
In this work, regulable perturbation of an intracellular signal transduction 
cascade, namely IFN-β induction, was performed by means of synthetic 
expression cassettes. In these cassettes, viral genes that are known to interfere 
with this particular pathway were expressed from a tetracycline-inducible 
promoter. The HCV NS3/4A gene or the IAV NS1 gene was fused to HaloTag 
V7, which could be visualized by the use of specific fluorescent ligands in single 
living cells. 
By means of these cassettes, information about the efficiency and the temporal 
dynamics of NS1-H and NS3/4A-H perturbation as well as IFN-β induction 
could be yielded. Invertibility of ongoing IFN-β induction was demonstrated. 
Besides, an influence of NS1-H and NS3/4A-H on IFN stimulated signaling 
(JAK/STAT signaling) could be excluded. Quantitative and qualitative data 
were gained by the perturbation experiments which will serve as a base to create 
a mathematical model of early type I IFN induction. 
Furthermore, synthetic modules were explored for the generation of a stable, 
synthetic oscillator in mammalian cells. Expression in the respective cells is 
based on two mammalian expression systems that are independently 
controllable. 
4.1 Influence of HaloTag V7 fusion on the perturbators 
To gain information about the expression characteristics of a gene product, 
fusion of the protein to a reporter is generally performed. In the present work, 
the viral perturbators NS1 and the NS3 cofactor NS4A were C-terminally fused 
to HTV7 to enable their visualization. However, the fusion of a reporter protein 
to a certain protein can be delicate and cause drastic changes in the protein‟s 
characteristics. 
The fusion could cause a partial or full loss of functionality of the native protein. 
This could be due to a change in the secondary structure of the gene product. 
Thus, in this work functionality concerning the perturbation activity of NS1-H 
and NS3/4A-H was investigated and could be demonstrated (fig. 20). 
Also, the localization of the protein within the cell can be affected by e.g. 
structural changes or the size of the fusion protein. Potential binding sites or 
hiding of localization signals can result from this. IAV NS1 proteins shuttle 
between the cytoplasm and the nucleus in a strain-, time- and cell type specific 
manner (Han et al, 2010; Hayman et al, 2006; Melén et al, 2007). In the present 
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case, NS1 from PR8 was used and it was still able to localize in both, the 
cytoplasm and the nucleus (data not shown). NS3/4A has been shown to act in 
the cytoplasm and also the fusion protein was found in this cellular compartment 
(data not shown). 
Besides, transcriptional regulation or/and degradation of RNA or the mature 
gene product can also differ compared to the single, native gene products 
(perturbator or reporter). As a consequence, lower or higher steady state levels 
and turnover of the protein fusion can occur. 
Such influences were hypothesized to be responsible for the lack of visualization 
of low amounts of the respective fusion protein, which could be observed at 
early time points after induction (fig. 16B, 20A). Certainly, gene expression 
needs some time to be induced, but additional factors might cause this. 
Differential maturation of the components of the fusion proteins might be 
responsible for a potential delay in action and visualization of the proteins. For 
instance, maturation of HTV7 might take longer than that of the perturbator 
moiety and consequently, binding of and visualization via the reactive ligand 
occurs delayed. However, if present, this is a minor effect since constant low 
levels of the perturbators as basal levels (figs. 9A and 15A) or NS3/4A-H levels 
at low doxycycline concentrations (fig. 22B and 23B) cannot be visualized 
either. In the case of flow cytometry analyses, a detection limit of the cytometric 
device causes delayed visualization (fig. 16B) as time-lapse results displayed 
earlier visualization of the reporter in multiple cell clones (fig. 19, 26). 
Taken together, the fusion protein reflects the basic properties of the native 
protein, but differences in the efficiency and the turnover of the perturbator-
HTV7 fusions compared to the single native gene products cannot be excluded 
and need to be considered for the results obtained in this work. 
4.2 Controlled perturbation of IFN-β induction by the influenza A virus 
NS1 protein 
NS1-H expression levels within IFN-β NS1-H cells 
The IAV NS1 protein counteracts early IFN induction at multiple levels. The 
intensity of this interfering effect and therefore the pathogenicity is strain-
specific. This behavior of IAV relies on the respective NS1 sequence which also 
differs between influenza strains (Geiss et al, 2002). In this study, the NS1 
protein of influenza A virus PR8 strain was used and all experiments were 
performed in reporter cells based on the NIH3T3 cell line. So far, no data exist 
for the controlled expression of NS1 and consequently, the values of ectopically 
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controlled NS1-H compared to the amount occurring during native IAV 
infection could not be estimated. In this work, the respective NS1 values in 
NIH3T3 cells were compared to the levels of NS1 produced upon infection of 
NIH3T3 cells with influenza A virus PR8. Quantification was done after 
Western Blotting (fig. 10). These data reveal that NS1 levels during early stages 
of infection (up to 6 h pi) can be mimicked by ectopically expressed NS1-H in 
the cell clone analyzed. However, levels during later stages of infection (12 – 24 
h pi) are 2.5 - to 4-fold higher than for ectopically controlled NS1-H, indicating 
that ectopic NS1-H levels might not be sufficient to totally block IFN-β 
TurboGFP expression in this cell clone. 
In the uninduced state, IFN-β TurboGFP reporter cells ectopically expressing 
NS1-H, IFN-β NS1-H, do not display leaky expression of NS1-H neither in flow 
cytometry analyses (fig. 8) nor in the Western Blot (fig. 10). Nevertheless, the 
amount and the intensity of IFN-β TurboGFP expressing cells is decreased (fig. 
9). This gives the indication that basal expression under the detection limit of the 
flow cytometric device occurs in uninduced cells. Indeed, these cells are 
adequately expressing IFN-β TurboGFP and could be used for the perturbation 
experiments as long as total IFN-β TurboGFP values of IFN-β NS1-H and 
related cells were not compared to each other. 
The influence of NS1-H on IFN-β TurboGFP expression 
The effect of NS1-H on IFN-β TurboGFP expression was determined for a 
population of IFN-β NS1-H cells. NS1-H expression was induced at different 
time points relative to induction of the IFN-β induction cascade via NDV to 
determine the effect of pre-induced NS1-H and to find out whether and in how 
far belated NS1-H induction still affects IFN-β TurboGFP expression. 
The effect of NS1-H induction at different time points relative to infection 
reveals a continuous decrease in the amount of IFN-β TurboGFP positive cells 
(figs. 20A and 21A). A little stricter perturbation occurs between time points 3 
and 6 h pi. Perhaps, NS1-H affects ongoing signaling quite fast at this time point 
for unknown reasons. Indeed, this time frame approximately correlates with the 
expression of influenza virus genes after natural infection. Indeed, the amount of 
NS1-H 3h pi is comparable to the amount of native NS1 after natural infection at 
an MOI of 1 (fig. 10). In fact, viral mRNA is synthesized in the early stages of 
infection about 0.6 h pi (Vester et al, 2010). A delay occurs for translation and to 
obtain a respective amount of NS1 within the cell. Altogether, this time window 
could fit to the declared hypothesis. 
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A similar experiment was performed by tuning intracellular NS1-H levels by the 
administration of differing doxycycline concentrations. With this, the amount of 
NS1-H which is required for the block of IFN-β TurboGFP could be determined 
or it could be demonstrated whether a certain level (threshold) exerts an 
exceptional effect on IFN-β TurboGFP. 
When a certain level of NS1-H was constantly induced overtime, a strong 
perturbing effect was measured already at intermediate doxycycline 
concentrations (25 – 100 µg/ml; figs. 22A and 23A). Accordingly, a pre-
treatment gives highest perturbation efficiency. These results indicate that the 
amount of NS1-H primarily seems to be important for perturbation and not the 
time point of induction. 
The dot plots from these perturbation experiments (figs. 20A and 22A) 
demonstrate that IFN-β TurboGFP cannot be totally blocked in the established 
reporter cells. This can have multiple reasons. First, PR8 NS1-H IFN 
counteracting abilities are not strong enough. Second, maximally inducible NS1-
H levels (fig. 10) are not sufficient to totally block IFN-β TurboGFP expression. 
To reach these high levels appearing during native infection by inducible 
expression of NS1-H, other cell clones would have to be generated in which 
inducibility is significantly increased. In this respect, a rational design of a 
chromosomal locus to achieve minimal basal expression and maximal 
inducibility would be advantageous. Such strategies have become feasible 
exploiting strategies for site directed integration of expression cassettes into 
predefined chromosomal sites. It would be interesting to analyze whether the 
shielding of the expression cassette from surrounding influences by e.g. 
insulators would cause higher inducibility (Gaszner & Felsenfeld, 2006). 
A total block of IFN-β TurboGFP expression might be reached, when native 
levels of NS1-H can be adjusted within a cell. On the other hand, this effect 
might be cell-type or strain-specific and a total block cannot be achieved even at 
higher NS1-H levels. 
4.2.1 Influence of NS1-H on JAK/STAT signaling 
NS1 from some IAV strains obtains regulatory functions by interacting with 
components that are necessary for the transcription, splicing and translation of 
cellular RNAs. The cleavage and polyadenylation specific factor 30 (CPSF-30) 
is bound by NS1 and therefore polyadenylation of cellular mRNAs is inhibited 
(Noah et al, 2003). Also, NS1 interacts with the poly(A)-binding protein II 
(PABPII) inhibiting its function and nuclear export of the protein and host cell 
mRNAs (Chen et al, 1999). Further, nuclear-cytoplasmic transport of cellular 
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mRNAs is inhibited by interaction of NS1 with factors of the nuclear export 
machinery (Satterly et al, 2007). These mechanisms can have strong effects on 
the induction of ISGs. H5N1 avian influenza NS1 was even demonstrated to 
directly interfere with JAK/STAT signaling by inhibiting STAT phosphorylation 
(Jia et al, 2010). 
To verify whether NS1-H derived from IAV PR8 affects the induction of ISGs, 
its effect on Mx2 induction was determined in Mx2Luc NS1-H reporter cells 
(fig. 34). The results suggest that NS1-H does not exert any effect on 
JAK/STAT signaling (fig. 36A). The fact that Mx2 is properly induced without 
showing any reduction in the presence of NS1-H upon IFN-β induction also 
demonstrates that the mRNA was properly processed. These results are 
supported by the findings of Hayman et al. (2006) and Kochs et al. (2007) who 
demonstrated that PR8 NS1 efficiently perturbs IFN-β induction, but it does not 
work on the post-transcriptional level or on secondary signaling. 
4.3 Dynamics of IFN-β TurboGFP perturbation by HCV NS3/4A-H 
TLR-3 dependent signaling does not occur in NIH3T3 cells 
The early IFN antagonistic functions of HCV NS3/4A are quite distinct. It was 
demonstrated to proteolytically cleave IPS-1. Cleavage of the TLR-3 adaptor 
protein TRIF is controversially discussed (Dansako et al, 2007; Li et al, 2005). 
This might be due to the fact that HCV is, as IAV also, underlying strong 
genetic drifting and subtypes might show different behavior, especially in 
variation of the cell type. In this study, NIH3T3 cells were used and analysis for 
the presence of TLR-3 was performed by direct administration of poly I:C, a 
dsRNA analogon, to the supernatant of NIH3T3 IFN-β reporter cells. Under 
these conditions, only a marginal induction of IFN-β expression could be 
measured (data not shown) confirming the absence of TLR-3 signaling pathway. 
Consequently, a potential effect of NS3/4A-H on TRIF can be ignored and 
NS3/4A-H is extremely specific for cleaving IPS-1 of RIG-I-mediated signaling. 
Establishment of IFN-β NS3/4A-H KRAB cells 
The establishment of IFN-β TurboGFP cells with inducible NS3/4A-H was 
challenging (compare with chapter 3.2.3), but clonal populations of cells 
exhibiting inducibility of both NS3/4A-H and IFN-β TurboGFP were lately 
obtained after introduction of KRAB caused by down-regulation of basal 
NS3/4A-H expression (figs. 14 and 15A). 
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IFN-β NS3/4A-H KRAB cells show slightly lower IFN-β TurboGFP induction 
compared to untransfected cells (fig. 15A). As for the IFN-β NS1-H cells, a 
decrease in the mean intensity of IFN-β TurboGFP occurred (fig. 15B) which 
might indicate that cells are still marginally expressing NS3/4A-H. Indeed, the 
cells express adequate values of IFN-β TurboGFP. As no comparison for total 
IFN-β TurboGFP amounts between IFN-β NS3/4A-H KRAB cells and cells 
related to untransfected cells should be performed, these cells were used for 
subsequent perturbation experiments. 
The influence of NS3/4A-H and core on IFN-β TurboGFP expression 
With respect to the experiment for NS1-H, also the influence of NS3/4A-H on 
IFN-β TurboGFP expression was determined. NS3/4A-H expression was 
induced at different time points relative to NDV infection to determine, whether 
a time point exists at which NS3/4A-H has an exceptional influence on IFN-β 
TurboGFP expression. 
The data for this experiment demonstrate an abrupt decrease in IFN-β 
TurboGFP expression 3-6 h pi (figs. 20B and 21B). In the case of NS1-H 
stronger perturbation occurs at the same time point, but this effect is more 
drastic for perturbation via NS3/4A-H. So far, the reason for enhanced 
perturbation at these time points remains unclear, but it might be advantageous 
for the virus to early perturb IFN-β TurboGFP expression in a highly efficient 
manner. Further, this time point might fit to NS3/4A expression after native 
infection. However, data for this were not obtained in this work, but are a future 
perspective. 
In the case of NS3/4A-H, a total block of IFN-β TurboGFP expression can be 
visualized from 12 h ai on or earlier (fig. 20B). In the case of NS1-H (fig. 20A), 
a total block of IFN-β TurboGFP expression could not be shown for any time 
point (24 h or earlier, fig. 20; data not shown). This indicates a stronger 
perturbing effect for NS3/4A-H than for NS1-H, which has not been shown so 
far. Indeed, this was expected since strong IFN antagonistic properties can be 
related to the persistence of a virus within the host which efficiently happens in 
the case of HCV. 
mRNA and protein levels of NS1-H and NS3/4A-H cannot be directly compared 
with each other, since NS1-H and NS3/4A-H show different expression 
intensities for equal culture conditions. This becomes obvious when flow 
cytometry data for both factors are compared (e.g. figs. 20 and 22). 
Nevertheless, approximate declaration can be done especially when significant 
fluctuations occur as for the perturbation patterns. Also, maximal NS1-H 
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intensity is much higher than for NS3/4A-H, but concomitantly the effects of 
NS3/4A-H are stronger. 
When IFN-β NS3/4A-H KRAB cells were monitored for the effect of different, 
constant NS3/4A-H levels on IFN-β TurboGFP expression, the significant 
difference in the perturbation mechanisms and consequently in the perturbation 
patterns between NS1-H and NS3/4A-H became even more obvious (figs. 22 
and 23). For the latter, the lowest concentration tested (10 ng/ml doxycycline) 
was sufficient to almost fully block IFN-β TurboGFP expression. This 
demonstrates that few NS3/4A-H molecules are sufficient to cleave the IPS-1 
proteins within the cell. In contrast, NS1-H needs to build dimers and to bind its 
interaction partners in a stoichiometric manner. Consequently, much more 
molecules of NS1-H seem necessary for a similar effect. 
Taken together, these results demonstrate that NS3/4A-H very efficiently 
perturbs IFN induction leaving no residual IFN-β TurboGFP expressing cells. 
This might contribute to persistence of the virus within a host. However, further 
experiments would be needed to show that ectopically induced NS3/4A-H levels 
contribute to levels comparable to natural infection conditions. 
Fine-tuned perturbation is only possible for very low concentrations of the 
perturbator. The tuning could be more efficient if NS3/4A-H would exert a 
shortened half-life which would also affect basal levels within the cell. 
Consequently, the usage of destabilizing tags could cause tighter regulation of 
the perturbation. 
4.3.1 Influence of HCV NS3/4A-H on JAK/STAT signaling 
NS3/4A-H as expressed from the synthetic expression cassettes was 
demonstrated to strongly interfere with IFN-β TurboGFP induction and to give 
reproducible data concerning perturbation intensity (figs. 20B and 22B). The 
fact that perturbation via NS3/4A-H just relies on the interaction with RIG-I-
mediated signaling makes this system very specific. Though, it has not been 
clarified yet whether NS3/4A-H affects the induction of ISGs after JAK/STAT 
signaling. Helbig et al. (2008) demonstrated an inhibitory effect on STAT1 
phosphorylation. Controversially, Cheng and co-workers (2006) could not 
display any effect of NS3/4A on IFN-induced signaling. By means of synthetic 
reporter cassettes, this question was addressed to at least demonstrate the 
specificity of our system. In figure 38A, it is clearly demonstrated that the 
presence of NS3/4A-H does not affect IFN-β-induced Mx2 expression, but 
Mx2Tom expression is completely abolished when NS3/4A-H perturbs IFN-β 
induction after NDV infection (fig. 38B). This again demonstrates the 
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impenetrable block of RIG-I signaling via NS3/4A-H and also underlines the 
specificity of NS3/4A-H to affect IFN-β induction 
Combination of IFN-β and JAK/STAT perturbation in single cells 
Both, NS1-H and NS3/4A-H were demonstrated to specifically perturb IFN-β 
TurboGFP expression. The combination with a second synthetic perturbation 
cassette for the interference with JAK/STAT signaling in one cell would be 
challenging. By this, interference of early type I IFN induction and subsequent 
JAK/STAT signaling could be performed in one cell. Thereby, information 
about the influences of both pathways on each other as well as data about the 
spatiotemporal dynamics between both pathways could be gained. 
For this purpose, a factor known to interfere with JAK/STAT signaling would 
be expressed in the context of a second inducible system like the coumermycin 
system. This system was demonstrated not to interact with the Tet system 
(Kästner, 2007). 
Various viruses have evolved strategies to interrupt JAK/STAT signaling as 
reviewed in Randall & Goodburn (2008). One appropriate candidate for 
JAK/STAT perturbation could be the HCV structural protein core which was 
demonstrated to interfere with JAK/STAT signaling at the level of STAT-1 
phosphorylation (Lin et al, 2006) as well as SOCS-1 and SOCS-3 regulation, 
even though these results were contradictory (Bode et al, 2003; Miyoshi et al, 
2005; Walsh et al, 2006). 
The establishment of stable reporter cells for perturbation of these two pathways 
was initiated during this project, but clones that express core over time could not 
be established for unknown reasons (data not shown). Indeed, loss of expression 
during cell passaging/expansion could neither be overcome by single cell sorting 
nor by integration of KRAB. Actually, the attributes of core to participate in 
proliferation and carcinogenesis should be regarded as beneficial for the 
establishment of a stable cell clone (reviewed by Irshad & Dhar, 2006). Indeed, 
several groups were able to establish stable cell clones for tetracycline-
repressible core in UTH cells or the osteosarcoma cell line U2-OS (Berg et al, 
2009; Moradpour et al, 1996). Constitutive expression of core could be 
performed in HepG2 and Chang Liver cells, respectively (Ruggieri et al, 2007). 
Also in NIH3T3 cells, stable overexpression of core was demonstrated (Han et 
al, 2002; Kim et al, 2004). 
The reason for the failure of stable core expression in this work is unclear. It can 
be hypothesized that HTV7 detection is not sensitive enough to allow 
visualization of potential low levels of core which might be sufficient for the 
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observed effects demonstrated by other groups. Indeed, when combined with the 
perturbation module for IFN-β interference a different reporter would have to be 
chosen for the detection of core. A more sensitive reporter could be used in this 
case, which might lead to visualization of core. 
Also, mutations within core according to the HCV strain (JFH-1 in this case) 
could influence integration and stable expression of core. The corresponding 
protein might harm the cells and cause cell death. Non- or low-expressing cells 
would benefit from that and outcompete potential high-expressing cells. Thus, 
changing the core variant could be of benefit. Another way to overcome this 
problem could be further screening for strictly regulated clones or shortening of 
half-life to circumvent potentially harmful intracellular accumulation of the core 
protein. The half-life of core (~ 9 h for the protein; Moradpour et al, 1996) could 
be shortened by the usage of a destabilization tag. 
4.4 Interference with ongoing IFN-β expression by viral counteractors 
deciphers cellular signaling dynamics 
Signal transduction pathways are delicate mechanisms which are strictly 
regulated at multiple levels. Once initiated, they are able to continuously fix this 
state as long as the conditions are not changed. Also, IFN-β expression was 
demonstrated to maintain a certain expression level after reaching plateau phase 
(Rand, 2010). 
In the present work, an observation attracted attention upon exploring the 
question whether ongoing IFN-β TurboGFP expression can be interrupted by 
perturbation via NS1-H or NS3/4A-H. This observation was the appearance of 
cells that were positive for both, IFN-β TurboGFP and the perturbator. This was 
especially obvious in the time-dependent perturbation experiments (fig. 20), but, 
at a lower extent, also in the dose-dependent experiments (fig. 22). In the latter 
experiments, pre-treatment with doxycycline induced an “anti-IFN state” due to 
the constant presence of the IFN-antagonist within the cells. It was further eye-
catching that more cells were positive for NS1-H and IFN-β TurboGFP than for 
NS3/4A-H and IFN-β TurboGFP in the dose-dependent experimental setup. For 
time-dependence, cells expressing NS3/4A-H and IFN-β TurboGFP were either 
low in the one or in the other fluorescence, whereas a wide broader distribution 
of cells expressing both reporters could be visualized for NS1-H. This supports 
the above discussed indication for a stricter perturbation mechanism via 
NS3/4A-H or/and a fast shut-down of IFN-β TurboGFP after NS3/4A-H onset. 
The existence of cells expressing both markers is very intriguingly since it 
indicates that the perturbation is not a strict all-or-nothing event, but has a 
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certain dynamic. Cells are able to express both, even though interference is 
expected to occur. It is conceivable that this is a transient state of the cell 
between perturbator onset and IFN-β TurboGFP termination; alternatively, this 
state might persist. The latter would suggest that ongoing activation of IFN-β 
induction pathway is not needed for maintenance of expression. Indeed, there 
are no data which show that RIG-I signaling needs to be continuously running 
for causing sustained IFN-β TurboGFP expression. Thus, it could be that only 
an initial trigger of RIG-I-mediated signaling is needed to establish continuous 
IFN-β expression. The methods set-up in this thesis allowed studying this 
question. 
Withdrawal of the activation signal is sufficient to interrupt IFN-β 
expression indicating a “dead man’s switch”-like mechanism 
To clarify whether ongoing IFN-β TurboGFP expression can be disrupted, 
single cell analyses needed to be performed. For this approach, an improvement 
of IFN-β NS1-H cells was ventured by introduction of KRAB, which can reduce 
the basal activity of rtTA-dependent promoters. Tight induction of NS1-H was 
maintained and the amount and intensity of IFN-β TurboGFP within the 
responding cells were comparable to untransfected cells (fig. 25). Obviously, the 
small, undetectable amount of NS1-H in IFN-β NS1-H cells was sufficient to 
cause alteration in the frequency and intensity of IFN-β TurboGFP expression. 
Accordingly, the IFN-β NS1-H KRAB and the already improved IFN-β 
NS3/4A-H KRAB cells were used to follow living cells that express both 
reporters overtime. As could be visualized, cells positive for both, NS1-H and 
IFN-β TurboGFP, stay in this state constantly in the displayed cell and IFN-β 
TurboGFP expression does not seem to decrease apparently (fig. 26). Indeed, 
determination of the fluorescence profiles for both markers of a representative 
number of single cells revealed that IFN-β TurboGFP goes to a premature 
plateau phase or inverts expression in response to perturbator induction (see 
examples in figs. 27A and 28A). A correlation of perturbator onset versus IFN-β 
TurboGFP plateau/inversion further points out that these events are related to 
each other in the case of NS1-H (fig. 27B). This result was even more stringent 
for NS3/4A-H (fig. 28B) since lower standard deviation from the regression line 
could be visualized in this case. 
In the flow cytometry experiments it was demonstrated that IFN-β TurboGFP 
expressing cells still appear even though NS1-H is fully induced (compare with 
figs. 22A and 23A, doxycycline concentrations 0.5 – 2 µg/ml). 
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On the single cell level, it could also be visualized that the cells do not 
necessarily express NS1-H continuously, but expression decreases for unknown 
reasons; then IFN-β TurboGFP turns on (data not shown). The reason could be a 
lack in doxycycline, since medium cannot be exchanged during a time-lapse 
microscopy run. Certainly, other cells remained switched on at this time point 
which could again be related to the stochastic expression behavior of the cells. 
However, this and other effects cannot be visualized in cell populations what 
makes the tool of single cell analysis over time an indispensable tool for 
questions like this. 
Together, these data show that IFN-β TurboGFP expression needs a constant 
trigger to maintain expression. Perturbation causes an interruption of the 
signaling. This behavior resembles a “dead man‟s switch”, where a signal is 
transmitted as long as a button is pushed and turns off when the button is 
released. Thus, interruption of the induction pathway at cytosolic stages can 
subsequently block or invert IFN-β expression. This finding has important 
implication for an infected host. In particular, this means that after induction of 
viral perturbator expression, IFN-β expression can be arrested or even down-
regulated which disrupts the establishment of an antiviral state within the host 
and neighboring cells. Consequently, counteraction of infection cannot or only 
alleviated be performed anymore. 
Mechanisms upstream of IFN-β TurboGFP induction are perturbed by 
NS1-H 
The perturbation of IFN-β induction by NS1-H was demonstrated in this work. 
A relation in the dynamics between the translocation of IRF-7 into the nucleus 
and IFN-β TurboGFP induction was demonstrated before (Rand, 2010). Here, 
IRF-7 could act as a substitute for IRF-3 which is activated by the same kinases. 
By means of IRF-7 translocation, perturbation via NS1-H could be demonstrated 
on a different level of RIG-I-mediated signaling. 
Reporter cells constitutively expressing a fusion protein of IRF-7 and CFP as 
well as doxycycline-inducible NS1-H were characterized and did not show 
significant basal expression of NS1-H (fig. 29). However, the translocation 
potential of IRF-7 CFP in these cells was slightly attenuated (fig. 31). This can 
be caused by basal NS1-H expression if relocation indeed occurs after 
perturbation. 
To verify this mechanism, single cells were analyzed for the ability of IRF-7 
CFP to relocate from the nucleus to the cytoplasm according to NS1-H 
induction. Since relocation is a natural incident, a correlation of NS1-H onset 
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with the relocation time point of IRF-7 CFP was performed (fig. 32). Indeed, a 
striking correlation was confirmed by mathematical regression, even though a 
certain deviation is obvious. This indicates that the two events are related to 
each other by a constant time frame between them. 
Together, the data show that IRF-7 shuttling to the nucleus is reversible upon 
pathway interference – a new finding which has not been demonstrated before. 
Along with these results, it could also be shown that the mean retention of IRF-7 
CFP in the nucleus (12.6 h) was decreased after doxycycline treatment 
compared to untransfected cells (5 h; fig. 33). 
In total, these data show that relocation of IRF-7 CFP is coupled to NS1-H onset 
and consequently RIG-I-mediated signaling is interrupted also on this level, 
what makes the hypothesis of a “dead man‟s switch” more valid. 
4.5 Dynamics of IFN-β induction with respect to the perturbation via 
NS1-H and NS3/4A-H 
Even though the mechanisms of the diverse interacting components of the IFN 
system are known, only minor information could be gained yet for its 
spatiotemporal dynamics. The data shown in this thesis demonstrate that 
perturbation of the network via NS3/4A-H results in a total block of IFN-β 
TurboGFP induction (figs. 21 B and 23B). Since NS3/4A-H was shown to work 
specifically on IPS-1 in these cells (fig. 38A) and no TLR-3 dependent pathway 
can be induced (data not shown), the strong block indicates that no bypass to the 
IFN-β TurboGFP induction via IPS-1 exists. The loss of IPS-1 cannot be 
circumvented; this probably makes the NS3/4A protease that efficient. 
It was further shown in this work that NS1-H and especially NS3/4A-H cause a 
drastic decrease in IFN-β TurboGFP expression when induced 3 - 6 h pi (fig. 
21). This result was already previously discussed (chapter 4.3). Additionally, 
one could speculate whether at this time point where most efficient perturbation 
is displayed, NS3/4A-H is just induced before signaling has reached the relevant 
stages. Therefore no IFN-β TurboGFP induction occurs. Later perturbation does 
not have such strong effects, because the downstream signaling of IPS-1 was 
already started and the above described patterns of IFN-β TurboGFP transition 
to plateau phase or inversion occur, which are less effective than pre-treatment. 
Since a less efficient but still apparent decrease at this time point also occurs for 
NS1-H (fig. 21A), it is likely that the same or a closely related factor is 
exceptionally influenced via NS1-H. In fact, NS1 was already demonstrated to 
build a complex with RIG-I, thereby inhibiting further signaling (Pichlmair et al, 
2006). Despite of this aberration, NS1-H constantly perturbs IFN-β TurboGFP 
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induction in a time- and dose-dependent manner. This further indicates that 
NS1-H acts on multiple levels and does not show specific perturbation at a 
certain time point. 
U. Rand (2010) demonstrated that the process of nuclear accumulation of IRF-7 
CFP takes 30 – 60 min. He further showed that IRF-7 accumulates inside the 
nucleus for 12.6 h in average (SD 7.2 h). In this work, it was demonstrated that 
IRF-7 NS1-H cells display shortened retention of IRF-7 CFP in the nucleus (fig. 
33). This, together with the correlation on relocation and NS1-H induction (fig. 
32), indicates premature relocation and consequent interruption of the signaling 
via NS1-H. Unexpectedly, induction of NS1-H expression did not lead to 
significant changes in IRF-7 nuclear accumulation periods. Due to the strong 
variability of these events, lack of significance might originate from too small 
sample numbers (n = 12 for uninduced cells; n=8 for induced cells). 
U. Rand further demonstrated that between IRF-7 CFP translocation and IFN-β 
TurboGFP onset, a relative constant time span of 2 to 6 h is maintained. 
In this work, it was demonstrated that the time span between NS1-H induction 
and IRF-7 CFP relocation is quite short (2.7 h; SD: 2 h). The period between 
NS1-H onset and IFN-β TurboGFP arrest is about 12 h (SD 5.4 h). 
Consequently, the time period between IRF-7 relocation and IFN-β TurboGFP 
arrest could be about 9.3 h. However, it would be interesting to observe these 
events upon NS1-H perturbation in a single cell clone to verify this value. 
These obtained data give further information about the temporal dynamics of 
RIG-I-mediated IFN-β induction and data that are necessary for the 
establishment of a reliable mathematical model. 
4.6 Challenges in the establishment of cells displaying doxycycline-
dependent transgene expression 
Within this work, control of perturbator expression was realized upon 
transcriptional control via synthetic regulatory cassettes/modules. Indeed, the 
establishment of cells with tightly regulated expression was challenging since 
only few clones provided good inducibility and absence of relevant basal 
activity. This limitation is frequently encountered upon establishment of tightly 
regulated clones. 
In fact, differences in the inducibility of single clones were demonstrated (fig. 
7). Also, varying levels of basal expression were observed between cells (figs. 7 
and e.g. 11 and 29). In the case of IFN-β NS3/4A-H cells, basal expression was 
too high to allow IFN-β TurboGFP induction (fig. 12). These differences in the 
expression of a transgene after random integration into a host can be explained 
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by position effect meaning that the new, neighboring sequences and effectors 
can influence the expression of the integrated transgene or from an integrated 
promoter (West & Fraser, 2005). For the latter, promoter crosstalk between the 
integrated and surrounding promoters can happen (Hampf & Gossen, 2007). 
Inducible promoters are exceptionally susceptible to this effect. Thereby, the 
outcome of downstream transgene expression can be strongly altered in basal 
expression or/and maximal induction as it could be observed for PTet in this 
work. Also, the constitutively active promoter driving rtTA2 could affect PTet 
when expressed from the same construct. To avoid at least the latter effect, the 
two units were provided on two separate plasmids. 
A different approach to overcome this effect is the use of previously defined and 
potentially modified chromosomal loci. One modification could be the 
integration of two insulators which shield DNA segments between them from 
neighboring influences (reviewed by Gaszner & Felsenfeld, 2006; also described 
in chapter 4.2). 
4.7 Expression and stochasticity of the doxycycline-dependent constructs 
Doxycycline-dependent regulation of the reporters was demonstrated in chapter 
3.3 for cells stably harboring NS1-H under control of PTet. Even though 
differences in regulation can occur within individual cell clones, the overall 
induction pattern stays comparable. The cells displayed reproducible time- and 
dose-dependent regulation of NS1-H (fig. 16). Indeed, a gradual expression 
response should be given using the classical Tet system, relying on constitutive 
expression of the transactivator (Schucht et al, 2010). 
However, Hop et al (1997) demonstrated with the classical Tet-Off system that 
doxycycline affected the number of expressing cells rather than the expression 
level. Such a pattern would be expected for an on/off-type (bimodal) rather than 
the expected graded expression pattern (compare with chapter 1.6 of the 
introduction). In flow cytometry experiments it was later shown that a broad 
peak of differentially induced cells occurs in this system with increasing 
concentrations of doxycycline indicating heterogenous expression within single 
cells (Bornkamm et al, 2005). 
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The data on the single cell level shown here clearly demonstrate that this issue is 
more complex and differs between single cells (fig. 18). Indeed, heterogeneity of 
doxycycline-induced expression was observed at multiple levels: 
- Time point of NS1-H induction 
- Maximal level of expression 
- Differential course of NS1-H induction 
In this work, it was demonstrated that genetically identical cells do not respond 
uniformly to doxycycline stimulation as concluded from flow cytometry based 
data (Schucht et al, 2010). Thus, the potential of a cell to be induced seems to be 
governed by stochasticity. 
Importantly, the overall expression pattern obtained by the design of the 
expression cassettes in this study is distinct from the clear bimodal expression 
pattern described for cassette designs in which the tetracycline transactivator 
drives its own expression via a feedback mechanism. In this case, only two 
distinct populations occur (on/off), since expression is always distinct if turned 
on (May et al, 2008). 
Definitely, this complex expression pattern remains to be elucidated in further 
detail; microscopic monitoring as used in this study could contribute. 
For single cell analyses of this work, only cells were chosen which fulfill the 
requirements of perturbator induction on the verge of IFN-β TurboGFP arrest or 
rather IRF-7 relocation, making the data valid. For flow cytometry experiments, 
a certain error emerges, since cell populations are not synchronized. Indeed, this 
error is expected to be moderate since analysis in comparable settings showed 
that most cells respond to doxycycline early after administration and only a 
minor population does not immediately respond (Behme and Wirth, 
unpublished). 
4.8 Synthetic perturbation 
Advantages of synthetic expression modules for perturbation of cellular 
networks 
In this work, a synthetic perturbation approach was performed. Here, synthetic 
perturbations are defined as the expression of an ectopic perturbator-reporter 
fusion by an externally regulable mammalian expression system, the Tet system. 
So far, no comparable approach has been performed and consequently, 
information concerning this area is rare. Certainly, the herein described method 
will be discussed with some other methods to cause perturbation. 
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Perturbation is generally achieved by the use of chemicals, RNAi or by gene 
knock-out to gain insight into a proteins‟ function (chapter 1.3). 
In the present work, two different mechanisms of perturbation were performed. 
One causes a knock-down of the desired signaling (NS1-H; figs. 22A and 23A) 
by working on multiple factors. The effect of knocking down, but rarely 
knocking-out gene expression is in common with RNAi approaches. siRNA-
mediated interference can also be coupled to the Tet system (Berger et al, 2010). 
This method can also be used to specifically knock-down gene expression in a 
regulated manner with even higher specificity as for NS1-H. 
The second approach described herein principally leads to a knock-out of IPS-1 
and consequently to a total block of the signaling (NS3/4A-H; figs. 22B and 
23B). Such an effect can be achieved by the deletion or disruption of a GOI 
causing a knock-out as it was shown for IRF-3 and IRF-7 (Sato et al, 2000). By 
this method, first evidences for the work mechanisms of IRF-3 and IRF-7 were 
gained after analyses of IFN-α and –β outcome in IRF-3 -/- or both IRF-3 -/- and 
IRF-7 -/- mouse embryonic fibroblasts. However, such a perturbation is time-
consuming and irreversible. Furthermore, the deletion or disruption of a gene 
can cause lethality. 
Chemical perturbation can probably be regulated by the administration of a 
certain dosage of the inducer. Indeed, it is often unspecific and can cause the 
knock-down of groups of proteins. Also, it cannot be ruled out that the 
respective chemical affects the host cell metabolism leading to false results. 
Tetracycline or doxycycline as inducer for the synthetic cassettes, however, is 
generally used in cell culture and does not affect the cell metabolism in the 
concentrations applied. 
Certainly, all described methods have assets and drawbacks. Most of the 
alternatively described perturbation strategies cannot (properly) be regulated. 
Consequently either no or maximal perturbation by the respective method is 
possible. Indeed, regulation of the perturbator can give further information about 
both, the perturbator and/or the gene/network of interest, as demonstrated in the 
present work. Thus, the strong and strict perturbation of NS3/4A-H on IFN-β 
TurboGFP at relative low intracellular levels was demonstrated (fig. 23B). 
Taken together, synthetic perturbation as described in this work has the 
advantage to be regulable and reversible compared to other methods. Since the 
perturbator is arbitrary, the effect achieved by it can be specific or acting on 
multiple levels. Also, knock-down or knock-out can be achieved as desired. 
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4.9 Towards a stable, synthetic oscillator in mammalian cells 
The composition of systems for the controlled expression of a transgene is quite 
simple and already well established in eukaryotes (compare with chapters 1.4 
and 1.5 of the introduction). Indeed, combination of these circuits to higher 
order synthetic circuits is challenging. 
While oscillating expression circuits could be established in prokaryotic systems 
(Elowitz & Leibler, 2000; Stricker et al, 2008), so far only systems for transient 
oscillation have been implemented in mammalian cells (Tigges et al, 2010; 
Tigges et al, 2009). Accordingly, the construction of mammalian cells with a 
stable, oscillating circuit is challenging. In this work, such a higher order 
synthetic network was aimed. While the single components were demonstrated 
to work, the final cell with all necessary constructs integrated does not show 
oscillation. Reasons for this could be that oscillations are not properly visualized 
by the reporters or that the interplay between or composition of the components 
does not fit. To get suggestions, under which conditions the circuit as 
established in this work, could oscillate, a mathematical model was developed 
by Ana Teixeira (Animal Cell Technology Lab, ITQB/IBET in Oeiras, 
Portugal). This gave rise to the definition of some conditions that need to be 
taken into account to successfully implement such a network. Also, the diverse 
variables would be difficult to handle without a representative model. This is 
discussed in the following chapter. 
4.9.1 Mathematical model development 
For the underlying approach, a deterministic modeling was performed which 
should represent single-cell oscillations. In this model, production and 
degradation of the three regulatory proteins tTA, CouTA and KRAB as well as 
the reporters tRFP and tGFP is considered. Also the interactions between them 
were included. Transcriptional and translational processes were modeled for 
each parameter as well as mRNA and protein translocations between nucleus 
and cytoplasm. The time-delays between the different oscillation steps were also 
taken into account since they are essential to obtain proper oscillation. 
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Some parameters were assumed as follows: 
- Association of RNA polymerase with DNA does not work limiting 
- No limitation of nucleotides and amino acids 
- A comparable translation rate exists for the proteins 
- Components are homogenously distributed within the nucleus/cytoplasm 
- The regulatory proteins bind to the respective promoters as dimers 
Furthermore, the absence of doxycycline and the constant presence of 
coumermycin were ascertained (Teixeira, unpublished). 
4.9.2 Model simulation and improvement of the potential oscillator 
A model simulation was performed with varying parameters to ensure the best 
conditions to obtain sustained oscillations. Indeed, conditions could be defined 
that would lead to oscillations in cells proving that the designed synthetic 
network has the potential to oscillate. Initially, equal transcription rates for the 
respective genes and equal affinities for the activator as for the repressor were 
assumed. Like this, it was found out that the copy number of the Tet-Unit should 
be 3-fold higher than for the Cou-Unit. However, it is not likely that the 
transcription rate of all genes will be equal since it mainly depends on the 
integration site (compare with chapter 4.6). Rather, this suggests that the Tet-
Unit expression level should be 3-fold higher than the Cou-Unit to obtain 
sustained oscillations. 
In this study, a screening for clones was performed that exhibit this feature. 
However, such clones could not be identified. This indicates that the probability 
to meet these requirements randomly might be rather low. Accordingly, 
strategies that allow the prediction of expression levels seem to be required to 
balance transcription rates of the various components. For this purpose, a 
rational design of cells seems to be mandatory. This would include the usage of 
pre-defined chromosomal loci to integrate the synthetic cassettes together with 
regulatory elements such as silencers, insulators and/or enhancers. 
Elowitz and Leibler (2000) already found that comparable protein and mRNA 
decays support the generation of oscillations. Also in this work, protein and 
mRNA of tTA, CouTA and KRAB should have appropriate half-lives. To 
visualize oscillations in this circuit, also the reporter half-life should match (fig. 
42). Proper oscillations only occur for low half-lives (2 - 4 h). Long protein half-
life (12 – 24 h) would cause accumulation of the reporters with increasing 
oscillations and quickly lead to synchronization of oscillations (Teixeira, 
unpublished). 
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Figure 42: Oscillations of the components according to their half-life. 
Oscillation of the system is demonstrated for different half-lives of the components. Proper 
oscillation can be obtained for low half-lives since for long ones, accumulation of the proteins 
and subsequent synchronization of the signal occurs. Oscillations according to half-lives of 2 
h (upper left), 4 h (lower left), 12 h (upper right) and 24 h (lower right) were simulated with 
the model. These data were kindly provided by Ana Teixeira (Animal Cell Technology Lab, 
ITQB/IBET in Oeiras, Portugal). 
In the experimental part, the usage of the destabilized proteins, especially tGFP, 
was limited since the protein could hardly be visualized both in flow cytometry 
and in time-lapse microscopy. This suggests that the half-life of these proteins 
might be too short to be visualized. Loss of at least the Tet-Unit in the single 
cells could be excluded, since tTA was demonstrated to work properly in 
context with non-destabilized eGFP (fig. 41B). Consequently, future work on 
this circuit will incorporate an improvement in stable reporter gene expression. 
It is considered to choose different destabilizing tags which might provide 
slightly enhanced half-life, thereby allowing visualization of the reporters. 
Also, tTA, KRAB and CouTA should be fused to destabilizing tags to obtain 
comparable, short half-lives of the proteins. Then, proper relation of the 
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components to each other could be obtained by the use of defined chromosomal 
loci for the units or by the use of insulators. 
It has to be taken into account that tTA and KRAB build heterodimers due to an 
equal dimerization domain. Heterodimers are probably non-functional and 
would reduce the concentration of proteins that could form homodimers. 
Generally, this multimerization could be circumvented by providing different 
dimerization domains as performed by Forster and co-workers (1999). 
The results underline the complexity and challenge of building a higher order 
synthetic network. Indeed, the mathematical model could provide hints for the 
improvement of the circuit to aim at the stable implementation of a mammalian 
oscillator. 
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5 Outlook 
Perturbation experiments are usually performed to get insight into the function 
of a protein or a cellular network. In this work, a synthetic biology approach was 
performed to specifically interfere with an intracellular network, namely the IFN 
system. Perturbation was performed by means of natural, viral perturbators that 
are stably expressed from a tetracycline-dependent promoter within reporter 
cells. Selected items that would further the development of such systems as well 
as future applications are described in the following. 
A: Achieving predictable expression of transgenes in mammalian cells 
The heterogenous expression behavior of single clones after random integration 
relies on the position effect meaning the influence of neighboring sequences and 
effectors on the integrated cassette. As a consequence, varying expression levels 
of the GOI can be obtained. Inducible promoters are exceptionally affected by 
promoter crosstalk leading to variation in basal leakiness and maximal 
inducibility between stable cell clones as could be observed in this work. In 
order to achieve predictable transgene expression in future approaches, some 
recently established methods could be performed. 
i) A pre-defined chromosomal locus could be exploited for targeted integration 
of the construct of choice via recombinase-mediated cassette exchange 
(RMCE). The benefit of this method is the predictable expression from the 
previously characterized locus which should provide similar expression in 
single clones. This method can be further improved by the modification of a 
certain chromosomal site by integration of insulators. The composition of the 
locus would be arranged in a way that allows targeted integration of a 
construct of choice in between two insulators. Expression from the construct 
is not influenced by the environment due to shielding attributes of the 
insulators. 
Insulators can also be positioned up- and downstream of the region of interest 
on vector DNA. However, integrating the DNA randomly into a host can 
cause interruption within the vector constellation making targeted integration 
more precise. 
ii) BAC constructs are used to achieve predictable expression of a GOI after host 
cell integration. In contrast to RMCE performed in mammalian cells, the 
construct of interest is integrated into a pre-defined locus in bacteria. The 
BAC containing the DNA of interest in a defined locus is subsequently 
transferred to the host cell. 
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By means of the described methods, predictable expression of a GOI within 
mammalian cells can be obtained in a reproducible manner. 
B: Precise regulation of protein levels 
In the present work, NS1-H and NS3/4A-H were demonstrated to efficiently 
perturb IFN-β TurboGFP induction. However, tight regulation could not be 
achieved for NS3/4A-H, since low levels already showed drastic effects. In this 
case, transcriptional regulation by means of the Tet system does not seem to be 
an appropriate tool, since basal leakiness of the inducible promoter can cause 
accumulation and consequently a high steady state level of the transgene within 
the cells. Also, reversion of inducible transgene expression by withdrawal of the 
inducer takes some time. Here, two possibilities will be described how to 
overcome this problem by enhanced degradation or post-translational regulation 
of NS3/4A-H. 
i) A combined approach using the Tet system and fusing a destabilizing 
sequence as PEST (Li et al, 1998; Rogers et al, 1986; also used for 
destabilizing the reporters in the oscillator approach) to HTV-7 would be 
feasible. The native half-life of HTV7 is 6 h, but it can be down-regulated to 
~ 2 h by this fusion (Yamaguchi et al, 2009). The constant presence of 
destabilized HTV7 also causes lower steady state levels in the cell. These 
findings could be implemented to obtain lower basal levels and increased 
protein turnover of NS3/4A-H. 
ii) An approach to regulate intracellular levels of NS3/4A-H solely on the 
protein level could be advantageous. One system to perform this implies the 
fusion of NS3/4A-H to a destabilizing sequence of a mutant of the E. coli 
dihydrofolate reductase (ecDHFR). It should allow tight regulation of the 
protein levels by the small-molecule ligand trimethoprim (TMP) which 
rapidly and reversibly stabilizes the destabilizing domain (Iwamoto et al, 
2010). By administration of the respective amount of TMP, dose-dependent 
stabilization of the fusion protein can be triggered. With this tool, intracellular 
NS3/4A-H levels could be regulated and even reduced to a minimum. By this 
method, a more homogenous presence of NS3/4A-H could be obtained. 
Though, the system is not as well established as the Tet system. 
C: Synthetic perturbation of pathway progression 
The perturbation of IFN-β induction was demonstrated to be efficient, regulable 
and reproducible. By means of this approach, insights into the spatiotemporal 
dynamics of virus-induced IFN-β induction could be gained. Indeed, the 
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perturbators used in this work are highly specific for this cascade. It would be of 
interest to analyze whether the herein described approach could be transferred to 
different intracellular signaling pathways as e.g. pathways for apoptosis, 
proliferation or differentiation to get insight into their dynamics. For this 
purpose, different (viral) perturbators that are known to specifically interfere 
with the network of interest would need to be exploited. 
The perturbation of a unique pathway was successfully implemented in this 
work. A future perspective is the perturbation and visualization of the respective 
effect on multiple signaling networks in one cell. By means of such an approach, 
interactions and spatiotemporal dynamics between pathways can additionally be 
elucidated. With this work, a similar attempt was initiated combining NS1-H-
mediated perturbation of IFN-β induction with HCV core-mediated perturbation 
of JAK/STAT signaling. As independent progression of the Tet and the Cou 
system could be demonstrated before (Kästner, 2007), these expression systems 
can be used for the regulation of the two perturbators. Indeed, reporter cells for 
the visualization of an early IFN as well as an ISG as Mx2 will needed to be 
developed. 
Synthetic pathway perturbation was demonstrated within mammalian cells in 
this work. In order to validate the function of the synthetic cassettes in vivo, the 
use of an animal model would be beneficial. Proven functionality in such a 
model can give rise to the further establishment of synthetic approaches for 
network analyses in living organisms. 
Future perspectives for the synthetic biology technologies 
By the synthetic perturbation approach, information cannot only be gained on 
the cellular level, but also for the perturbators as demonstrated in this work for 
NS1-H and NS3/4A-H. The reporter cells harboring NS1-H or NS3/4A-H 
described in this work could be excellent tools to screen for components acting 
against NS1 or NS3/4A, since both factors are clinically extremely relevant. 
Especially in the case of NS3/4A, the search for efficient protease inhibitors 
could be performed. 
Further, such synthetic perturbation approaches could be validated for gene 
therapy, since diseases are often related to the deregulation of intracellular 
pathways. So far, gene therapeutic approaches mainly depend on the 
overexpression of genes which might act in a rather unspecific manner and can 
cause severe side effects. Indeed, it could be beneficial to specifically interfere 
with the respective pathways to verify a specific counteraction of the disease. 
Thereby, more pronounced effects of the perturbator could be obtained. Also, 
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the regulation of the respective perturbator level can be of benefit, since high 
doses might cause side effects. The use of clinically approved inducers like 
doxycycline would also be advantageous. 
For this purpose, the establishment of the above mentioned in vivo mouse model 
would also be of interest as a proof of principle in a living organism. 
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6 Materials and Methods 
6.1 Equipment 
Table top centrifuge   Heraeus Biofuge 13 
      Heraeus Biofuge PICO 17 
 
Cooling centrifuges   Beckman GS-15R 
      Heraeus Megafuge 1.0 
      Sigma 3K20 
Heraeus Biofuge fresco 
      Sorvall Superspeed RC5C 
      Inflexible rotors: GSA, GS3, SS34 
      Swinging rotor: HB4 
 
Photometer  Nanodrop Spectrophotometer ND-1000, 
Peqlab 
 
ELISA Reader  Multiskan EX reader, Thermo Electron 
Corporation 
 
Gelelectrophoresis systems BRL Horizon 58 
  BRL Horizon 1114 
  BRL Horizon 2025 
  Owl Separation System A2 
 BioRad (Protean II XL) 
 
Western Blot cell Bio-Rad Trans-Blot Cell 
 
Power supplies Gibco BRL ST 504 
Biorad Power PAC 200 
Biotec-Fischer Phero-STAB 550 
 
Autoclave     BelimedDampf Sterilisator 6-6-6 HS1, FD 
 
Microscopes  Nikon TMS 
 Leitz Labovert FS 
Olympus CK2 
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Olympus CK X41 
Fluorescence microscopes  Olympus IX81 
Zeiss Axiovert TV 135 
Zeiss LMS 510 META 
 
Micropipettes    Gilson 
 
UV-chamber Hanau 
 
Phosphoimager Molecular Dynamics Storm 860 
 
Videograph Biotec Fischer Video densitometer 
  Mitsubishi thermo printer and personal 
computer 
 
FACS machines and Software FACSAria, Becton Dickinson 
FACSCalibur, Becton Dickinson 
  FACSVantage SE, Becton Dickinson 
  LSR II, BD Biosciences 
  Macintosh Quadra 650 
 
Luminometer  Berthold Lumat LB 9501 
 
Cell Counter Casy-DT 1, Schaerfe Systems 
 
Cell culture incubators Forma Scientific Water jacketed Incubator 
3336 
  Labotect C200 
 
Safety benches  Sterile Gard Class II Type A/B3, Baker 
SG 400E 
 Herasafe, Heraeus HSP 18 
  Herasafe, Heraeus KS15 
 BDK-SK 1500 
 
Sterile work benches Mecaplex, Sterilgard Hood VBM600 and 
SG400 
  Heraeus HLB 2448 
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  Heraeus HSP 18 
ph Meter Beckmann M340 
 
Thermomixer  Eppendorf Thermomixer 5436 
 Eppendorf Thermomixer compact 
 
Vortexer  Scientific Industries Vortex Genie 2 
  Heidolph REAX 2000 
 
Shaker  Heidolph Duomax 1030 
 
Dionized Water Supply Millipore MilliQ 
 
Electroporator Biorad Gene Pulser and Pulse Controller 
 
Thermocycler T3 Thermocycler, Biometra 
 
Precision Weighing Scale  Sartorius 
 
Microwave     Whirlpool 
 
Water Bath     GFL 
 
4°C refrigerator    Liebherr Comfort 
 
-20°C freezer    Liebherr 
 
-70°C freezer    Thermo Forma 
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6.2 Materials 
6.2.1 Chemicals 
The used chemicals were purchased from: Amersham Biosciences, Bayer, 
Biolabs, Bioline, Biorad, BRL Difco, Gibco, Merck, Miles, Pharmacia, Prenner, 
Qiagen, R&D Systems, Roche, Seromed, Serva and Sigma. 
Enzymes were purchased from New England BioLabs (NEB), Bioline, Roche, 
Invitrogen and Amersham Biosciences. 
Antibodies were obtained from Santa Cruz Biotechnology, Calbiochem and Cell 
Signalling. 
Oligonucleotides were purchased from Eurofins MWG and TIB MolBiol. 
DNA-sequencing was done by the “Genome Analysis” department of the 
Helmholtz Centre for Infection Research.   
6.2.2 Consumables 
Cell culture plates      Nunc, Corning 
(96-well, 48-well, 24-well, 
12-well and 6-well) 
Tissue culture dishes     Corning, Greiner Bio-one 
(100mm * 20mm, 
145mm * 20mm) 
Tissue culture flasks     Nunc 
(25 and 75 mm
2
) 
Falcon tubes      Greiner Bio-one 
(15 ml and 50 ml) 
Flow cytometry / luminescence    Sarstedt 
Measurement tubes (5 ml) 
CombiTips       Eppendorf 
(0.5 ml, 1.25 ml, 2.0 ml, 
2.5 ml, 5 ml) 
Safe Lock Tubes (1.5 ml, 2.0 ml)   Eppendorf 
PCR Tubes       Biozym 
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Cryogenic vials      Corning 
Pipette tips       Star Labs 
(20 µl, 200 µl, 1000 µl) 
Microscopic chambered cell slides   Nunc / ibidi 
Syringes       Omnifix® 
(1 ml, 5 ml, 20 ml) 
Syringe filters      Sartorius 
(0.2 µM and 0.45 µM) 
6.2.3 Applied Software 
This manuscript was written employing the Microsoft Office 2007 package 
(Word, Power Point, and Excel). Microsoft Office Access was used for database 
entries. 
Flow cytometry data were performed with the BD Cellquest pro and BD 
FACSDiva software, Cyflogic or FlowJo v7.6 and earlier. For the design of 
primers and cloning strategies Vector NTI AdvanceTM10 from Invitrogen was 
used. 
The analyses of microscopical images was performed with ImageJ (National 
Institute of Health) and corresponding plugins. Zeiss LSM510 software was also 
used. 
The Quantity One software (Bio-Rad) was used for the Western Blot analysis 
and quantification. 
Sequencing results were analyzed with Chromas version 2.32 from 
Technelysium Pty Ltd. 
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6.3 Basic methods 
6.3.1 Sterilisation 
Heat sterilization was performed in Belimed autoclaves. Glass ware was 
sterilized at 180°C for 4 h. Solutions and plastic ware (pipette tips, eppendorf 
tubes) was sterilized at 121°C, 1 Bar for 25 minutes (min). Sterile filtering was 
performed in the case of non-autoclaveable solutions (sterile filter, pore 
diameter 0.22 µm). 
6.3.2 Agarose gelelectrophoresis 
(According to Maniatis et al, 1982) 
1 x TAE-Buffer 40 mM Tris/acetate, pH 7.5 ; 20 mM NaOAc ; 1 
mM EDTA 
5 x loading buffer 15 % Ficoll, 50 mM EDTA, 1 x TAE; 0.05% 
Bromophenolblue; 0.05 % Xylenecyanole 
Agarose gelelectrophoresis is used to separate double-stranded DNA according 
to its size. DNA moves from the cathode to the anode within an electrical field 
since it is negatively charged. 
In this work, 1 % agarose gels were used for the separation. To produce a 1 % 
gel, 1 g of agarose was dissolved in 100 ml TAE by boiling in a microwave 
oven and 1 µl of ethidiumbromide (10 mg/ml) was added. The gel was poured 
into a tray and after becoming solid, it was transferred to an electrophoresis 
chamber filled with 1 x TAE. The DNA samples were mixed with the respective 
amount of 5 x loading buffer and loaded onto the gel. A marker (Hyperladder I, 
Bioline) as loaded in parallel to determine the size of DNA fragments. Gel 
electrophoresis was performed at 100 V and 30 mA. Gels were monitored under 
UV light (360 nm). 
6.3.3 Purification of DNA 
Purification of agarose gels: 
The DNA bands of the desired size are cut out under UV-light using a scalpel. 
From those DNA containing agarose pieces, DNA is extracted and purified 
using the “QIAquick” gel extraction kit (Qiagen) according to the 
manufacturer‟s instructions. 
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Purification of PCR samples: 
DNA from PCR samples was purified using the “QIAquick” PCR purification 
kit (Qiagen) according to the manufacturer‟s instructions. 
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6.4 Modification of DNA 
6.4.1 Restriction of DNA 
To determine the size of DNA fragments or for cloning strategies, restriction of 
DNA plasmids and PCR fragments was performed. For these purposes, 
restriction enzymes were used that recognize specific nucleotide sequences of a 
length of 4 - 8 base pairs. The enzymes cut within this region providing 
overhanging or blunt ends. Each enzyme reacts optimally under conditions 
(temperature and buffer) recommended by the manufacturer (NEB, Bioline). 
The reaction was stopped by heat inactivation for 20 min at 65°C/80°C or by 
purifying with the “QIAquick” purification kit (Qiagen). 
6.4.2 Fill in reaction of 5’ overhangs 
10 x Klenow buffer 50 mM Tris/HCl in ddH2O, pH 7.2; 10 mM 
MgSO4; 0.1 mM DTT 
dNTP-Mix    1 mM of dATP, dCTP, dGTP, and dTTP each 
In a total volume of 50 µl, 1 µg of DNA with overhanging 5‟ ends was treated 
with 1 U of Klenow enzyme (NEB) in the presence of 3 µl of dNTP mix. After 
30 min of incubation at RT, the reaction was stopped by heat inactivation (20 
min at 80°C) or by the use of “QIAquick” purification kit (Qiagen) according to 
the manufacturers‟ instructions. 
6.4.3 Dephosphorylation of DNA fragments 
10 x NEB buffer 3 500 mM Tris/HCl, 1 M NaCl; 100 mM MgCl2, 
10 mM DTT; adjusted to pH 7.9 
3‟ and 5‟ overhanging ends were dephosphorylated by alkaline phosphatase (calf 
intestinal phosphatase, CIP; NEB) to prevent relegation of a restricted vector. 20 
– 100 pmol of the restricted DNA was incubated with the appropriate buffer 
(NEB) and 1 – 2 U CIP in a total volume of 50 µl. Incubation occurs at 37°C for 
30 min. Afterwards, the DNA is purified using the “QIAquick” purification kit 
(Qiagen) according to the manufacturers‟ instructions. 
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6.4.4 Ligation of DNA fragments 
10 x Ligase buffer 500 mM Tris/HCl; 100 mM MgCl2; 10 mM 
ATP; 100 mM DTT; adjusted to pH 7.5 
In a total volume of 10 µl, 2 µl of the ligase buffer were incubated with 1 – 2 U 
of T4-DNA ligase (NEB) as well as the insert and backbone DNA (relation > 10 
: 1) at RT for 2 h. The ligation was then directly used for transformation into E. 
Coli. 
6.4.5 Polymerase Chain Reaction (PCR) 
PCR was performed to amplify the DNA sequences of IAV NS1, HCV core and 
HCV NS3/4A genes from appropriate vectors. Oligo-nucleotide primers for 
DNA synthesis were obtained from MWG or TIP. Elongation of the two primers 
that hybridize to the 5‟- and the 3‟- end of the sequence to be amplified occurs 
over repeated reaction steps. In the first step, denaturation of the DNA is 
performed at 94°C. Afterwards, temperature is reduced to the optimum for 
primer annealing to the complementary DNA sequence. Then, temperature is 
shifted to the polymerase optimum. This cycle is repeated 25 – 35 times, thereby 
amplifying the sequence of interest exponentially. 
The Expand Long Template PCR System (Roche) was used for amplification of 
long DNA sequences (>1000 bp). 
Average PCR sample: 
Supplied PCR buffer (10 x conc)  5 µl 
containing MgCl2  
10 pmol/µl forward primer   5 µl 
10 pmol/µl reverse primer   5 µl 
10 mM dNTP Mix     4 µl 
(10 mM of each dNTP) 
DMSO      1 µl 
DNA polymerase mix (Roche)   0.5 µl 
DNA template as required 
ddH2O      ad 50µl 
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Average PCR programme (using T3 Thermocycler, Biometra): 
   Temperature [°C] Time   Step 
1)   94°C   5 min  denaturation 
2)   92°C   1 min  denaturation 
3) ~55°C   1 min  annealing 
4)* 68°C   2 min  elongation 
5)   70°C   5 min  final elongation 
6)     4°C   pause 
*steps 2-4 were repeated 30 times before proceeding to step 5. 
The annealing temperatures rely on the GC content and the length of the 
primers. The elongation time depends on the length of the DNA fragment to be 
amplified (30s/kb). 
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6.5 Work with E. Coli 
6.5.1 Laboratory strains of E. Coli 
TOP10 F- mrcA ∆ (mrr-hsdRMS-mcrBC) Φ80dlacZM15, ∆lacX74 recA1 
araD139 ∆ (ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG 
XL1-Blue recA1, endA1, gyrA96, thi-1, hsdR17, suppE44, relA1, lac *F‟ 
proAB, lacI q Z) M15, Tn10, (Tet r)] 
6.5.2 Culture medium and selective drugs for bacteria 
LB-Medium 10 g/L Bacto-Trypton, 10 g/L Bacto-Yeast extract, 
5 g/L NaCl 
Agar plates   15 g of solid agar are added to 1 L of LB-medium 
 
Antibiotic   stock solution  LB-medium  agar plate 
Ampicillin   5 mg/ml in ethanol 5 µg/ml  25 mg/ml 
Chloramphenicol  5 mg/ml in ethanol 2.5 µg/ml  12.5 µg/ml 
Kanamycin   5 mg/ml in H2O  2.5 µg/ml  12.5 µg/ml 
Tetracycline  20 mg/ml in ethanol 5 µg/ml  10 µg/ml 
Stock solutions were sterile filtered before use. 
6.5.3 Preparation of chemical competent bacteria 
Bacteria are pre-incubated overnight in 5-10 ml LB-medium under shaking (180 
rpm) at 37°C. The next day, the bacteria culture is diluted in 1L LB-medium and 
cultivated at 37°C (180 rpm shaking) until an O.D. value of 0.5 - 0.6 at 600 nm 
is reached. Afterwards, the bacteria suspension is pelletted by centrifugation in a 
cooled GSA-rotor at 4°C and 5000 rpm for 10 minutes. The supernatant is 
removed and the bacterial pellet is continuously kept on ice. The pellet is 
resuspended in 100 ml ice-cold 100mM MgCl2 and incubated on ice for 20 - 30 
min. Then, cells are spinned down at 4000 rpm for 10 min at 4°C and the 
supernatant is removed. The pellet is again kept on ice and resuspended in 10 ml 
of ice-cold 100 mM CaCl2-15%. Aliquots of 50 µl were frozen and stored at – 
70°C. 
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6.5.4 Transformation of chemically competent bacteria 
A 50 µl aliquot of the chemically competent cells was thawed on ice for 10 to 15 
min and thoroughly mixed with 0.5 - 1 µl DNA or ligation. This mixture was 
incubated on ice for 5 min and subsequent heat-shock was performed at 37°C. 
Afterwards, the cells were resuspended in 1 ml of LB medium and incubated for 
phenotypical expression of antibiotic resistance for 1 h at 37°C. Then, cells were 
plated on a selective solid medium and incubated overnight at 37°C. 
6.5.5 Preservation of E. Coli strains 
For short time storage, E. Coli was expanded overnight at 37°C on agar plates 
and subsequently kept at 4°C. For long-term storage, 500 µl of a bacteria 
suspension were mixed with 87 % glycerol and stored in special glass vials at -
80°C. 
6.5.6 Small scale plasmid DNA isolation 
STET buffer 80g/l Sucrose; 0,5% Triton X100; 50 mM EDTA; 10 
mM tris/HCl pH8,0 
TE buffer   0,1 mM EDTA;10 mM Tris/HCL, pH 8,0 
Lysozyme   10 mg/ml lysozyme in TE buffer 
Ammonium acetate 8 M NH4OAc 
TE RNase   10 µg/ml RNase A in TE buffer 
2 ml of LB medium containing the respective antibiotic(s) are inoculated with 
the bacteria containing the desired plasmid DNA. Those are cultivated under 
shaking at 37°C for 12 – 16 h. Afterwards, the bacteria are transferred to 
eppendorf tubes and centrifuged for 1 min at 13.000 rpm. Then cells are 
resuspended in 500 l of STET buffer and 50 µl lysozyme are added. The mixture 
is carefully mixed and after 2 – 3 min of room temperature incubation, the 
reaction is heat inactivated at 95°C for 90 sec. The viscous pellet is removed 
using a toothpick. 50 µl of ammonium acetate and 500 µl of isopropanol are 
mixed with the left solution and carefully mixed. Then, the mixture is 
centrifuged at 13000 rpm for 5 min. The supernatant is decanted and after air-
drying, the pellet is dissolved in 50 µl TE-RNase (according to Maniatis et al, 
1982). 
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6.5.7 Large-scale plasmid DNA isolation 
For large-scale isolation of plasmid DNA, the Plasmid Maxi Kit from Qiagen, 
the PureYield Plasmid Midiprep from Promega or the PhoenIX
TM
 Filter 
Maxiprep Kit (Qbiogene) was used according to the manufacturer‟s instructions. 
200 ml LB medium containing the appropriate antibiotic were inoculated with 
the desired bacteria and incubated overnight at 37°C (180 rpm). Centrifugation 
at 4500 rpm was performed for at 4°C 20 min to pellet the bacteria (GS3 rotor). 
The pellets were treated as described in the kit‟s manual and DNA was finally 
dissolved in an appropriate amount of TE buffer. 
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6.6 Culture and manipulation of eukaryotic cells 
6.6.1 Cell lines used 
NIH3T3: embryonic mouse fibroblast (MEF) cell line, ATCC CRL 1658 
HEK-293T: human embryonic kidney cell line transformed by adenovirus type 5 
(DSMZ ACC 110), into which the temperature sensitive gene for 
SV40 T-antigen was inserted 
6.6.2 Media components 
DMEM    13.63 g/L DMEM powder (Sigma), 3.67 g/L  
(Dulbecco‟s Modified   (44 mM) NaHCO3, 2.6 g/L 10mM HEPES, pH  
Eagle‟s Medium)    7.2 
PBS 140 mM NaCL, 27 mM KCl, 7.2 mM Na2HPO4, 
14.7 mM KH2PO4, pH 6.8-7.0 
TEP (trypsin EDTA)  6 mM EDTA, 0.1 % trypsin (Gibco) in PBS  
100 x Pen/Strep 6.06 mg/ml ampicillin (10,000 U/ml), 10 mg/ml 
streptomycin, set pH to 7.4 by addition of NaOH 
for dissolving (stored at –20°C) 
100 x Glutamine 29.23 mg/ml glutamine, filter sterile, (stored at –
20°C) 
FCS (Fetal Calf Serum)  Lonza 
G418 100 mg/ml G418 in ddH2O, filter sterile, (stored 
at -20°C) 
Puromycin 5 mg/ml Puromycin in ddH2O, filter sterile, 
(stored at -20°C) 
Hygromycin 480 U/µL Hygromycin in ddH2O, filter sterile, 
(stored at 4°C) 
Gentamycin 50 µg/ml (Sigma), (stored at -20°C) 
Doxycycline 2 mg/ml doxycycline-hyclate (Sigma) in 70% 
ethanol, filter sterile, (stored at -20°C) 
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Coumermycin 5 µM in 100 % DMSO, filter sterile, (stored at -
20°C) 
6.6.3 Media composition 
DMEM 3+    1 x Pen/Strep  
1 x Glutamine  
10% FCS  
DMEM 
6.6.4 Supplementation of media with antibiotics 
Strain   Antibiotic   Concentration 
NIH3T3   G418    1 mg/ml 
NIH3T3   Puromycin   2.5 µg/ml 
NIH3T3   Hygromycin  150 - 300 U/ml 
HEK-293T   Puromycin   0.3 µg/ml 
HEK-293T   Hygromycin  300 U/ml 
NIH3T3/HEK-293T Doxycycline  2 µg/ml 
(if not depicted differently) 
NIH3T3/HEK-293T Coumermycin  5 nM 
6.6.5 Cultivation of eukaryotic cells 
Cells are cultivated in appropriate culture plates or flasks at 37°C and 5 % CO2 
at maximal humidity. The medium was changed every 3 – 4 days. Confluent 
cells were passaged into new culture plates or flasks containing fresh DMEM 
3+. For passaging, cells were once washed with PBS and subsequently 
trypsinized for some minutes. Then, cells were removed from the surface by 
thoroughly shaking the cell flask. For the inactivation of trypsine, the cell 
suspension was diluted into 2 volumes of FCS containing medium. Afterwards, 
cells were transferred to a new culture flask containing fresh medium. 
For determination of the cell number, an aliquot of the cell suspension was 
counted with the Casy-1 DT cell counter (Schaerfe Systems, Germany). 
6.6.6 Long-term storage of eukaryotic cells 
For the storage of eukaryotic cells, exponentially growing cells were washed, 
trypsinized and centrifuged (1000 rpm, 5 min). The cell pellet is resuspended in 
cold FCS containing 5 % of DMSO and transferred to Cryo vials (Corning). 
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After 30 min on ice, the vials containing the cell suspension were transferred to 
isolating boxes and stored at -70°C. 1 - 2 d later, cells were transferred into 
liquid nitrogen for long-term storage. 
Thawing of cells was quickly performed in a 37°C water bath since DMSO 
could damage the cells. The cell suspension was diluted into 5 ml of pre-warmed 
DMEM 3+. The suspension was transferred into a 15 ml Falcon tube and 
centrifuged at 1000 rpm for 5 min. Afterwards, the supernatant was removed, 
the cell pellet was resuspended in fresh medium and cells were seeded on a new 
cell culture flask. 
6.6.7 IFN-β stimulation of cells 
Recombinant murine IFN-β was produced in-house using supernatants of stably 
transfected BHK-1 cells. The IFN-β titers were determined by an antiviral assay 
or by a bioassay which is based onNIH3T3 cells stably expressing Mx2-driven 
luciferase (Pulverer, 2008). Standard curves were determined with commercially 
available IFN-β. 
For stimulation of the cells, 500 U/ml were directly added to the supernatant. 
6.6.8 Viral infection 
Prior to virus infection, cells were seeded on appropriate cell culture plates. To 
prevent inhibition of viral replication by FCS, cells were washed three times 
with antibiotic- and FCS-free medium. Infection was also performed in this 
medium. The virus was left on the cells for 1 h and afterwards, cells were again 
washed three times with DMEM3+. 
Newcastle Disease virus (NDV) [20,000 HAU/ml] (Lohmann Tierzucht GmbH, 
Cuxhaven, Germany) was used in 1:250 dilution. 
Influenza A/PR8_FRE_EMG_0901 (provided by Prof. Dr. Klaus Schughart, 
department for infection genetics, Helmholtz Centre for Infection Research, 
Braunschweig) was used at an MOI of 1 or 5. 
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6.6.9 Gene transfer methods 
6.6.9.1 Transfection by calcium phosphate/DNA precipitation 
2 x HEBS buffer 280 mM NaCl, 50mM HEPES, 1.5 mM Na2HPO4, pH 
7.1 (filter sterile) 
CaCl2 solution  2.5 M CaCl2 in ddH2O (filter sterile) 
1 x 10
5
 NIH3T3 or 3 x 10
5
 HEK-293T cells were seeded on a 6-well. The next 
day, the DNA(s) to be transfected were mixed with CaCl2 solution in a 5 ml 
tube (15 µL CaCl2, 1-10 µg DNA und H2O (Σ = 150 µL)). Afterwards, the 
mixture is dropped into 150 µl of 2 x HEBS buffer under vortexing. This 
mixture is then incubated at room temperature (RT) for 3 – 10 min and then 
dropped onto the cells which are subsequently carefully pivoted to dispense the 
solution and then cultured as described before (chapter 5.5.5). One day after 
transfection, medium was changed and selection pressure was imposed 2 days 
after transfection if necessary. 
6.6.9.2 Lipofection 
Transfection was also performed using Metafectene (Biontex Laboratories 
GmbH). 0ne day prior to transfection, cells were seeded as described in chapter 
5.5.9.1. The respective amount of DNA was mixed with 5 µl of Metafectene 
(mixed before use) in 45 µl of DMEM and incubated for 10 - 15 min at RT. This 
mixture was then added to the cells and stored in the incubator. The next day, 
medium was changed and selection pressure was imposed 2 days after 
transfection if necessary. 
6.6.9.3 Infection with lentivirus 
Virus production: 
Medium for production:   1x Pen/Strep, 1x glutamin 
10 % (v/v) FCS 
DMEM 
20 mM HEPES 
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Day 1: 1.2 x 10
6
 HEK-293T cells are seeded on a 55 cm
2
 cell culture 
dish. 
Day 2: HEK-293T cells are transfected with the transfer plasmid as 
well as the helper plasmids (ViraPowerTM Lentiviral 
Expression System, Invitrogen) (table 1) by 
calciumphosphate/DNA precipitation (chapter 5.5.9.1) in 5 
ml of DMEM3+. 
Day 3:  The medium is exchanged for 5 ml of production medium. 
Day 4 and 5: The production medium (virus supernatant) is collected and 
replaced by fresh production medium. After filtration (0.4 µm 
pore diameter, the virus supernatant is immediately frozen at 
-70°C and stored until its use. 
Plasmid                                                 amount 
Transfer plasmid:                                 7.7 µg 
Helper plasmids (Invitrogen): 
pLP1 (gag/pol)                                      5 µg 
pLP2 (rev)                                            1.9 µg  
pVSV-G                                               3.5 µg 
Virus infection: 
The cells to be infected were seeded at a density of 2 x 10
5
 (NIH3T3) on a 55 
cm² dishes. The next day, the virus supernatant is supplemented with 8 µg/ml 
polybrene and administered to those cells. After 24 h, the medium is exchanged 
and 48 h pi, selection and expansion of the transduced cells is induced. 
6.6.10 Isolation of selected clones 
When single colonies were grown up after the respective drug selection, those 
clones were marked at the bottom of the dish. Cell clones were washed with 
PBS and fresh PBS was added to cover the surface of the cell culture plate. A 
microscope was placed under a clean bench and colonies were gently removed 
with a 20 µl Gilson pipette. Cells were transferred to a microtiter plate harboring 
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150 µl of fresh DMEM3+ containing the respective antibiotic and distributed by 
up-and down-pipetting. From this plate, cells are expanded. 
If single clones could not be picked, cells were sorted onto microtiterplates by 
Fluorescence Activated Cell Sorting (FACS, 5.5.11) using FACSVantage or 
FACSAria (Becton Dickinson). The medium within the single wells (each 
150µl) contains 50 µg/ml of gentamycin to avoid contamination of the plates. 
6.6.11 Fluorescence Activated Cell Sorting (FACS) 
FACS was performed to determine amounts and intensities of cells expressing a 
respective fluorescent marker.  
For HaloTag detection, the respective cells were stained overnight with 100 nM 
TMR or with 333 nM for 30 min. Oregon Green was used overnight at a 
concentration of 1 nM. Meanwhile staining, the cells are incubated at 37°C. 
Since the HaloTag ligands are very light-sensitive, all works with it were 
performed in the absence of flashy light. 
For the measurement, cells were washed with PBS, trypsinized and harvested in 
measurement tubes (Sarstedt). After centrifugation (1000 rpm, 5 min), the 
supernatant was removed and the cells were resuspended in FACS buffer (PBS 
containing 2 % FCS). Analysis of the cells was performed in a FACSCalibur 
machine (Becton Dickinson). Debris was eliminated from the analysis by setting 
the forward scatter < 200. 
Sorting of cells was performed with a FACSVentage or FACSAria (Becton 
Dickinson). 
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6.7 Microscopy 
6.7.1 Fluorescence Microscopy 
Fluorescence microscopy allows the visualization of fluorescently labeled 
proteins within a cell. In this work, it was performed with a Zeiss Axiovert 135 
TV microscope. By the use of a mercury arc lamp, the extinction of 
fluorophores could be achieved and visualization occured by the use of Omega 
Optical Filters. 
6.7.2 Time-Lapse Microscopy 
The visualization of single cells or even cell components can be performed 
overtime using a fluorescence microscope in combination with an incubation 
chamber and position automation. 
The respective microscope used in this work uses an Xe-Arc burner excitation 
light source, an automated objective revolver as well as a wheel harboring 
harboring the fluorescent filters (BFP, CFP, eGFP, dsRED, mcherry). The 
objective used in this work was the 20 x (UPLSAPO 20 x immersion oil). 
During the experiments, the cells, seeded on a special microscopy slide (ibidi), 
were applied to the automated PRIOR stage, which was heated to 37°C and was 
verbunden with a CO2 source to provide optimal culture conditions. In order to 
maintain maximal humidity, fresh, destilled water was provided within a 
reservoir every 24 h. 
The cells (10
5
 cells/ml) were seeded onto a collagen IV-treated chambered 
microscopy slide (ibidi, µ-slide 8-well). Using collagen-treated slides, the 
movement of the cells should be inhibited to increase the number of cells resting 
within the determined area during long-term experiments. 
The time series pictures were taken from multiple positions per slide in 20 or 30 
minutes intervals. CellM software (version 3.1) was used for the data acquisition 
and for positioning as well as autofocus function. The autofocus function was 
used on bright field pictures, which were additionally taken at any chosen time 
point and position, to avoid photobleaching effects. 
The image series were analyzed using imageJ software (National Institute of 
Health). Before the analyses, background substraction was equally performed 
for al taken pictures. To facilitate the tracking of single cells in image series as 
well as the measurement of basic track statistics, the plugin MTrackJ (Meijering, 
Biomedical Imaging Group Rotterdam) was used. 
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6.8 Protein analysis 
6.8.1 Preparation of cell extracts 
Cell solubilization buffer 50 mM Tris/HCl pH 7,5, 150 mM NaCl, 2 mM 
EDTA, 1 % Triton, 0,5 % Nonidet p-40 (Sigma), 
100 x Protease Inhibitor Cocktail SetI 
(Calbiochem) 
For the determination of firefly luciferase expression levels, it was necessary to 
extract all water soluble proteins from the cells. To this end, cells were 
harvested from a 6-well and resuspended in 50 µl Tris-HCl (pH 7.6) by 
vortexing. Cells were solubilized by 4 x repeated freeze and thaw cycles in 
liquid nitrogen and a 37°C water bath. Afterwards, centrifugation was performed 
(13.000 rpm, 10 min, 4°C). The supernatant was used for BCA- and luciferase 
assay. 
6.8.2 Luciferase assay 
Luciferase buffer 25 mM glycylglycine, 15 mM MgSO4 in ddH2O, 
pH 7.8 (stored at 4°C) 
ATP solution   5 mM ATP in ddH2O, pH7.5 (stored at –20°C) 
Luciferin solution   0.1 mM synthetic D-luciferin (Promega), 25 mM  
glycylglycine in ddH2O, pH 7,8 (stored at –
20°C) 
Reaction buffer   1:5 ATP solution: luciferase buffer 
The oxidation of D-luciferin to oxyluciferin is catalyzed by firefly luciferase. 
Emitted photons are detected for the determination of expression levels of the 
luciferase reporter gene. 
For the luminometric assay, 10 µl of the protein supernatant from chapter 5.6.1 
was added to 400 µl of of the reaction buffer. 50 µl of luciferin were injected at 
the luminometer. Light of 610 nm is emitted since luciferase utilizes luciferin as 
a substrate and detection occurs via the luminometer. 
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6.8.3 BCA assay 
(according to Smith et al, 1985) 
BCA A solution   1 g bicinchoninic acid 
1.71 g Na2CO3 
0.95 g NaHCO3 
0.16 g Na2Tartrat 
100 ml ddH2O 
pH set to 11.25 with 10 N NaOH (stored at 4°C) 
BCA B solution 4 g CuSO4 x 5 H2O/100 ml dissolved in ddH2O 
(stored at 4°C) 
Reaction solution   98 % BCA A, 2 % BCA B, freshly prepared 
Protein standard   3 mg/ml lysozyme in ddH2O (stored at –20°C) 
The protein content of the luciferase samples (chapter 5.6.2) or samples used for 
the Western Blot (chapter 5.8.3) was determined by a BCA assay. By relating 
them to the total protein content of the luciferase samples, the results for them 
were normalized. Equal amounts of protein levels were calculated and used for 
the Western Blot. 
Into the first row of a 96-well microtiter plate for optical tests, each 190 µl of the 
reaction solution was pipetted into the wells. Into the other rows each 100 µl of 
the reaction solution were added. In order to determine the background signal of 
the reaction, 10 µl of Tris-HCl (pH 7.6) were pipetted into the first well of the 
first row. To the right, 10 µl of the protein standard were added. Into the other 
wells of the first row, each 10 µl of a protein sample are given. In each well, the 
solution is carefully mixed by up- and down-pipetting via a multichannel 
pipette, avoiding bubble formation, and 100 µl of the first row are then 
transferred and mixed with the reaction solution in the second row. This 
procedure was repeated until the last row was reached and final 100 µl were 
discarded so that each well harbors 100 µl in the end. Then, the plate was 
incubated at 37°C for 30 – 60 min and absorption was measured at 595 nm by a 
Multiskan EX reader (Thermo Electron Corporation). Background levels (first 
column) were automatically subtracted and protein contents were calculated on 
the basis of a calibration curve. 
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6.8.4 SDS Polyacrylamide gel electrophoresis 
Preparation of the cell lysate: 
Table 1: Composition of cell lysis (RIPA) buffer 
Substance Concentration 
of stock solution 
Target 
concentration 
Volume 
Tris-HCl, pH 7.5 1 M 10 mM 2 ml 
NaCl 4 M 150 mM 7.5 ml 
Triton X-100 100 % 1 % 2 ml 
SDS 10 % 0.1 % 2 ml 
Deoxycholic Acid = Na-
Deoxycholat 
10 % 1 % 20 ml 
DTT 1 M 1 mM 0.2 ml 
Na3VO4 1 M 1 mM 0.2 ml 
NaF 1 M 1 mM 0.2 ml 
PICIII - 1/1000 0.2 ml 
ddH20 - - 165.7 ml 
Total volume 200 ml 
*DTT, Na3VO4, NaF and PICIII have to be freshly added 
The cell pellets were lysed in 40 µl RIPA buffer and incubated for 20 min at 
4°C. Afterwards, centrifugation was performed at 13.000 rpm and 4°C for 10 
min. The supernatant was further used. 
Performance of SDS-PAGE 
Separating gel 14.4 ml acrylamid (30 %), 11.1 ml 1.5 M 
Tris-HCL (pH 8.8), 450 µl 10 % SDS, 225 
µl 10 % APS, 18.9 ml ddH2O, 18 µl 
TEMED 
Stacking gel 2 ml acrylamid (30 %), 4 ml 0.5 M Tris-
HCL (pH 6.8), 160 µl 10 % SDS, 160 µl 
10 % APS, 9.6 ml ddH2O, 16 µl TEMED 
SDS-PAGE running   144 g glycin, 30.3 g Tris, 10 g SDS, made 
buffer (10 x)    up with ddH2O to 1l 
SDS-polyacrylamide gel electrophoresis (Laemmli 1970) is used to separate 
proteins in a polyacrylamide gel matrix. This occurs according to their size. 
Before the samples are applied on a gel, a sample buffer, containing SDS as an 
anionic detergent that denatures proteins and charges them negatively is 
administered (NuPAGE® LDS sample buffer, Invitrogen). Consequently, the 
proteins are separated by electrophoresis without the influence of protein charge 
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and conformation. The Polyacrylamide gels used in this work consist of a 
stacking and a separating gel (10%). They were prepared of different 
polyacrylamide concentrations and with buffers of different pHs. By this 
method, the proteins are focused on the border between the two gels to 
guarantee an equal starting point for the proteins. Gel electrophoresis was 
performed in vertical electrophoresis chambers by BioRad (Protean II XL). 
After polymerisation of the gel, combs were removed and the slots were washed 
with SDS running buffer. The supernatant of each sample was mixed with SDS 
loading buffer and boiled at 95°C for 5 min to fully denature proteins. 
Afterwards, equivalent protein values (30 µg) were applied to each chamber of 
the gel, which is assembled in the electrophoresis chamber. A prestained 
Molecular Weight marker (Invitrogen, Benchmark
TM
 pre-stained protein ladder) 
was placed at the beginning and at the end of the gel. 
The gel run was performed in 1 x SDS-PAGE running buffer at 100 – 120 mA 
for 2 – 2.5 h. 
6.8.5 Western Blotting 
TBS   20 mM TRIS pH 7.5, 150 mM NaCl 
TBST   TBS, 0.05% TWEEN-20 
TBSTM  TBST, 5% non-fat dry milk 
In order to detect the desired proteins, Western blotting was performed using the 
Bio-Rad Trans-Blot Cell. For this reason, they were transferred to a 
nitrocellulose membrane (Amersham Biosciences; Towbin et al, 1979). The 
membrane was activated by 15 s incubation in methanol. The membrane was 
placed face-to-face with the gel and enclosed by whatman paper as well as fiber 
pads which were soaked with transblot buffer before. The blot cell was placed in 
a blotting tank filled with transblot buffer with the membrane facing the anode. 
Blotting was performed in a 4°C room at 300 mA for 2 – 3 h. Afterwards, the 
membrane was washed 3 x with TBST and 1 x with TBS for each 5 min. Then, 
the membrane was blocked with TBSTM for 1 h at RT or overnight at 4°C in 
order to saturate unspecific protein interactions. Then, TBSTM was removed 
and replaced by a 1:500 dilution of the primary antibody (anti-NS1, sc-130568, 
Santa Cruz Biotechnology) in 20 ml of fresh TBSTM. After overnight 
incubation at 4°C, the membrane was washed as described before and then 
incubated for 1 h in a 1:20.000 dilution of the secondary antibody, an anti-
mouse HRP conjugate, in TBSTM. Another washing step as described before 
was performed. Detection of the protein was performed in a BioRad ChemiDoc 
XRS system after administration of the detection reagent (Lumigen TMA-6). 
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Acquisition and quantification of the data was performed using the Quantity 
One program. 
Membrane stripping: 
To reuse the membrane for a second round of protein detection, antibody 
bindings had to be solved. For this reason, the membrane was 1 x washed with 
TBST and 1 x with TBS for 5 min at RT and the membrane was incubated with 
20 ml of 1 x strip reagent (ReBlot Plus Mild Antibody stripping solution, 
Millipore) for 15 min at RT. Afterwards washing was performed by 3 x 
incubation with TBST and 1 x with TBS. Blocking and antibody staining were 
performed as described above, despite the antibody concentrations. For the 
primary antibody (anti actin HRP conjugate, Calbiochem) a dilution of 1:15.000 
was used and for the secondary antibody (same as above), a 1:5000 dilution was 
used. 
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7 Vectors and Oligonucleotides 
7.1 Applied vectors 
pCCLEF1aPuroKRABrtTA3  Schulze, HZI (2008) 
(#3561) 
pCMVBL-IRF3-5D   (Lin et al, 1999) 
(#1908) 
pCMVKRAB    (Forster et al, 1999) 
(#2271) 
pCMVRTA2HYG    May, HZI (2002) 
(#2288) 
pCuR.luc.HTV7    Promega 
(#3248) 
pFK_i389lucEI.JFH1 dGDD  Th. Pietschmann, TWINCORE 
(#3484) 
pFK-JFH1/wt_dg    Th. Pietschmann, TWINCORE 
(#3578) 
pNS1.S8.SS2.NIBSC   Timo Frensing, MPI Magdeburg 
(#3579) 
pTREtight     Clontech 
(#3891) 
pturboGFP-PRL-dest1   Evrogen 
(#3863) 
pturboRFP.dest1    Evrogen 
(#3882) 
pCR-Blunt     Invitrogen 
pUHD13-3     (Gossen & Bujard, 1992) 
(#947) 
pUHRT62-1    (Urlinger et al, 2000) 
(#2209) 
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7.2 Cloned vectors 
pTet-Unit2   Tet-Unit-encoding construct: 
(#4024) The vector ptet.tGFPest (#4025) was cut with 
SalI and filled in by Klenow. pTet-Unit (#3879) 
was cut with XhoI and ScaI and filled in with 
Klenow. The 5234 bp fragment of pTet-Unit 
containing hyg, EMCV IRES, tTA, PbidiTet and 
CouTA was ligated into the backbone of 
ptet.tGFPest. 
pbidi.Cou-Unit   Cou-Unit-encoding construct: 
(#4023) The vector pbidi.Cou (#3883) was cut with 
HindIII and XhoI (loss of TurboGFP) and was 
filled in by Klenow. pCou-Unit (#3878) was cut 
with SmaI and HindIII and was filled in by 
Klenow. The 1048 bp fragment containing 
KRAB was ligated into the pbidi.Cou backbone. 
pKrab.PGK.puro   KRAB-expressing construct: 
(#3860) The vector pKrab.rtTA2.PGK.Puro (#3880) was 
cut with SnaBI and NotI (loss of rtTA2). 
Overhanging ends were blunted by Klenow and 
religation was performed. 
pCMV.CouTA.puro  CouTA-expressing vector: 
(#3877)    The vector prtTA2.Krab.PGK.Puro (#3861)  
was cut with HpaI (loss of rtTA2, EMCV IRES, 
KRAB and part of SV40 polyA). The vector 
pTETproCurTA (#3368) was cut with BamHI 
and HpaI. Overhanging ends were filled in by 
Klenow. The 1878 bp fragment containing the 
CouTA and the complementing part of SV40 
polyA was ligated to the backbone of 
prtTA2.Krab.PGK.Puro. 
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ptight.NS1-HTV7   NS1-H-expressing construct: 
(#4019) The vector pTREtight.Hyg (#4018) was cut with 
MluI and EcoRV. The vector ptet.NS1-
HTV7delta neo (#3874) was cut with XbaI and 
filled in by Klenow. It was further digested with 
MluI. The 1661 bp fragment containing NS1-H 
was ligated to the backbone of pTREtight.Hyg. 
 
prtTA2.PGK.puro   rtTA2-expressing construct: 
(#4022) The vector prtTA2.Krab.PGK.puro (#3861) was 
cut with AvrII and NotI (loss of KRAB). 
Overhanging ends were filled in by Klenow. The 
vector was religated. 
ptet.NS1-HTV7   NS1-H-expressing construct: 
(#3589) The vector ptet.Core (#3584) was digested with 
MluI and NotI (loss of core). pconst.NS1-HTV7 
(#3582) was cut with MluI and NotI. The 1772 
bp fragment containing NS1-H was ligated to the 
backbone of ptet.Core. 
ptet.NS3/4A-HTV7 NS3/4A-H-expressing construct: 
(#3587) The vector ptet.NS1-HTV7 (#3589) was 
digested with MluI and BglII (loss of NS1). A 
PCR fragment was amplified with the Primers 
NS3/4A_3' (# 3754) and NS3/4A_5' (# 3755) 
using pFK_i389lucEI JFH1 dGDD (# 3484) as a 
template. This fragment was filled in by Klenow 
and ligated with pCR-Blunt (Invitrogen).The 
target sequence was excised by cutting with MluI 
and BamHI and ligated with the backbone of 
ptet.NS1-HTV7, thereby fusing NS3/4A to 
HaloTag V7. 
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ptet.NS3/4A-HTV7Δneo NS3/4A-H-expressing construct: 
(#3869) The vector ptet.NS3/4A-HTV7 (#3587) was 
digested with BstBI and PstI and overhanging 
ends were filled in by Klenow reaction. The 
3708 bp fragment was ligated to the 2345 bp 
fragment of ptet.NS1 (#3588) which was 
digested with AatII and NheI and filled in by 
Klenow reaction. 
ptet.NS3/4A-HTV7Δneo NS3/4A-H-expressing construct: 
(#3869) The vector ptet.NS1 (#3588) was digested with 
AatII and NheI (loss of neomycin 
phosphotransferase, PbidiTet and NS1) and filled 
in by Klenow. The vector ptet.NS3/4A-HTV7 
(#3587) was digested with BstBI and PstI and 
overhanging ends were filled in by Klenow 
reaction. The 3708 bp fragment containing 
PbidiTet and NS3/4A-H was ligated to the 
backbone of ptet.NS1. 
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7.3 Oligonucleotides 
pNS1 3„ (#3760): 
5‟ GGAACAATTAGGTCAGAAGTTTGGCAGATCTTCGCGACTAGCGGC 
CGCAAATTAA 3‟ 
pNS1 5„ (#3761): 
5‟ TTAATTTCGATCGACGCGTCCATGGATCCAAACACTGTGTCAAG 
C 3‟ 
pNS3/4A 3„ (#3754): 
5‟ GCTTTTGATGAGATGGAGGAATGCGGGATCCTCGCGACTAGCGGC 
CGCAAATTAA 3‟ 
pNS3/4A 5„ (#3755): 
5‟ TTAATTTCGATCGACGCGTCCATGGCTCCCATCACTGCTTATGC 3‟ 
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8 Appendix 
8.1 Abbreviations 
α   alpha 
β   beta 
γ   gamma 
δ   delta 
ε   epsilon 
κ   kappa 
λ   lambda 
μ   my and micro 
ω   omega 
 
aa   amino acids 
ATP   adenosintriphoshate 
a.u.   arbitrary units 
 
BAC   bacterial artificial chromosome 
bp   base pair 
β-gal   β-galactosidase 
 
C-terminus  carboxy-terminus 
CARD  caspase recruitment domain 
CAT   chloramphenicol acetyltransferase 
CBP   CREB-binding protein 
CFP   cyan fluorescent protein 
CMV   cytomegalovirus 
Cou   Coumermycin 
CouTA  coumermycin transactivator 
CpG   cytosine phosphatidyl guanine 
 
Da   dalton 
DC   dendritic cell 
DMEM  Dulbecco's modified Eagle's medium 
DNA   desoxyribonucleic acid 
dNTP   desoxynucleotide triphosphate 
Dox   doxycycline 
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dsRNA  double-stranded RNA 
 
E. coli  Escherichia coli 
eGFP   enhanced GFP 
EMCV  encephalomyocarditis virus 
 
FACS  fluorescence activated cell sorting 
FCS   fetal calf serum 
Fig.   figure 
 
G418   aminoglycosid-2´-deoxystreptin 
GFP   green fluorescent protein 
GOI   gene of interest 
GTPase  guanosine triphosphatase 
GyrB   gyrase B subunit 
 
h   hours 
HAU   haemagglutinating unit 
HCV   hepatitis C virus 
HMG   high-mobility group 
HTV7  HaloTag V7 
Hyg   hygromycin phosphotransferase 
 
IAV   influenza A virus 
IFN   interferon 
IFNAR  IFN-α receptor 
IKK   IκB kinase 
IPS-1   IFN-β promoter stimulator 
IRAK   IL-1-receptor-associated kinase 
IRF   IFN regulatory factor 
ISG   IFN stimulated gene 
ISGF   IFN stimulated gene factor 
ISRE   IFN stimulated response elements 
 
JAK   Janus activated kinase 
 
KRAB  Krüppel-associated box 
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L   liter 
LGP-2  laboratory of genetics and physiology-2 
LIF   leukemia inhibitory factor 
LPS   lipopolysaccharide   
Luc   luciferase 
 
m   milli or meter 
M   molarity 
mCherry  monomeric Cherry (red fluorescent protein) 
MDA-5  melanoma-differentiation-associated gene 5 
MDCK  Madin-Darby canine kidney 
MEF   murine embryonic fibroblast 
min   minute 
MOI   multiplicity of infection 
mRNA  messenger RNA 
Mx   myxovirus resistance gene 
MyD88  myeloid differentiation primary-response gene 88 
 
n   nano 
N-terminus  amino terminus 
NDV   Newcastle disease virus 
NF-κB  nuclear factor κB 
NS   non-structural protein 
NS1-H  fusion of NS1 to HaloTag V7 
NS3/4A-H  fusion of NS3/4A to HaloTag V7 
NLS   nuclear localization signal 
NoLS   nucleolar localization signal 
NTR   Non-translated region 
 
OAS   oligoadenylate synthetase 
OD   optical density 
OG   Oregon Green 
ORF   open reading frame 
 
p   piko 
PABPII  poly(A)-binding protein II 
PAMP  pathogen-associated molecular pattern 
PbidiTet   bidirectional tetracycline-responsive promoter 
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PBS   phosphate buffer saline 
PCR   polymerase chain reaction 
PCou   coumermycin-responsive promoter 
PGK   phosphoglycerate kinase 
PhCMV*  human minimal Cytomegalus promoter 
PKR   protein kinase R 
polyA  polyadenylation signal 
poly I:C  polyinosinic-polycytidylic acid 
PR8   influenza A/PR/8/34 
PRR   pathogen recognition receptor 
PTet   tetracycline-responsive promoter 
PTight   tight tetracycline-responsive promoter 
 
RFP   Red fluorescent protein 
RIG-I   retinoic-acid-inducible gene I 
RLR   RIG-I-like receptors 
RMCE  recombinase-mediated cassette exchange 
RNA   ribonucleic acid 
RNAi   RNA interference 
RNase  ribonuclease 
Rpm   rounds per minute 
RT   room temperature 
rtTA   reverse tetracycline transactivator 
 
s   second 
ssRNA  single-stranded RNA 
SD   standard deviation 
SDS   sodium dodecyl sulfate 
SOCS  suppressor of cytokine signaling 
STAT  signal transducer and activator of transcription 
STING  stimulator of IFN genes 
SV40   simian virus 40 
 
TBK-1  TANK-binding kinase 1 
tdTomato  tandem dimer Tomato 
Tet   tetracycline 
tetO   tetracycline operator 
Tet-On  tetracycline-dependent expression system 
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Tet-Off  tetracycline-dependent expression system 
tetR   tetracycline repressor 
tGFP   destabilized turbo green fluorescent protein 
TurboGFP  Turbo green fluorescent protein 
tRFP   destabilized turbo red fluorescent protein 
TIR   TLR-interleukin-1 receptor 
TLR   toll-like receptor 
TMR   Tetramethylrhodamin 
TNFα   tumor necrosis factor alpha 
TRAF  TNF-receptor associated factor 
TRIF   TIR-domain-containing adapter-inducing interferon-β 
TRIM25  tripartite-motif 25 
Tris   tris-hydroxymethyl-aminomethan 
tTA   tetracycline transactivator 
Tyk2   tyrosin kinase 2 
 
U   unit 
 
YFP   yellow fluorescent protein 
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